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An Interface of the Taste and Reward Systems in the Brainstem and Its Role in 
Feeding 
Abstract 
We eat what tastes good. We also eat because it is necessary for our health. In fact, some of the most 
nutritious foods (e.g., vegetables) are often less appetizing, and the tastiest (e.g., fast food, ice cream) 
may be the least healthy. Despite the former, we may also have a lower limit of what we accept at which 
point nutrition becomes irrelevant (e.g., “spinach is just too yucky”). Further, we may eat unhealthily 
because of overwhelming urges. We investigated the complex interactions of taste and feeding at the 
neurobiological level using the experiments described. 
In one sense, this neurobiology begins at the periphery with information about ingested substances (i.e., 
presumably food) being sent to central nuclei. The taste pathways provide one of these routes to the 
central nervous system. In terms of regulating feeding, we have the neurobiological substrates for urge, 
pleasure, and displeasure. The relationship of the dopamine (DA) system with reward is well-known, and 
indeed, studies have shown taste nuclei project to these areas. 
Since earlier studies and data collected in our lab showed that the neurons of the parabrachial nucleus 
(PBN) projected to the ventral tegmental area (VTA), and lesioning the PBN attenuates taste-elicited 
release of DA in the nucleus accumbens, we hypothesized this connection plays a crucial role in the 
control of feeding, especially with regard to the processing of both appetitive and aversive stimuli, and the 
relationship of this processing to classical reward circuitry. We therefore utilized a number of 
neuroanatomical and behavioral techniques to probe taste and intake-related activity in the PBN, VTA, and 
the PBN-to-VTA circuit. The overarching goal was to contribute to a comprehensive understanding of the 
taste and reward neural mechanisms that mediate feeding. 
We used a variety of immunohistochemical methods to test our hypotheses, including one measuring c-
Fos-like immunoreactivity (FLI) in neurons (a measure that correlates with neuronal activation in some 
systems such as taste). Intraoral stimuli increased FLI in the PBN across a number of subnuclei, and in 
this case, we used a diaminobenzidine stain (DAB) with brightfield microscopy. Comparing C57BL6/J (B6) 
with mice lacking TRPM5 (KO) showed that some of this increase is driven by taste receptor input, but 
this effect is predominantly for quinine hydrochloride (QHCl). On the other hand, increases in FLI to 
sucrose (relative to water) in the lateral PBN were the same for both B6 and KO mice, leading to the 
conclusion that this FLI may be visceral in nature. Sucrose-elicited FLI in the external lateral subnucleus 
(el) was probably visceral, whereas QHCl-elicited FLI there was taste-related. We also combined 
measurement of FLI with retrograde tracing under fluorescent microscopy to compare activity in PBN 
projections to the VTA and gustatory thalamus (VPMpc). Retrograde tracing revealed two largely 
independent projections, with VTA-projecting neurons found more contralaterally, and VPMpc-projecting 
neurons found ipsilaterally. However, both types of cells are found in the caudal, gustatory “waist” portion 
of the PBN. Interestingly, there is a lack of VTA-projecting cells in the el. Patterns of FLI were consistent 
with the DAB 
experiment, except with higher expression as compared to water in this fluorescent experiment in a few 
subnuclei. This may have been due to methodological differences. As for double-labeled cells, more VTA-
projecting cells expressed FLI in response to sucrose or QHCl than to water; this numbered to only about 
5% of cells, however, and did not differ according to side. This was compared to double-labeling in 
VPMpc- projecting cells, where the percent of tracer was around 10% for both QHCl and sucrose on the 
ipsilateral side and 5% on the contralateral side. 
We looked at FLI throughout the VTA as well to see if the activity indicated there was a differential 
response to stimuli with varying taste valence. First, using the same intraorally-stimulated mice with DAB-
stained sections, we observed FLI in the VTA. It did not occur in a stimulus-specific fashion and 
apparently not in a taste-dependent fashion (no significant differences between B6 and KO). In another 
experiment using fluorescent stains and confocal microscopy, we looked at the FLI in the VTA while 
delineating it by subnuclei, counting section by section, and identifying DA and GABA cell types. There 
were many more DA cells in the VTA than GABA cells, and they had distinct patterns of expression across 
subnuclei and section levels (i.e., within the anteroposterior [AP] dimension). The rostromedial tegmental 
area was located as a region with higher GABA cell expression. More DA cells were double-labeled with 
FLI for QHCl than for water or sucrose in the caudal linear nucleus of the raphe. Few GABA cells were 
double-labeled with FLI. 
To show the PBN-to-VTA circuit’s role in taste-mediated feeding, we attempted a procedure that would 
selectively activate VTA-projecting PBN neurons using designer receptors exclusively activated by 
designer drugs (DREADDs). However, we were unable to verify the efficacy of clozapine-N-oxide to 
activate the circuit and opted for an alternative manipulation. We instead inhibited the VTA with direct 
injections of the GABA agonist, muscimol. This resulted in mice reducing their licking (relative to 
baseline) of sucralose, but not QHCl or water (i.e., an arrangement of non-caloric stimuli with palatable, 
aversive, and neutral valence). Muscimol also reduced licking of sucrose and QHCl-adulterated sucrose 
(i.e., caloric stimuli). The reduction in licking to caloric stimuli was accompanied by a decrease in the rate 
of intake, i.e., muscimol-inhibited mice slowed their lick rate and possibly stopped licking sooner 
compared to vehicle- injected controls. 
Overall, this project confirmed that both the PBN and VTA function to communicate taste and reward 
information. Although the PBN-to-VTA circuit’s function remained elusive, the evidence of the direct path 
connecting these two nuclei was fortified. Further, to our knowledge, this was the first time evidence was 
found of its existence as a PBN projection pathway that is mostly separate from the projection to the 
gustatory thalamus. Combined with the knowledge of this circuit, the activity in these nuclei and the 
ability to affect consumption by inactivating the VTA suggest the PBN and VTA work together to influence 








John D. Boughter, Ph.D. 
Keywords 
Addiction, Dopamine, Eating, GABA, Gustation, Obesity 
Subject Categories 
Biochemical Phenomena, Metabolism, and Nutrition | Medical Biochemistry | Medical Sciences | Medicine 
and Health Sciences | Neurosciences 
















The Graduate Studies Council 
The University of Tennessee 







In Partial Fulfillment 
Of the Requirements for the Degree 
Doctor of Philosophy 











































Copyright © 2018 by Louis Saites. 












 I start with my mentor, Dr. John Boughter, who welcomed me into his lab as well 
as his home. I met Dr. Boughter while taking his Behavioral Neuroscience class and 
enjoyed his enthusiastic approach to teaching. Later, I would come to Dr. Boughter to 
complete the final official rotation allowed by our graduate program. I was seeking a lab 
in which to study addiction, and he made it clear that was not something which his lab 
researched. Still, he agreed to let me rotate. To my delight on the first day of the rotation, 
I was given a 12-inch stack of articles and told to propose a project studying the overlap 
of reward (a phenomenon related to addiction) and taste (the broad field Dr. Boughter’s 
lab studies). I happily accepted the challenge and welcomed the opportunity to foster my 
independence. This rotation assignment launched me into the trek that would culminate 
into the work presented in this dissertation. As if providing an awesome lab in which to 
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teaching me immunohistochemistry and offering critical insight. Dr. Jennifer Saputra, I 
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Jordan Ross. Dr. Fletcher, I do not know how Chapter 8 would have turned out had you 
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mice brains, and the use of your lab space for some of my last dissertation experiments. 
Jordan, thank you for teaching me how to use the microsyringe pump and lending me 
your headscrews. 
 
 Finally, to all my family and friends, to whom this dissertation is dedicated, there 
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please know you all mean so much to me. For all the moments of patience, 
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 We eat what tastes good. We also eat because it is necessary for our health. In 
fact, some of the most nutritious foods (e.g., vegetables) are often less appetizing, and the 
tastiest (e.g., fast food, ice cream) may be the least healthy. Despite the former, we may 
also have a lower limit of what we accept at which point nutrition becomes irrelevant 
(e.g., “spinach is just too yucky”). Further, we may eat unhealthily because of 
overwhelming urges. We investigated the complex interactions of taste and feeding at the 
neurobiological level using the experiments described. 
 
 In one sense, this neurobiology begins at the periphery with information about 
ingested substances (i.e., presumably food) being sent to central nuclei. The taste 
pathways provide one of these routes to the central nervous system. In terms of regulating 
feeding, we have the neurobiological substrates for urge, pleasure, and displeasure. The 
relationship of the dopamine (DA) system with reward is well-known, and indeed, studies 
have shown taste nuclei project to these areas. 
 
 Since earlier studies and data collected in our lab showed that the neurons of the 
parabrachial nucleus (PBN) projected to the ventral tegmental area (VTA), and lesioning 
the PBN attenuates taste-elicited release of DA in the nucleus accumbens, we 
hypothesized this connection plays a crucial role in the control of feeding, especially with 
regard to the processing of both appetitive and aversive stimuli, and the relationship of 
this processing to classical reward circuitry. We therefore utilized a number of 
neuroanatomical and behavioral techniques to probe taste and intake-related activity in 
the PBN, VTA, and the PBN-to-VTA circuit. The overarching goal was to contribute to a 
comprehensive understanding of the taste and reward neural mechanisms that mediate 
feeding. 
 
 We used a variety of immunohistochemical methods to test our hypotheses, 
including one measuring c-Fos-like immunoreactivity (FLI) in neurons (a measure that 
correlates with neuronal activation in some systems such as taste). Intraoral stimuli 
increased FLI in the PBN across a number of subnuclei, and in this case, we used a 
diaminobenzidine stain (DAB) with brightfield microscopy. Comparing C57BL6/J (B6) 
with mice lacking TRPM5 (KO) showed that some of this increase is driven by taste 
receptor input, but this effect is predominantly for quinine hydrochloride (QHCl). On the 
other hand, increases in FLI to sucrose (relative to water) in the lateral PBN were the 
same for both B6 and KO mice, leading to the conclusion that this FLI may be visceral in 
nature. Sucrose-elicited FLI in the external lateral subnucleus (el) was probably visceral, 
whereas QHCl-elicited FLI there was taste-related. We also combined measurement of 
FLI with retrograde tracing under fluorescent microscopy to compare activity in PBN 
projections to the VTA and gustatory thalamus (VPMpc). Retrograde tracing revealed 
two largely independent projections, with VTA-projecting neurons found more 
contralaterally, and VPMpc-projecting neurons found ipsilaterally. However, both types 
of cells are found in the caudal, gustatory “waist” portion of the PBN. Interestingly, there 
is a lack of VTA-projecting cells in the el. Patterns of FLI were consistent with the DAB 
 
vii 
experiment, except with higher expression as compared to water in this fluorescent 
experiment in a few subnuclei. This may have been due to methodological differences. 
As for double-labeled cells, more VTA-projecting cells expressed FLI in response to 
sucrose or QHCl than to water; this numbered to only about 5% of cells, however, and 
did not differ according to side. This was compared to double-labeling in VPMpc-
projecting cells, where the percent of tracer was around 10% for both QHCl and sucrose 
on the ipsilateral side and 5% on the contralateral side. 
 
 We looked at FLI throughout the VTA as well to see if the activity indicated there 
was a differential response to stimuli with varying taste valence. First, using the same 
intraorally-stimulated mice with DAB-stained sections, we observed FLI in the VTA. It 
did not occur in a stimulus-specific fashion and apparently not in a taste-dependent 
fashion (no significant differences between B6 and KO). In another experiment using 
fluorescent stains and confocal microscopy, we looked at the FLI in the VTA while 
delineating it by subnuclei, counting section by section, and identifying DA and GABA 
cell types. There were many more DA cells in the VTA than GABA cells, and they had 
distinct patterns of expression across subnuclei and section levels (i.e., within the 
anteroposterior [AP] dimension). The rostromedial tegmental area was located as a region 
with higher GABA cell expression. More DA cells were double-labeled with FLI for 
QHCl than for water or sucrose in the caudal linear nucleus of the raphe. Few GABA 
cells were double-labeled with FLI. 
 
 To show the PBN-to-VTA circuit’s role in taste-mediated feeding, we attempted a 
procedure that would selectively activate VTA-projecting PBN neurons using designer 
receptors exclusively activated by designer drugs (DREADDs). However, we were 
unable to verify the efficacy of clozapine-N-oxide to activate the circuit and opted for an 
alternative manipulation. We instead inhibited the VTA with direct injections of the 
GABA agonist, muscimol. This resulted in mice reducing their licking (relative to 
baseline) of sucralose, but not QHCl or water (i.e., an arrangement of non-caloric stimuli 
with palatable, aversive, and neutral valence). Muscimol also reduced licking of sucrose 
and QHCl-adulterated sucrose (i.e., caloric stimuli). The reduction in licking to caloric 
stimuli was accompanied by a decrease in the rate of intake, i.e., muscimol-inhibited 
mice slowed their lick rate and possibly stopped licking sooner compared to vehicle-
injected controls. 
 
 Overall, this project confirmed that both the PBN and VTA function to 
communicate taste and reward information. Although the PBN-to-VTA circuit’s function 
remained elusive, the evidence of the direct path connecting these two nuclei was 
fortified. Further, to our knowledge, this was the first time evidence was found of its 
existence as a PBN projection pathway that is mostly separate from the projection to the 
gustatory thalamus. Combined with the knowledge of this circuit, the activity in these 
nuclei and the ability to affect consumption by inactivating the VTA suggest the PBN and 
VTA work together to influence feeding by detecting and integrating information about 






 The studies of this dissertation set out to investigate the phenomenon of why we 
eat what we eat and test some of the hypotheses derived from this concept by asking 
specific questions in the category, “What is the underlying neurobiology?” Consider two 
scenarios that illustrate how the sense of taste interacts with mechanisms for affect and 
feeding. Both scenarios begin with the organism experiencing the state of hunger and 
subsequent exposure to appetitive pre-ingestive stimulation (e.g., the organism smells 
something it identifies as potentially food). The organism will experience an urge to 
consume the substance and an anticipatory pleasure of alleviating hunger. The point at 
which the organism causes the substance to enter its oral cavity is where the two 
scenarios diverge. In the first scenario, the organism experiences a palatable taste. This 
further elicits pleasure and the urge to swallow. In the second scenario, the organism 
experiences a strongly aversive taste. This opposes the initial appetitive effects, elicits 
displeasure, and reverses the directionality of behavior motivated by urge, causing 
egestion. The neurobiology underlying the markedly differential behavioral responses 
(and the suspected differences in the mediation of its preceding pre-ingestive taste 
sensation and affect) in these two scenarios is the subject of this dissertation. 
 
 The pleasure and displeasure of food tastes are mediated by the reward system, 
and dysfunctions within any of the neurobiology for eating may lead to pathological 
consequences. The ability of addictive drugs to hijack the reward system is well known. 
Drugs disrupt the normal release of dopamine (DA) in response to cues which typically 
prime behavior to consume something which will evoke pleasure. However, as tolerance 
to drugs develops, the pleasure may wane, leaving behind a compulsion to consume 
despite the elevated cost-to-benefit ratio. Interestingly, some substances we call “food” 
actually have scant nutritional value yet taste pleasurable. Because of their ability to elicit 
our affect, these may cause a similar pathological and maladaptive behavioral pattern as 
drugs. The pleasure derived from the food may lower, but if the drive to consume 
remains, feeding may continue despite neither pleasure nor nutrition being present. Such 
a phenomenon blurs the line between drugs and food, but empirical validation of this 
remains scarce. 
 
 The DA system and its mesoaccumbens and nigrostriatal pathways are connected 
to centers for both taste and feeding. Modulation of DA release likely drives urges to 
consume palatable food, pleasurable drugs, and to approach their associated cues. 
Lesioning the parabrachial nucleus (PBN) in the pons of the brainstem disrupts the ability 
of palatable food to elicit DA release in the nucleus accumbens (NAc). Changes in the 
expression of ΔFosB in D1-receptor-expressing GABAergic medium spiny neurons of 
the NAc—a sign that plasticity potentiating addiction has occurred—has also been shown 
to change after the consumption of some foods. In contrast, another change in plasticity 
to palatable foods and addictive drugs actually differentiates these. Similar to cocaine, 
operant responding procedures used for food or sucrose potentiated glutamatergic 
synapses in the ventral tegmental area (VTA); however, these effects were shorter, with 
the ratio of AMPA to NMDA receptors returning to its original expression between 7 
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days and 3 weeks after the last session. Even further, habituation of DA release to food 
rewards occurs in the NAc shell, but not in medial prefrontal cortex and NAc core. 
Chronic, but not acute morphine, can sensitize the NAc shell so that habituation of DA 
release to food reward no longer occurs. This may mean that although food itself cannot 
cause “food addiction” via sensitizing the DA system, the prior use of some addictive 
substances can. 
 
 Paradoxically, feeding behavior can become pathological in either direction. 
Bulimia nervosa (BN) and anorexia nervosa (AN) occur when someone refuses to allow 
food to be ingested or absorbed. Both of these are accepted and defined in the 5th edition 
of the Diagnostics and Statistics Manual (DSM-V) used by psychiatrists. Conversely, 
binge eating disorder (BED) is only considered a research category. Despite BED’s 
nascent status, neurobiological content on taste-mediated feeding is more relevant to the 
pathological effects of overeating; thus, I will briefly direct attention to BED and the 
effects of long-term overeating. 
 
 The first description of BED may have been in the 1990s. The working definition 
proposed that BED is, “eating an amount of food in a discrete period of time that is 
definitely larger than most people would eat in a similar period of time under similar 
circumstances”. Over a lifetime, prevalence of BED is estimated at 3.5% in women and 
2.0% in men. These rates are twice as high as either AN or BN. As might be expected, 
BED is higher in obese individuals. BED has been proposed to parallel Koob and 
LeMoal’s allostatic model of addiction, and extensive evidence indicates the involvement 
of the dopaminergic system in the modulation of feeding. No long term, effective 
treatment for BED has been identified, and BED is associated with obesity and diabetes. 
 
 Moreover, obesity and diabetes come with their own pathologies and may result 
from a lifetime of unhealthy eating habits. Obesity in the United States has skyrocketed 
in the last couple of decades with more than 35% of U.S. adults and about 17% of 
children and adolescents aged 2 – 19 years being obese. Obesity is associated with heart 
disease, stroke, type 2 diabetes, and some kinds of cancer. Obesity is estimated to cost the 
U.S. $147 billion annually, and healthcare costs of obese people are approximately 
$1,429 more than those of individuals with normal weights. Type 2 diabetes is further 
associated with cardiovascular disorders, and left untreated, can cause necrosis of digits 
and appendages. Perhaps the most disturbing aspect of this trend is that these disease 




 Often when feeding is the focus, attention is either on the forebrain or the 
hypothalamus. Yet, we know the VTA is a site of extensive neural convergence, offering 
unparalleled signal processing for the early stages of motor output and behavioral 
determination. Since the PBN, the second relay of the taste system, also located in the 
brainstem, provides some of these inputs, it is reasonable to hypothesize this connection 
may function to partially control feeding. To test this, I designed the project described in 
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this dissertation to investigate the direct neural pathway from the PBN to the VTA and 
whether it provides such functional connectivity to the taste and reward systems. 
 
 First, I want to note that after this preface, I chose to use the collective pronoun 
“we” as opposed to “I”. None of the work done herein was solely completed by me alone, 
as noted in the acknowledgements. Thus, with the team effort invested in completing the 
projects presented, I chose to write my dissertation with a style reflective of this fact. 
However, as these stylistic choices as well as those regarding chapter structure were 
mine, in the preface, I use I/me/my. 
 
 Secondly, I found myself facing the decision of whether to write a dissertation on 
feeding that happened to be influenced by taste via the reward system or on an interaction 
between taste and reward that happened to influence feeding. My decision was to write 
the latter. As such, the following choices about chapter organization were made. 
 
 In the first four chapters, I summarize the history and science of taste, reward, and 
feeding. I begin by defining relevant phenomena and provide examples to ensure a priori 
clarity about the field’s concepts and what I investigated. Further, I introduce the 
background most salient to my experiments, which is elaborated on in the three literature 
review chapters that follow (Chapters 2 - 4). I found that providing the history of the 
science of feeding was most challenging to cover because less had been done to compile 
its philosophical foundation. Thus, the historical perspectives focused on taste and 
reward. The second and third chapters expound the neurobiology of taste and reward, 
respectively. 
 
 The fourth chapter narrows down on the research concerning the PBN and VTA. I 
explain the important anatomical and physiological findings of these areas. I continue by 
pointing out their connectivity, finishing with my proposal to test their collective 
involvement in taste reward and feeding. I conclude this chapter by outlining the aims of 
my experiments. 
 
 Naturally, the fifth through eighth chapters detail the methods used in the 
investigation as well as the results of each. The fifth chapter provides general 
methodology which was used in multiple parts of the experiments that follow. Each of 
chapters six to eight provides more specific methodology as well as what was found 
resulting from investigations into the PBN, VTA, and circuit/nuclei manipulations, 
respectively. 
 
 Chapter nine discusses findings specific to each of the investigations as well as 
relationships of the findings across investigations. After making some final statements 
about the limitations of the methodology, I briefly conclude the discussion by predicting 
the future of this field and philosophizing on this dissertation’s findings.  
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CHAPTER 1.    HISTORICAL PERSPECTIVES ON TASTE AND REWARD, 
AND HOW THEY RELATE TO FEEDING 
 
 
 The influence of taste on feeding is almost so obvious it might be overlooked as a 
matter for scientific inquiry. We eat what tastes good. However, we might also eat less 
appetizing but nutritious foods (e.g., vegetables) and avoid the tastiest but unhealthy 
foods (e.g., fast food, ice cream). Despite the former, we may also have a lower limit of 
what we accept at which point nutrition becomes irrelevant (e.g., “spinach is just too 
yucky”). Further, we may eat unhealthily because of overwhelming urges. We used the 






 To understand how taste influences feeding, we need to begin by defining the 
taste sensory system and the mechanisms that use that information to generate action. In 
this case, the taste system forms the interface between our environment and the affective 
components that later determine decisions about feeding. 
 
 
The Taste Nervous System 
 
 The Greek philosopher, Alcmaeon (5th century B.C.), was one of the earliest 
scholars to suggest a mechanism for how the tongue sensed taste 1. He posited that 
particles entered pores in the tongue to elicit taste in the “sensorium”. Incidentally, he 
also believed the sensorium, and therefore, the perception of taste, was located in the 
brain. As one of the chemical senses, we now know molecules do enter pores in the 
tongue where they can then bind receptors located in the taste buds of papillae 2,3. The 
father of anatomy, Galen (2nd century A.D.), hypothesized the necessity that the 
molecules be solubilized, indicating specifically that the tongue must be moist for it to 
sense properly 1. He also correctly identified the glossopharyngeal nerve as one which 
innervated the tongue and carried taste information centrally. The beginning of the 
alimentary canal contains taste buds, the most peripheral sense organs of this system, 
which are innervated by cranial nerves, beginning the communication of taste 
information centrally 4. Albrecht von Haller (1708 – 1777) was the first to describe 
papillae, the epithelial tongue structures which “house” taste buds 1. Taste buds, 
composed of taste receptor cells (TRCs) and basal cells 2,3, were discovered later by 
Gustav Schwalbe (1844 – 1916) and Otto Christian Lovén (1835 – 1904) 1.  Carlo 
Francesco Bellingeri (1789 – 1848) discovered that the chorda tympani branch of the 
facial nerve conducted taste from the anterior tongue (i.e. from fungiform taste buds) 
more than a millennium after Galen’s identification of the function of the 
glossopharyngeal 1. Discoveries of the taste system’s central pathways began in the 19th 
century with lesion studies in animals 1. These were followed by human neuropsychology 






 The sensory modality of taste is also known as “gustation”. Two aspects of taste 
sensation that can be discerned psychophysically are the basic taste categories (i.e., 
qualities) and taste valence (i.e., the perceptual identification of a taste stimulus' hedonic 
affect) 5. Aristotle (4th century B.C.) correctly identified bitter, salty, sour, and sweet as 
basic tastes, although he also included astringent, harsh, and pungent in his list 1,6,7. A 
fifth taste known as umami (Japanese word meaning “good taste”; refers to a savory taste 
sensation) elicited primarily by certain L-type amino acids was first described by Ikeda in 
1909 8. Having entered the common parlance, umami taste is widely known and accepted 
as a distinct primary taste, perhaps especially following the discovery of specific taste 
receptors for its prototypical stimuli. Whether there is a distinct quality for fat and other 
tastes is still debated. In conjunction with taste, other sensations contribute to perceptions 
of food. Olfaction (i.e., smell) combines with taste to produce flavor, a complex 
perception to which somatosensation (texture) and pain (spicy) may also contribute. 
Although all of these sensations may occur to one substance in the oral cavity, taste is not 
the same as flavor. Interestingly, recent findings have even shown vision and hearing 
may interact with taste 9, but no consensus establishes whether this interaction is 
impacting flavor or a separate and more complex perception. 
 
 Taste is also associated with other psychological phenomena such as affect, 
reward, and motivation. Hedonic impact indicates how palatable or aversive a taste is and 
is measured using taste reactivity 10. In animals with less developed brains, such as 
rodents and young primates, stereotypical facial expressions and behaviors can be used to 
quantify hedonic impact in taste reactivity tests. Positive hedonic impact (i.e., evidence of 
a pleasurable taste) is a necessary component of the development of incentive salience 
related to taste (see below), an attribute of taste stimuli (and associated non-taste stimuli) 
which causes or primes approach and/or ingestion (i.e., makes the taste appetitive). While 
it is known that negative hedonic impact (i.e., evidence of displeasure) of taste stimuli is 
associated with avoidance and/or egestion, no counterpart to incentive salience which 
would cause or prime these behaviors (i.e., make them repulsive) has been identified. The 
positive and negative extremes of hedonic impact might be taken to imply that the 
underlying neurobiology can be sufficiently explained by associating it with one 
dimension of affect, however others link the neurobiological systems with two or more 
orthogonal dimensions. Further attention to the relationship of neurobiology with 
affective dimensions will be given below in the section on reward. 
 
 Care was taken here to avoid conflating one of the sensory aspects of taste, 
valence, with the affective aspect, hedonics (see Table 1-1). (While this hypothetical 
distinction may not ubiquitously align with the terminology used by other researchers, 
attention was paid to ensure these terms were used consistently within this dissertation.) 
In addition to quality, humans and animals can innately sense valence of taste stimuli, the 
two extremes of which are like and dislike. Aristotle may have been the first to identify 
taste valence, as he stated sweet and bitter were the two extremes between which the 
other qualities lay. However, this conceptualization conflates quality and valence. Indeed, 
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Table 1-1. Terms used for taste, reward, and feeding phenomena. 
 
 Terms 
Phenomenon + - 
Perceptual Identification of Taste Stimulus’s 
Hedonic Affect (i.e., Taste Valence) 
Like Dislike 
   
Hedonic Affect Pleasure Displeasure 
   
Salience Incentive Disincentive 
   
Taste Hedonic = HedonicAffect*Taste Palatable Aversive 
   
Taste Salience = TasteHedonic*Urge Appetitive Repulsive 
   
Taste Reactivity (i.e., Facial/Behavioral Expression) Positive Negative 
   
Locomotion Approach Avoidance 
   




one is challenged not to conflate these, as the sensory and affective phenomena are 
typically experienced together. Teasing them apart has only been possible in more recent 
neurobiological experiments capable of specifically inhibiting each of their underlying 
mechanisms 5,10 (see Marks, 2011 11). In this dissertation, taste liking is the sensory 
experience associated with substances that are avidly ingested and elicit pleasure, and 
disliking is associated with substances that are avoided or egested and elicit displeasure. 






 Once the taste system has transduced stimuli from our environment into 
neurochemical signals, our brains can use the information to generate affect. Affect is 
related to reward and emotion, but all three rely on different neurobiology. Nonetheless, 
sensations like taste can contribute to reward and affect, and understanding the affect of 
taste helps explain how this sense contributes to the modulation of feeding. 
 
 
Historical Perspective of Reward 
 
 The first documented ideas about reward date back to four millennia ago when the 
poem “Song of the Harper” was inscribed on the tomb of the Egyptian King Intef 11. Its 
verses lament the finality of death and urge the reader to enjoy the pleasures of life in the 
present. This philosophy came to be known as hedonism. It would later be incorporated 
in the utilitarian theory of Jeremy Bentham (1748 – 1842), an influence on scientific 
thought in the 19th century, including on motivation and reward. Aristotle wrote 
presciently about motivation and pleasure in De Anima and De Sensu 11 . In trying to 
describe how sensory experience relates to knowledge, he asked questions about how to 
measure and qualify pleasure. He wrote about the contingency that can occur with 
conditional pleasures and biological states as when some deprivation states can elicit 
hunger for foods that alleviate that deprivation specifically. This phenomenon would later 
be described by Michel Cabanac as alliesthesia 12. Aristotle also predicted that pleasure 
occurs through different processes than motivation, a hypothesis later confirmed by Kent 
C. Berridge 10. 
 
 The delineation of sensation and reward increased as thinking came to specify 
how the nervous system worked in detail 11. Johannes Müller (1801 – 1858) explained in 
his doctrine of “specific energies of the nerve” that sensations were due to activity in the 
tracts in the brain rather than dependent on the associated modality’s stimuli. Müller’s 
student, Herman von Helmholtz, also implicated pleasure’s independence from stimuli, 
as Müller had of all qualities of sensation. Oswald Külpe further differentiated pleasure, a 
feeling, would be parallel to sensation instead of subsumed by it. 
 
 By the 20th century, the rich understanding of reward coupled with advancing 
techniques allowed science to begin empirically validating these hypotheses about 
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sensation and pleasure 11,13. Leonard Troland introduced beneceptors, nociceptors, and 
neutroceptors, each with a corresponding relationship to its associated stimuli’s benefit or 
harm. He attempted to explain motivation based on how stimuli activated these receptors. 
James Olds and Peter Milner confirmed the ability to drive behavior with electrical brain 
stimulation by training rats to press a bar for administration. Ivan Pavlov had already 
shown classical conditioning could drive dogs to salivate at the sound of a bell. But Olds 
and Milner thought they were providing a neurological explanation for Edward L. 
Thorndike’s Law of Effect, which originally suggested that responses which are 
satisfying (i.e., rewarding) are repeated, a fundamental principle that explains how 
operant conditioning occurs. More importantly, applying Thorndike’s principle indicates 
feeding-related behaviors which are rewarding—whether in a taste or visceral capacity—
will be repeated. 
 
 
Definitions of Reward 
 
 According to Berridge, reward includes distinguishable parts of pleasure, 
learning, and incentive salience 10,14. Rewards are stimuli which themselves elicit 
pleasure or are associated with stimuli that elicit pleasure. Associated rewards attain their 
status through learning. The brain transmitter dopamine (DA) is commonly associated 
with the concept of reward in popular culture, which in turn is often erroneously equated 
with pleasure. For example, consider a current article about “the science of love” on an 
educational neuroscience website (www.youramazingbrain.org 15):  
 
 “…newly ‘love struck’ couples [had] their brains examined and discovered they 
 have high levels of the neurotransmitter dopamine. This chemical stimulates 
 ‘desire and reward’ by triggering an intense rush of pleasure”. 
 
In fact, landmark studies by Wolfram Schultz showed that activity in midbrain DA 
neurons (and their resulting DA release in forebrain targets) encode reward prediction 
error, a result of the learning process which associates inherently pleasurable rewards 
with associated stimuli 16. However, DA is not itself responsible for mediating pleasure 
(see Chapter 3, especially the section titled The Role of the Dopamine System in Reward) 
or the learning process 17. Instead, DA release causes incentive salience, which is an 
attribute of a percept of a stimulus that causes approach and/or consumption of that 
stimulus, or primes the approach and/or consumption of another stimulus. Although 
incentive salience involves the motivational value of a percept of a stimulus, it lacks the 
targeting aspects necessary to guide the approach or consumption directly to that specific 
stimulus. In other words, incentive salience is a general urge to act that happens to occur 
when an organism is exposed to a reward. 
 
 An additional distinction is worth making between pleasure and meaning. The 
ancient Greeks referred to two forms of happiness as hedonia (pleasure or euphoria) and 
eudaimonia (meaningful, contentment, or joy) 18,19. While it is generally accepted that 
rewards are stimuli that elicit pleasure or are associated with stimuli that elicit pleasure, 
meaningful experiences do not fit this definition and may not work through the same 
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neurological mechanism. Eating and sex are inherently pleasurable and lead to the 
development of incentive salience through the DA system’s mechanism described above. 
However, it is not clear how meaningful experiences like those described by Viktor 
Frankl would fit into Berridge’s theory of DA and reward. Frankl describes creating 
works of art and science, nurturing close relationships, and the challenging act of 
choosing to mentally overcome suffering as examples of meaningful experiences 20. 
Nascent evidence from the treatment of depression with serotonin modulators and the 
recreational and medicinal use of psychedelics and entheogens suggests the serotonin 
system underlies the conscious experience of meaning 21-30. Further work may be needed 
to verify that the experience of meaning is due to a separate neurobiological mechanism. 
 
 For this dissertation, feeding and its associated affect are generated in such a way 
that Berridge’s definition of reward is adopted. Some foods happen to elicit pleasure. We 
learn to eat the foods we find pleasurable. The incentive salience of associated cues 
causes or primes us to approach and consume them. However, avoiding and egesting are 
not explained by incentive salience; thus, the addition of an orthogonal dimension of 
affect, displeasure, is necessary. This dissertation extends the general urge to act beyond 
Berridge’s conceptualization to include the driving of behaviors which occurs upon 
exposure to aversive stimuli. The interplay of neurobiological mechanisms associated 
with urge and displeasure is elaborated in Chapter 3. 
 
 
Affect and Sentiment 
 
 To extrapolate on these definitions of reward, a delineation of affect and 
sentiment based on Baruch Spinoza’s Ethics Part III is provided here 31. Sentiments are 
experiences of emotions, and emotions, themselves, are physiological responses to events 
(e.g., the release of epinephrine at the sight of a 12 point buck). While emotion occurs 
subconsciously, sentiment is a conscious experience resulting from the emotion (e.g., 
feeling surprised after epinephrine binds receptors in the hypothalamus). Affect is one of 
three aspects of sentiments and can be isolated from the other two—sensation and 
cognition—according to how they are perceived temporally in relation to their associated 
event (Papanicolaou, personal communication 32). While sensation and cognition are 
identifiable immediately, affect can only be recognized in retrospect (i.e., the sight of the 
buck caused urge). Due to the phenomena associated with affect, one may choose to 
prolong, repeat, prevent, or end an experience (e.g., urge which leads to crouching down, 
stalking, and spearing the buck; pleasure while feeding on venison). An empirical 
validation using neurobiological studies to delineate affect from sentiment is possible but 
outside the scope of this introduction. 
 
 Affect’s relationship with reward is straightforward: Pleasure is one dimension of 
affect and a recognized component of reward. Additional dimensions of affect are 
displeasure, urge, and meaning. Earlier, urge was suggested as halfway to being 
synonymous with Berridge’s incentive salience (by excluding the negative component 
that relates urge to displeasure), and meaning was differentiated from pleasure. The 
neurobiology of pleasure as well as the DA system and urge will be treated in more detail 
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in Chapter 3, and meaning was already indicated as plausibly being mediated by the 
serotonin system. Displeasure seems it could be of the same mechanism as pleasure but 
working in the opposite direction. However, phenomenological evidence suggests it is a 
separate dimension associated with a different neurobiological mechanism. For example, 
one may simultaneously experience pleasure in eating their favorite food and displeasure 
in knowing they will soon have consumed the entire meal. Thus, displeasure may be 
mediated via neural mechanisms other than those that subserve pleasure. 
 
 
Feeding and Reward 
 
 Feeding, or the consumption of nutritious substances (e.g., calories for energy), is 
fundamental to life. We may eat to satisfy metabolic needs (homeostasis), to experience 
pleasure (palatability, ‘liking’), and/or due to an urge/incentive/motivation (appetitive, 
‘wanting’) (Figure 1-1). Feeding (i.e., eating) primarily involves the two stages, hunger 
and satiety, and is influenced by the reward system described above. Depending on their 
affect, tastes are a powerful factor that may increase or decrease feeding. 
 
 Our survival as a species was in part dependent on our ability to feed in effective 
and safe ways. Evolution favored those of us who developed mechanisms that aided these 
processes. Some tastes are inherently aversive (e.g., bitter), and the urge and displeasure 
we experience from these prime or cause us to avoid consuming substances with these 
tastes. For example, the majority of toxins found in nature have bitter, aversive tastes. 
Some tastes are inherently appetitive (e.g., sweet), and the urge and pleasure we 
experience from these prime or cause us to approach and consume substances with these 
tastes. The systems at work promote survival by performing the heuristic function of 
indicating which foods are toxic and which are nutritious. 
 
 The subjects of taste and reward begin to overlap when one considers the 
psychology of feeding, and an additional subject arises in learning associations about 
foods, tastes, and post-ingestive effects. As food enters the alimentary canal, soluble 
molecules begin to bind taste receptors and tastes are sensed. If the food is palatable, 
pleasure may be experienced. If the food is appetitive, an urge to continue consuming 
may be perceived. In contrast, an aversive substance may elicit displeasure and provoke 
rejection and lead to spitting or some behavior to allow passive drainage. “[H]umans and 
rats alike tend to eat less of food that is unpalatable, and to seek and eat more when 
available foods are more palatable” 33-38. However, if an animal is sickened and caused 
gastrointestinal malaise after consuming even the most palatable substance, if that 
substance is novel, the animal will develop an aversion to that substance and others that 
taste similar (i.e., a conditioned taste aversion [CTA]). Although learning processes are 
likely mediated at least in part through these systems, the full extent of their involvement 
is outside the scope of this dissertation. However, effects mediated through post-ingestive 





Figure 1-1. Process model of feeding. 
 
Factors of congruent and opposing valence are integrated in decisions to approach, feed, 
or avoid potentially edible substances. Appetitive inputs and outputs (left side) increase 
feeding. Aversive inputs and outputs (right side) decrease feeding. Integration occurs in 
systems represented in the middle, which ultimately lead to decisions and behaviors. 
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 The sensory process of taste begins when substances are consumed, and dissolved 
stimuli interact with the apical surface of taste cells in the oral cavity. Taste cells are 
modified neuroepithelial cells grouped together in discrete units called taste buds 2. Taste 
buds are found within papillae on the tongue as well as in other places in the oral cavity, 
on the soft palate, epiglottis, and in rodents within the nasoincisor duct, located anteriorly 
on the hard palate. In humans and other mammals, the three different types of papillae 
that contain taste buds are called fungiform (on the anterior tongue), circumvallate or 
vallate (posterior tongue), and foliate (sides of the tongue). Within the taste bud, there are 
anatomically- and molecularly-defined subsets of TRCs, as well as basal cells, which 
serve as TRC precursors; TRCs have a lifespan of approximately 7-10 days, and are 
replaced from the basal cell population. Traditionally, three types of TRCs were 
classified based on morphology, called Type I, Type II, and Type III cells. However, 
another way to categorize TRCs is according to which of the basic tastes it responds, 
which in turn is largely dependent on which taste receptors or mechanisms it expresses. 
Recent work suggests that many TRCs respond selectively to stimuli of a particular class, 
as well as a link between function and morphology: Type I cells respond to salts, subsets 
of Type II cells respond to sweet, umami, or bitter stimuli, and Type III cells respond to 
acids 2. 
 
 Transduction mechanisms for taste include both G-protein-coupled receptors, as 
well as ion channels expressed on the apical surface of TRCs 2,3. Sweet and umami 
stimuli bind to receptors in the T1R family, whereas bitter stimuli activate T2R receptors. 
NaCl, a potent taste stimulus for mammals, is transduced when sodium ions flow down a 
concentration gradient into the TRC through passive epithelial sodium channels (ENaCs). 
Surprisingly, the mechanism for taste detection of acids is less established, but thought to 
involve apical proton currents. Depending on transduction mechanism, activation of these 
receptors or channels leads to activation of a signal cascade, or direct effects on the 
TRC’s membrane voltage or conductance. Depolarization of the TRC, and/or calcium 
entry through basolateral cation channels, leads to transmitter release. An essential 
transmitter between TRCs and sensory nerve fibers is adenosine triphosphate (ATP), 
although some taste cells express and release other transmitters, such as ɣ-aminobutyric 
acid (GABA), serotonin, and norepinephrine. It is unclear to what degree these other 
transmitters contribute to TRC-nerve communication, as there is also evidence for 
neuromodulation among the TRCs themselves. 
 
 Axons of cranial nerves innervating the TRCs carry taste information centrally 
and include the facial (VIIth), glossopharyngeal (IXth), and vagus (Xth) nerves 39-44. The 
chorda tympani and greater petrosal branches of VIIth innervate taste buds on the anterior 
tongue (fungiform) and palate, respectively. The IXth innervates circumvallate and 
foliate taste buds on the posterior tongue. A small amount of taste buds are also found in 
the oropharynx on the aryepiglottic folds; these are innervated by the superior laryngeal 
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branch of X 4. Taste sensory neurons composing these cranial nerves are pseudo unipolar 






 Peripheral taste neurons terminate centrally in the brainstem, in the rostral-most 
portion of the nucleus of the solitary tract (NST) 39-47. These terminations occur in a 
rough rostral-caudal order, with VIIth nerve axons terminating in the most rostral part of 
the NST, and Xth nerve taste axons found most caudally. However, the terminal fields of 
different nerves overlap to some extent. At even more caudal levels of the NTS, vagal 
input is visceral. Taste-responsive neurons in the NST are glutamatergic, and in rodents, a 
majority of these project to and terminate in the parabrachial nucleus (PBN) in the pons 
43,48-56; however, central taste pathways in humans and other primates exclude the PBN 
57,58. 
 
 From the PBN, two major pathways have been traditionally described, termed 
thalamocortical and ventral (these pathways originate from the NST in humans). As the 
name implies, PBN neurons projecting to the forebrain as part of the thalamocortical 
pathway target the thalamic taste area, which is located in the parvicellular region of the 
venteroposteromedial nucleus of the thalamus (VPMpc). Taste-responsive thalamic 
neurons in turn project to the primary gustatory cortex (GC), which comprises part of the 
insular cortex. On the other hand, the ventral pathway includes known projections from 
the PBN to closely situated limbic forebrain structures such as the central amygdala 
(CeA), bed nucleus of the stria terminalis (BNST), and lateral hypothalamus (LH) 43,59-64. 
This dual-pathway classification is certainly an oversimplified concept, as individual 
neurons often collateralize to both pathways, and most of the gustatory target brain 
regions are interconnected. Still, conceptually its value has been in separating presumed 
functions, with the thalamocortical pathway thought to handle taste quality discrimination 
and conscious sensory perception, while the projections in the ventral pathway are 
implicated in hedonics, feeding behavior, association learning and reward. Iron-clad 
evidence for this segregation of function is lacking, however. A schematic of both the 
peripheral and central taste pathways is shown in Figure 2-1. 
 
 
The Parabrachial Nucleus 
 
 The PBN is comprised of cytoarchitecturally-defined groups of neurons 
surrounding the superior cerebellar peduncle (scp) in the pons, some of which may be 
considered taste neurons. The PBN functions as an important autonomic and multimodal 
sensory center in rodents—besides for taste processing, the PBN is a key structure for 
visceral processing, especially satiety. It also contributes to the processing of 
somatosensory and pain information, as well as respiratory control 65. Taste neurons tend 





Figure 2-1. Peripheral and central taste pathways. 
 
Taste information enters the central nervous system from facial (VIIth), glossopharyngeal 
(IXth), and vagus (Xth) cranial nerves. The first relay is the nucleus of the solitary tract 
(NST) which passes the signal on to the parabrachial nucleus (PbN). From the PbN, the 
pathways diverge, with one projecting to the parvicellular portion of the 
venteroposteromedial nucleus of the thalamus (VPMpc) which then innervates the taste 
portion of the insular cortex (IC). The other pathway projects to ventral forebrain areas, 
including the lateral hypothalamus (LH), central amygdala (CeA), and bed nucleus of the 
stria terminalis (BST). Descending input from all of the nuclei which the PbN innervates 
and the IC project back to each of the nuclei lower than it. Ascending pathways are 
drawn with solid, blue arrows; descending, with dotted, red arrows. Black lines are local 
circuit projections from NST to medullary nuclei: RF, reticular formation; V, VII, and 
XII, trigeminal, facial, and hypoglossal motor nuclei. 
 
Reprinted from Encyclopedia of Neuroscience, Smith DV, Boughter JD, Taste: 
Vertebrate Central Pathways, p. 876, 2009, with permission from Elsevier 4.  
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also responding to tactile or temperature stimuli, as well as others responding to visceral 
manipulation. Therefore, the PBN appears to be an area of sensory integration. 
 
 Gustatory neurons cluster caudally in the PBN in subnuclei found on either side 
of the white matter tracts of the scp (also called brachium conjunctivum or BC). At 
caudal levels the BC typically narrows in its center, and PBN neurons are found here 
crossing between the axon bundles, hence the nickname “waist area”, or “gustatory 
waist” (wa). Electrophysiology studies in the mouse show that taste-responsive cells are 
found enriched here in several PBN subnuclei, including especially the medial (m) and 
ventral lateral (vl) subnuclei; they are also found within the BC. Although taste neurons 
in the PBN can be identified/classified as firing “best” (most robustly) to a particular 
quality of taste stimulus, their tendency is to respond to multiple taste stimuli, and hence 
they range in their breadth of tuning 45. In a recent study in the mouse, taste cells were 
found that responded best to either sweet, salty, acid or bitter stimuli: Percentages of 
sucrose-, NaCl-, citric acid-, and quinine hydrochloride (QHCl)-best neurons were 
42.7%, 33.1%, 13.5%, and 10.7%, respectively. Overall, studies in rodents show that 
taste responsiveness in the PBN is roughly somatotopic, with a greater amount of 
sucrose-best neurons found medially and within the BC, and a greater amount of NaCl-, 
acid- and QHCl-best neurons found laterally. This pattern may reflect the differential 
distribution of neurons receiving input (via the NTS) from nerves innervating either the 
anterior or posterior oral cavity. 
 
 In addition to physiological approaches, many studies of taste function in the PBN 
have utilized expression of the immediate early gene (IEG) cFos to examine neuronal 
activity (i.e., a proxy for neuronal activation). Early studies in rats showed that intraoral 
(i.o.) stimulation with basic taste compounds resulted in Fos expression in the PBN that 
was strongly elevated relative to non-stimulation, and moreover that individual tastes 
elicited somewhat unique (though partially overlapping) patterns of Fos expression across 
subnuclei (e.g., Yamamoto et al., 1994 66). Furthermore, taste stimulation causes Fos 
expression in a wider range of PBN subnuclei than predicted by physiology. In addition 
to the m, vl, and BC, robust Fos expression is elicited by tastes in the dorsal medial (dm), 
dorsal lateral (dl), central lateral (cl), and external lateral (el) subnuclei. One likely 
explanation for this greater pattern of activity in the Fos studies is that while taste 
stimulation can be restricted to the oral cavity in anesthetized animals during in vivo 
electrophysiology, i.o. or free-licking stimulation in the awake animals also results in 
ingestion (depending on stimulus) and this likely provokes Fos expression in neurons that 
respond to visceral stimulation 67. Indeed, there is a strong visceral representation in the 
PBN, especially at more rostral levels, and especially in the el subnucleus 68. Studies in 
the mouse showed that two taste stimuli, sucrose and QHCl, resulted in disparate patterns 
of Fos expression across the PBN (although there is still overlap), including a strong 
QHCl signal in the dm, and a strong sucrose signal in the dl. 
 
 Understanding taste-related inputs and outputs of the PBN is another method to 
further analyze how this area encodes, stores, and recalls gustatory information. Tracing 
studies show that PBN neurons located in most subnuclei project to the thalamus, 
especially the VPMpc 69. Other populations of PBN neurons project to the CeA, 
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basolateral amygdala (BLA), BNST, LH and substantia innominata 59,62,63,69-71 . Some 
evidence also suggests that some cells collateralize to multiple forebrain regions, 
especially cells that project to both VPMpc and CeA. Differential organization of these 
projection cells across and within PBN subnuclei is also apparent. For example, the dl 
subnucleus contains LH, but not CeA or VPMpc-projecting neurons. A subset of the LH-
projecting neurons here shows elevated activity to i.o. presentation of appetitive, but not 
aversive, taste stimuli. This subnucleus also receives concomitant input from the LH. 
Intriguing evidence from studies by Palmiter and colleagues show a large set of CeA-
projection neurons found in the el subnucleus express calcitonin gene-related peptide 
(CGRP), respond to satiety cues, as well a variety of noxious stimuli (including the bitter 
taste of QHCl), and may play a role in a general “threat detection” circuit 72-74. Beyond 
this, there are few cellular markers of function, including taste, making cell population-
specific manipulation difficult. Other projections from the PBN target the periaqueductal 
grey, the midbrain dopaminergic (DAergic) areas (including ventral tegmental area 
[VTA]), and the ventral striatum. It is not clear if these projections have a gustatory-
related function 75. 
 
 As mentioned earlier, the PBN receives inputs primarily from the NST. An 
anterograde tracing study by Karimnamazi et al. (2002) 76 examined inputs from either 
the rostral, gustatory NST (rNST), or the caudal, visceral NST (cNST). Terminals from 
rNST were found enriched at caudal levels of the PBN (especially in the wa), whereas 
those from cNST were found predominantly rostral. However, there was some degree of 
co-mingling of both types of input at every level, and in most subnuclei. In addition to 
ascending input from the NST, the PBN also receives input from spinal afferents, 
especially in more rostral portions of the el and dl subnuclei. The PBN also accepts ample 
descending input from many of the same forebrain regions discussed above. Studies with 
glutamate decarboxylase (GAD) transgenic mice (i.e., express fluorescent molecules on 
the GAD promoter) indicate the presence of many GABAergic fibers and terminals 
throughout the PBN, while there are relatively few GABAergic cell bodies (Boughter, 
unpublished). However, many PBN cells express GABA receptor subunits. This reflects 
descending inhibitory modulation from forebrain areas. Indeed, taste responses in the 
PBN can be inhibited via stimulation of the CeA or LH 75,77. Anatomical studies also 
show that there is a substantial population of somatostatin+ cells in the CeA that co-
express GABA and project to the PBN 78,79.  
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CHAPTER 3.    THE NEUROBIOLOGY OF REWARD 
 
 
 In this chapter, we turn our attention to the neurobiological evidence that supports 
the categorization of urge, pleasure, and displeasure into orthogonal dimensions of affect. 
The relationship of DA with urge has accumulated the most evidence and is elaborately 
explained. After detouring to the anatomy of the VTA, we will then venture into 
reviewing pleasure and displeasure, focusing on their relationship with feeding while also 
incorporating the mechanisms of urge. 
 
 
The Role of the Dopamine System in Reward 
 
 A well-known group of DAergic nuclei are found in the midbrain that project to 
the striatum and other forebrain areas. Two pathways known as the nigrostriatal and 
mesocorticolimbic, whose function have been the subject of considerable debate, were 
alluded to earlier while introducing Schultz’s reward prediction error and Berridge’s 
incentive salience theories. The evidence provided below illustrates that the DA system’s 
primary function is to elicit urge, albeit some of the nuclei involved also encode a degree 
of information about pleasure and displeasure. For further clarity, the reader is referred 
back to the section on reward in Chapter 1 and to specific manipulations of the 
neurobiology underlying affect as it pertains to feeding covered in Chapter 4. Working 
together and/or in opposition, these systems can collaborate or compete to ultimately 
produce approach, consumption, and avoidance behaviors (Figure 1-1). 
 
 
Dopamine Neurons Mediate Urge in Response to Rewards 
 
 Midbrain DA neurons fire to novel, salient, and/or rewarding stimuli 16,80-86, 
resulting in DA release in forebrain structures 87,88. When the VTAs of rats are stimulated 
electrically, DA is released in the nucleus accumbens (NAc) 88. Further, the elevation of 
DA and its metabolites were correlated with current intensity. A meta-analysis of studies 
using in vivo microdialysis to measure DA release in the NAc concluded that the typical 
peak after intravenous administration of cocaine (a highly rewarding stimulus and 
potently addictive drug) is slightly less than 300% of baseline (2.39 nM) and that the 
dose-response is more correlated in the shell (NAcs) than core (NAcc) 87. 
 
  After firing to a reward stimulus on the first exposure, midbrain DA neurons tend 
to shift the phasic onset of their firing to correlate with the onset of reward-predicting 
stimuli 16,83,89,90. This shifting of phasic firing that occurs with subsequent exposures of 
the predictor-reward pair coincides with behavioral conditioning. After conditioning, 
midbrain DA neurons silence when reward fails to follow a reward predicting stimulus. 
From his electrophysiology experiments in primates, Schultz and his colleagues take this 
to mean midbrain DA neurons code for reward prediction error 83,89. Confirmation in 
humans was done with functional magnetic resonance imaging (fMRI) 83,91 and in mice 
with optogenetic single-cell identification of VTA DA neurons 83,92. “Typically, 
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dopaminergic (DA) neurons exhibit a highly stereotyped, short latency (<100 ms), short 
duration (~100 ms) population response to unpredicted stimuli in a variety of modalities 
that are salient by virtue of their novelty, intensity or reward value” 80 (but see Freeman 
and Bunney, 1987 81; Horvitz et al., 1997 82; and Schultz, 1998 16). Certainly, more can be 
said about the electrophysiology of midbrain DA neurons, but that level of detail is 
tangential to the point that DA mediates urge. Instead, the reader is referred to the 
numerous reviews and original research on this subject a few examples of which are cited 
here (Bruce Bean: Puopolo et al., 2007 93; Lammel et al., 2008 94; Fu-Ming Zhou: Ding et 
al., 2011 95; Roeper, 2013 96). 
 
 The aforementioned pervasive belief that DA release itself mediates pleasure has 
accumulated a wealth of empirical opposition. Depletion of DA with 6-hydroxydopamine 
(6-OHDA, which selectively destroys DAergic and noradrenergic neurons) lesions did 
not reduce positive facial reactions in taste reactivity tests, suggesting DA is not 
necessary for pleasure (or at least would not be necessary for activating the analogous 
circuitry which would be further processed in humans to elicit pleasure) 10,17,97. DA 
neurons in monkeys cease to fire to juice rewards after the prediction is fully learned, but 
we assume the juice remains palatable 10,89,98. Hedonic impact was not increased by 
activation of mesolimbic DA using several different methods, however, seeking and 
feeding was increased 10,99-103. Human Parkinson’s patients do not report lower subjective 
pleasure for sweet foods despite the disease’s depletion of DA 10,104. Parkinson’s patients 
with DA dysregulation syndrome (DDS) compulsively request extra L-3,4-
dihydroxyphenylalanine (L-DOPA; a precursor of DA and a drug which when 
metabolized, increases DA levels) but do not report experiencing pleasure 10,105. In fact, 
the dyskinesia, which the patients know results from excessive L-DOPA, is reported as 
extremely distressing. Rather than pleasure, DA release more likely elicits a general urge 
to act. 
 
 Two additional hypotheses about the function of the DA system remain the most 
competitive alternatives to the incentive salience hypothesis. The activation-sensorimotor 
hypothesis states that DA causes action generation, effort, movement, and general arousal 
or behavioral activation 10,106-110. A considerable amount of evidence is emerging to 
support this; however, it cannot fully explain the phenomenon altered when one 
manipulates the DA system. A learning hypothesis derived from Schultz’s work is less 
plausible (note that Schultz himself did not proffer this hypothesis). Anticipation of 
reward caused by conditioned stimuli that act as cues for rewarding unconditioned stimuli 
is associated with the activation of DA neurons 10,16,111-114. Some investigators inferred 
from this that DA mediates the learning process of using cues to predict reward. Indeed, 
studies indicate that after conditioning DA in the NAc increases temporally with 
exposure to stimuli predictive of reward, but not when the reward is presented alone 115-
118. However, this appears to be an encoding phenomenon rather than indicative of a 
learning process: DA deficient mice are still able to learn 10,119 and hyperdopaminergic 
mice do not show higher learning (only increased motivation and locomotion) 10,99,100,120-
122. Importantly, rats work harder for a reward when DA is activated 10,123,124, indicating 
an increase in motivation. Generally, ‘liking’ activates ‘wanting’: 6-OHDA lesions 
(suppress ‘wanting’) and phasic benzodiazepine administration (stimulate ‘liking’) teases 
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this apart 10,17. After lesioning DA neurons in rats, the benzodiazepine, diazepam, was 
still able to enhance positive facial reactions in rats i.o. infused with palatable 0.3 M 
sucrose. 
 
 Berridge and colleagues also devised an ingenious experiment to differentiate 
learning from incentive salience 10. Berridge identified the ventral pallidum (VP) as an 
area receiving convergent input from all that DA is doing, allowing tests of his theory of 
incentive salience. Note that the temporal relationship of the conditioned stimuli (CSs) 
with the unconditioned stimulus (UCS) is important. “When two CSs in series (CS+1 
followed by CS+2) always predict a sugar pellet reward (UCS), ventral pallidal neurons 
also gradually learn to shift firing forward, so that they eventually fire most to the first 
CS+2 tone” (Berridge, 2007 10 but see Tindell et al., 2004 125). Berridge explains another 
of this group’s studies in detail regarding how they teased apart incentive salience from 
the rest of incentive salience theory 102. They indicate CS+1 is more predictive of the 
reward because it occurs the furthest before a reward. CS+2 is more proximal because it 
occurs right before the reward is presented. Since the VP activity is ultimately highest for 
the CS+2, this indicates DA is ultimately influencing a process for incentive salience 
(proximal rewards) not learning (predictive rewards). Interestingly, this coincides with 
human reports of intensifying experiences which reach a zenith just before self-
administration of addictive drugs (Hamilton, personal communication 126). 
 
 
Dopamine and Displeasure 
 
 Although most evidence of DA release is to rewarding stimuli, NAc DA release 
has also been shown to occur in response to aversive stimuli such as QHCl, high NaCl 
concentrations, and red fox urine 127. In addition to firing to pleasant stimuli and cues 
signaling pleasant stimuli, VTA DA neurons also fire in response to aversive stimuli such 
as footshock 80 and air puffs 92. The DA projections from the VTA to NAc are activated 
by stress (i.e., the experience of emotion within modalities associated with negative 
sentiments such as fear, anger, or sadness) 128-138. Aversive and stressful events can cause 
DA release in the NAc 86,139-143. Since both DA release and neuronal firing—the 
neurobiological hallmarks Berridge uses to indicate the attribute of incentive salience to 
pleasurable stimuli—may also occur in response to aversive stimuli, further assimilation 
suggests DA might ascribe a general attribute of salience to both incentives and 
disincentives. In this way, DA would function to elicit urge while separate systems 
mediating pleasure and displeasure determine the directionality of behavior (e.g., whether 
to approach or avoid). Perhaps Schultz agrees since when explaining the function of DA, 
he defines salience as a capacity of stimuli to elicit arousal, alertness, and attention 144 
and sets “incentive salience” off to the side because it depends on positive valence. 
 
 However, Schultz also states that although many studies have shown aversive 
stimuli can increase DA neuron firing and striatal DA release 90,92,144-153, phasic 
depressions to aversive stimuli provide more evidence that the midbrain DA system does 
not function solely for reward. Moreover, Schultz indicates silencing of DA neurons may 
be a more powerful effector than activation and DA release 144. Consider that the relative 
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change (i.e., ratio) from 1 to near 0 approaches infinite, as opposed to the change from 1 
to 3, which is only 3. Several reward neurons, including in the VTA, orbitofrontal cortex 
(OFC), prefrontal cortex (PFC), dorsal and ventral striatum, premotor cortex, and parietal 
cortex, show temporal discounting—that is, decreases in reward response as the time 
between the predictive stimulus and reward stimulus increases. In other words, phasic 
depressions occur not only to when predicted reward stimuli do not occur, but also to 
aversive stimuli or predictive cues of aversive stimuli 80,90,92,142,144-152,154,155. Clearly, the 
VTA has a more multidimensional role than previously theorized, but more work is 
needed to explain these contradictory findings. 
 
 
The Ventral Tegmental Area 
 
 So far the function of the VTA has been discussed as it naturally follows from a 
discussion of reward and DA; however, we will now divert our attention to its anatomy 
and then how that contributes to the VTA’s function. The VTA is largely known for 
being 1 of 3 midbrain DAergic nuclei 83. Activity of the DA neurons in this region results 
in DA release in the NAc, dorsal striatum, and PFC. Neurons within the VTA are 
responsive to taste stimuli, in line with the idea that reward value ascribed to the tastes of 
food relies on this nucleus. A wealth of investigation has been done into the anatomy and 
cytoarchitecture of this nucleus as well as its connectivity with other brain areas 156,157. 
 
 The VTA includes projections for 1 of up to 3 DAergic pathways that have been 
identified, depending on the source 157: A8 (mesocortical), A9 (nigrostriatal), and A10 
(mesolimbic). A8, A9, and A10 specifically refer to the projections of DA neurons, 
whereas the nuclei and subnuclei, while marked by a primarily DAergic population, 
contain heterogeneous neuronal populations which also include glutamatergic and 
GABAergic cells (see Yetnikoff et al., 2014 157). Sometimes A8 and A10 are combined 
and referred to as the mesocorticolimbic. A8 is a projection from the retrorubral field 
(RRF) to the cortex. A9 neurons project from the substantia nigra (SN) to the striatum. 
A10 somas are located in the VTA and project to the NAc. Two additional subdivisions 
of A10 are the A10dc (dorsal, caudal) which projects to the ventrolateral periaqueductal 
gray and A10rv (rostroventral) which projects into the supermammillary nucleus. 
Additional DAergic neurons project from the VTA to the hypothalamus, amygdala 
(AMY), lateral habenula, pallidum, and BNST 143,158,159. The VTA can be broadly divided 
into 3 regions in mice: anterior (aVTA; from bregma - 2.92 to - 3.28 mm in the mouse), 
posterior (pVTA; from bregma - 3.28 to - 3.80 mm), and “tail” region (tVTA; from 
bregma - 3.80 to - 4.04 mm; but also see below) 160-167. Various VTA cell groups have 
been categorized as separate subnuclei 156,157,168-171 by cytoarchitecture and projection. 
Proposed subnuclei of the VTA include the rostromedial tegmental area (RMTg), 
interfascicular nucleus (IF), caudal linear nucleus of the raphe (CLi), rostral linear 
nucleus of the raphe (RLi), pigmented parabrachial nucleus (PBP), and paranigral 
nucleus (PN) 83,156,157,172. The PN is located ventromedially and is cell-dense, whereas the 
PBP is more lateral and dorsal. The IF, RLi, and CLi are midline structures 157,167,169,172. 
The VTA can be divided by its medial and lateral regions (mVTA and lVTA, 
respectively) based on its forebrain projection patterns 83,94,96,143,157,173-177. The medial 
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VTA tends to project to the NAcc, medial NAcs, PFC, and BLA 83,94,143,173-177. The lateral 
VTA tends to project to the lateral NAcs 83,94,167,173-181. DA neurons are less dense in the 
RLi and CLi, which spreads into the paramedian mesopontine tegmentum 157,167,182,183. 
VTA DA neurons have a differential latero-medial cellular co-expression of additional 
markers: amino acid decarboxylase (AADC), vesicular monoamine transporter 2 
(VMAT2), DA transporter (DAT), DA D2 receptor (D2R), and vesicular glutamate 
transporter 2 (VGluT2) 83,184. Calbindin-D 28 kD expression occurs preferentially in DA 
neurons projecting to the NAcc 157,185,186 and the RRF 157,187. 
 
 The structure of VTA neurons (with long dendrites) combined with an 
enormously heterogeneous set of inputs allows the VTA to function as a likely integrator 
of information relevant to reward: “In the VTA itself, long dendrites enmeshed in major 
fiber bundles provide a morphological basis for a tremendous integration of different 
inputs” (Geisler and Zahm, 2005 188). Inputs to the VTA include projections from the 
PFC, NAc, VP, CeA, BNST, LH, laterodorsal tegmental area (LDTg), and RMTg, among 
others 83,138,143,156,157,169,188-191. VTA inputs are highly overlapping 157,188,191,192—they are 
not discrete, but have difficult-to-define boundaries 157,193. 
 
 
Rostromedial Tegmental Area and Non-DA VTA Neurons 
 
 The debate over whether the RMTg is a VTA subnucleus (see Yetnikoff et al., 
2014 157) makes it worth additional discussion, especially as to how it might contribute to 
the function of the VTA and reward. It was first identified by Perrotti et al. (2005) 182 
who used the term “VTA tail” to describe a posterior region of the VTA in rats sparsely 
populated by tyrosine hydroxylase (TH) neurons and found to express ΔFosB in GAD+ 
neurons after chronic administration of psychostimulants. It later came to be known as 
the RMTg, located posterior to the VTA proper at -3.9 mm posterior to bregma, +/- 0.9 
mm lateral to the midline, and -3.6 mm ventral to the skull surface in mice 194. It 
primarily contains GAD67-expressing GABAergic neurons; GAD+ cells are also present 
outside its perimeter 166,195-198. Kaufling et al. (2009) 166 and Jhou et al. (2009) 197 appear 
to have located an anatomically similar (if not the same) area in rats and use either RMTg 
or the term “tail of the VTA”. (Note that the “tail” region of the VTA mentioned above 
refers to the most posterior volume of the VTA, but these latter terms are alternative 
names which have been used for the RMTg.) The RMTg is known to receive input from 
the lateral habenula (LHb). Stamatakis and Stuber (2012) 195 conducted a 
behavioral/system study in mice to determine the function of the LHb-RMTg circuit. 
Aversive stimuli activated a LHb excitatory input to RMTg neurons. Selective 
optogenetic stimulation of the LHb-RMTg circuit promoted avoidance. 
 
 Projections of the GABAergic neurons in RMTg, as well as other non-DA VTA 
projections, have been identified in mice 198. Overall VTA projection neurons are ~ 60 – 
65 % DAergic, ~ 30 – 35 % GABAergic, and ~ 2 – 5 % glutamatergic 157,198-201. 
However, VTA neurons are generally not systematically distributed across regions or 
subnuclei with respect to these neurotransmitters 157. Taylor et al. (2014) 198 characterized 
DA-independent efferents of mouse VTA, including to VP, lateral and magnocellular 
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preoptic nuclei, LH, LHb, CeA, mediodorsal thalamus, dorsal raphe, deep mesencephalic 
nuclei, PFC, and NAcs and NAcc. Some new technology reveals VTA input/output 
architecture some of which includes GABAergic neurons 202.  
 
 VTA GABAergic neurons increased firing in response to rewarding and aversive 
stimuli 92,148,198. However, activating VTA GABAergic neurons that project to the NAc 
did not modulate consumption of a reward 83,203. More work is needed to determine what 
role the RMTg and GABAergic neurons in the VTA play in affect. 
 
 
The Neurobiology of Affect in Taste and Feeding 
 
 Although DA is the neurotransmitter largely responsible for urge, other 
neurotransmitters/pathways may contribute pleasure and displeasure which add 
directionality to feeding behavior (i.e., approach, consume, avoid). A brief introduction to 
these relationships is covered here but excludes the work most relevant to the central 
focus of the experiments of this dissertation. Those neurobiological studies will be 
thoroughly covered in Chapter 4 (next). 
 
 The administration of opioid, cannabinoid, and benzodiazepine agonists to some 
brain areas may increase positive facial reactions to palatable food 10. Opioid and 
benzodiazepines are reported by humans to elicit pleasure, and administration of the 
cannabinoids found in cannabis has a long-standing reputation for enhancing the 
palatability of food. Systemic Δ-9-tetrahydrocannabinol (THC) administration increases 
hedonic reactions in response to intra-oral infusions of palatable stimuli 204. The OFC, 
NAc, and interestingly, the PBN (sometimes referred to as “hedonic hotspots”), mostly 
via manipulation of these neurotransmitter systems, have been implicated in mediating 
pleasure 205. The OFC mediates pleasure experience, valence, learning/memory, and in 
more posterior areas, it functions for sensory rewards such as taste 205-209. 
 
 All three hot spots for pleasure in the brain use opioids 205-209. Opioids in the VP 
also elicit ‘liking’ reactions 209,210. The hedonic hotspot in the NAcs is rostral. Opioid 
activation via agonist microinjection in NAc amplifies positive facial reactions in taste 
reactivity tests, suggesting this may cause an increase in pleasure (or at least activating 
the analogous circuitry which would be further processed in humans to elicit pleasure) 10. 
Mu opioid agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) in the 
rostrodorsal part of the medial NAcs caused a three-fold increase in positive taste 
reactions to sucrose 208,210. Delta and kappa opioid receptor stimulation there also 
increases positive taste reactions 206,210. 
 
 Systemic or intracerebroventricular (lateral) opioids increase food intake and 
positive taste reactions, and opioid antagonists block these effects 57. The systemic opioid 
agonist morphine increased sucrose consumption, but had no effect on QHCl 
consumption 211. Opioids administered systemically or to the lateral ventricles increased 
saccharin intake, but not neutral or aversive stimuli, and positive taste reactions in gastric 
fistulated animals. Beta-endorphins rise in blood and cerebrospinal fluid after palatable 
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food consumption, suggesting mediation is via the hypothalamus (ventromedial, 
paraventricular nuclei), however, the hypothalamus may only increase appetite through 
energy regulation rather than palatability. The NTS contains mu-opioid receptors but not 
delta- or kappa-, suggesting this as another possible cite of action for opioid-mediated 
palatability enhancement. Park and Carr (1998) 212 suggest the opioid system as the origin 
of the pleasure associated with food, however their work only confirms an increase in 
urge. Morphine injected into the VTA increased feeding, and naloxone blocked it. If this 
manipulation had also increased positive facial reactions, the intra-VTA opioid effect 
could be concluded to increase pleasure 212, however, this has not been shown. 
 
 Palatability and consumption effects are shown to occur via GABA system 
manipulations. The systemic benzodiazepine agonist midazolam increased sucrose 
consumption, but had no effect on QHCl consumption 211. GABA agonists increased food 
intake, especially palatable food intake, in gastric fistulated rats 57. Intra-PBN midazolam 
(GABA) infusion increased food intake and hedonia-associated taste reactions to intra-
oral infusions to sucrose + QHCl 10. Infusions into the PPT and NTS did not increase 
food intake, and taste reactivity was not tested for these areas. These effects suggest 
GABA manipulation impacts feeding through both pleasure and urge, including by 
specifically mediating effects through the PBN. 
 
 The NAc and PBN have also been implicated in mediating displeasure. Unlike the 
OFC and PBN, the NAc has been shown to act like a “keyboard” with an anteroposterior 
(AP) organization, wherein the anterior performs urge and pleasure functions, and the 
posterior, displeasure 205. The el projects to the laterocapsular portion of the CeA (CeAlc) 
73. The activation of this circuit decreases food intake, and inhibition prevents 
suppression of appetite. The el also projects to BNST, LH, medial thalamus, and the 
dorsal PBN. The el was not found to project to the arcuate or paraventricular nuclei of the 
hypothalamus. As mentioned above, neurons especially responsive to posterior oral 
stimulation have been found in the rat el 69,213,214. Fos expression was high in rat el when 
they were stimulated with intra-oral, but not intra-gastric, QHCl solution 66,68,215. Two 
other non-taste functions of el neurons include salt and nociceptive responses.  
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CHAPTER 4.    THE TASTE/REWARD INTERFACE OF THE PBN AND VTA 
 
 
Direct and Indirect Connectivity between Taste and Reward Areas 
 
 For taste, experiments conducted by Hajnal and Norgren (2005) 216 first showed, 
using a sham feeding preparation, that the taste of sucrose alone led to DA release in the 
NAc. They also found that this release was greatly attenuated when the PBN was 
lesioned, suggesting that the PBN plays a key role in this process. However, the exact 
nature of this connectivity was not known, despite evidence that tracing studies that some 
PBN neurons, including those characterized as glutamatergic, project directly to the VTA 
80,188 (Saites et al., 2015, poster 217). The nature of this projection, and its potential role in 
taste/reward/intake, is a topic of study of this dissertation. We hypothesized that taste 
information communicated from the PBN to the VTA may be used to generate urge, 
priming or causing the animal to approach and consume. If the PBN projection to the 
VTA is excitatory and its terminals synapse on DA neurons there, exposure to rewarding 
taste stimuli might activate this circuit and cause DA release. As explained in Chapter 3, 
VTA DA neurons shift their activity toward proximal cues, and this increases the urge 
associated with those cues. 
 
  It is possible that taste information in the PBN could take a more direct or an 
indirect approach to influencing striatal DA release. Li et al. (2012) 75 showed via in vivo 
physiology that a subpopulation of taste-responsive PBN cells projects directly to the 
NAcs in hamsters; while the mechanistic function of this projection is uncertain, they also 
showed that a reciprocal NAc to PBN projection is inhibitory with regard to taste 
responses. Retrograde tracing data from our laboratory, however, suggested that this is a 
rather small projection relative to others, at least in mice, with only a handful of cells 
projecting to NAc located in taste-related areas of the PBN (Figure 4-1; Saites et al., 
2016, poster 218). As mentioned above, the PBN also projects robustly to areas with 
known involvement in feeding and associative learning such as the CeA, BLA, and LH 
59,138,219-221. In turn, retrograde and anterograde tracing studies revealed both CeA-to-VTA 
and LH-to-VTA projections 188 in rats 189,222-224. Evidence suggests the BLA also projects 
to the CeA 43,225,226, which would indirectly connect the BLA to the VTA. The BLA and 
CeA have reciprocal connectivity with the gustatory brainstem (NST and PBN), and the 
BLA has reciprocal connections with the GC 227-231. Electrical stimulation of the BLA 
increases neuronal activity of the VTA 138,219-221. Orexin (OX) and melanin concentrating 
hormone (MCH) neurons in the LH project to the VTA 222-224. LH-projecting PBN 
neurons show elevated activity to i.o. gustatory stimuli 59. Collectively, these PBN to 
limbic to VTA circuits are not as direct as connections from the PBN to the NAc or VTA, 
but this anatomy clearly supports the possibility that multiple, parallel taste-responsive 
brainstem-to-midbrain/forebrain circuits could be simultaneously regulating DA release, 





Figure 4-1. Parabrachial nucleus (PBN) fibers and varicosities in midbrain and 
limbic regions. 
 
Top: Dopaminergic cells (green) are indicated by tyrosine hydroxylase (TH) labeling; 
higher power image (lower left) shows apposition of what may be PBN projection neuron 
terminals with DA neuron dendrites; inset (lower middle) shows the injection site in the 
PBN. Bottom: Nucleus accumbens (NAc), central nucleus of the amygdala (CeA), lateral 
hypothalamus (LH), and ventral pallidum (VP) were positive for PBN fibers; A13 of the 
zona incerta was an additional area labeled positive for TH. Substantia nigra pars 
compacta, SNpc; ventral tegmental area, VTA; brachium conjunctivum, BC; 
caudoputamen, Cpu; anterior part of the anterior commissure, aca; basolateral nucleus of 
the amygdala, BLA; internal capsule, ic; piriform cortex, Pir; preoptic nucleus, PO; 
horizontal band of Broca, HDB; substantia innominata, SI. Scale bar = 200 μm. 
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PBN and VTA in the Affect of Taste 
 
 In Chapter 3, we saw that several neurotransmitter systems throughout the brain 
can contribute to the affect of taste, which in turn, may influence feeding. Whereas DA 
tends to influence the dimension of urge, opioid, GABA, and cannabinoid receptor 
modulation may alter pleasure and displeasure. As noted, these systems work throughout 
the brain, but this section reviews the evidence specific to the PBN and VTA. 
 
 Evidence suggests opioids in the PBN may increase both the pleasure of, and urge 
to consume, palatable tastes, indicating a role in priming or causing of feeding. The PBN 
contains a high density of opioid receptors 57,212,232. Specifically, the lateral PBN contains 
mu-opioid receptors, suggesting this as a possible site of action of systemic opioid action 
and to be necessary and sufficient to mediate food intake and increase positive facial 
reactions 57. Intra-PBN naltrexone decreases feeding 212,233 and morphine increases 
saccharin preference in animals whose preference was lost due to LH lesioning 212,234. 
 
 The GABA system in the PBN may also increase pleasure and urge to palatable 
tastes. The GABAA agonist, midazolam, increases food intake and palatable taste 
reactivity when intraperitoneal (i.p.) injected, indicating GABA’s effect is mediated by 
GABAA receptors 57,235. Administration of GABA agonists also increased palatable food 
intake in gastric fistulated rats 57,236, meaning this effect occurs independently of 
postingestional input (i.e., taste specific). Intra-PBN midazolam (GABA) infusion 
increased food intake and hedonia-associated taste reactions to intra-oral infusions of a 
bittersweet 7% sucrose + 0.01% QHCl solution 10,237,238. 
 
 The processes by which DA may regulate feeding and interact with other 
neurotransmitter systems (and reward aspects) remain unclear. Examination of forebrain 
DA release and midbrain activity suggests the VTA causes urge or drive in response to 
stimuli with extreme taste hedonics regardless of valence. Stimulating rats with palatable 
foods elicits activity in the VTA 212. It also causes DA release in the NAc and medial 
PFC (mPFC) 127,239. However, DA release in the NAc and PFC occurs in response to both 
sweet (i.e., appetitive) and bitter (i.e., repulsive) substances 127. The pathway from the 
ventral striatum (approximately the same structure as NAc) to the VP (the downstream 
output of which was shown by Berridge to indicate salience) communicates taste but not 
caloric information 240; thus, taste salience information is likely to be communicated by 
the VTA-to-NAc pathway (also see next two sections on post-ingestive and taste input 
and manipulating VTA output). Interestingly, activating VTA DA neurons decreases food 
intake 241, and activating the VTA-to-NAc projection recapitulates the effects of this 
manipulation better than activating projections to either the PFC or AMY. This suggests 
the taste salience information carried by the VTA-to-NAc may lean towards negative. 
Habituation of DA release to food rewards occurs in the NAcs, but not in mPFC and 
NAcc 239. Chronic, but not acute morphine, can sensitize the NAcs so that habituation of 
DA release to food reward no longer occurs. This pattern of DA release habituation in the 
NAc to food rewards may occur in part due to effects in the VTA DA neurons. 
Pleasurable and urge effects on feeding of opioids are at least partially mediated via the 
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VTA because Fos expression increases in the VTA of rats in response to a palatable meal 
can be blocked with opioid antagonists such as naltrexone 212. 
 
 
Post-ingestive and Taste Interactions 
 
 That flavor–the composition of odor and taste–alone can elicit pleasure begs the 
question of Why do we swallow food? Indeed, if we are trying to prevent weight gain or 
even lose weight, Why would we not allow ourselves to experience the flavor and then 
spit the food back out? It stands to reason that something about swallowing or the 
“feeling of fullness” is also rewarding. It may be that viscerosensation communicates in 
its own way to pleasure centers. Furthermore, since post-ingestive effects (i.e., calories) 
are also likely drivers of appetite, various controls must be implemented to ensure 
consumption effects are in fact due to taste and palatability (addressed in methods 
sections throughout this dissertation). 
 
 Responsiveness in the PBN to intragastric (i.g.) stimulation differs from i.o. 68. 
Fos expression was measured in the area postrema, NST, and PBN to differentiate these 
effects. QHCl (bitter-aversive), sucrose (sweet-preferred-caloric), saccharin (sweet-
preferred-non-caloric), and water (control) were used to stimulate. I.g. and sucrose 
stimulation elicited more Fos expression in general, but water did not. Differential Fos 
expression of the brainstem areas occurred on the basis of i.g. versus i.o. and depending 
on the taste stimulus, including caloric versus non-caloric and preferred versus aversive. 
Besides in the PBN, the path visceral information takes centrally parallels that of taste, 
except for at least one difference in that the cNST (rather than rNST) is responsive 
57,242,243. 
 
 Additional work has shown that viscerosensation and the transmission of caloric 
signals may be just as effective at driving consumption behaviors as taste. Trpm5 -/- mice 
which are blind to sweet taste (see Chapter 6 methods) 244,245 continue to develop a 
preference to the caloric sweetener, sucrose, but not to the non-caloric sucralose 246. 
Further, sucrose, but not sucralose, caused significant NAc DA release in trpm5 -/- mice. 
The authors suggest these effects are due to post-ingestive feedback, which remain intact 
despite the disruption to the taste pathways. Moreover, separate circuits at levels higher 
than the PBN and VTA were implicated in the communication of hedonic and nutritional 
information about sugar 240. 
 
 
Effects of Manipulating VTA Function on Feeding 
 
 Manipulating VTA neurons with lesioning and designer receptors exclusively 
activated by designer drugs (DREADDs) activation produces mixed results. Bilateral 
lesions induced electrolytically in the VTA of rats had a negative effect on sucrose 
consumption, but not of other non-palatable fluids 211. Although activating VTA DA 
neurons with DREADDs had little effect on feeding latency, it decreased average meal 
size, increased feeding frequency, and decreased total food intake 241. The effects of this 
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manipulation appeared to be primarily dependent on the VTA neurons that project to the 
NAc. Although activating the VTA-NAc projection did not change total food intake, it 
decreased average meal size and increased feeding frequency. Neither VTA-PFC, nor 
VTA-AMY projections had significant effects on these factors. That loss-of-function and 
gain-of-function experiments yielded similar effects on feeding indicates both the VTA 
contains mechanisms for change in both directions and more targeted approaches are 
necessary for teasing apart how the VTA modulates feeding. 
 
 Rats given subcutaneous morphine (opioid) or i.p. midazolam (GABA agonist) 
increased sucrose consumption, but this was blocked with bilateral VTA lesioning of DA 
neurons with 6-OHDA 211. Opioid agonists injected into the VTA increased feeding 212,247 
and had positive reinforcing effects 212,248,249. I.p. opioid antagonists blocked the increase 
in feeding 250. Activation of neurons in VTA by meal or meal-paired environment was 
decreased by naltrexone, possibly due to activation of opponent neurons by naltrexone 
212. This evidence suggests the intra-VTA opioid effects are on urge, however, it seems 
more likely to occur via an effect on pleasure. Taste reactivity would need to be tested in 
conjunction with intra-VTA opioid manipulation to verify this. 
 
 VTA GABA effects interact with opioids and appear opposite for feeding relative 
to classical versus operant conditioning. GABA agonists administered directly to the 
VTA increased feeding 251. Both muscimol, a GABAA agonist and baclofen, a GABAB 
agonist, increased feeding, and the baclofen-induced increase was blocked by the 
GABAB antagonist, saclofen. Naltrexone had no effect on the increased feeding induced 
by intra-VTA muscimol, but it blocks the baclofen-induced increase 252. Interestingly, 
intra-VTA GABA agonists (combined muscimol and baclofen) inhibited lever pressing 
after rats were trained to respond to a CS+ for food pellets 253. 
 
 Results in experiments in which the VTA is unilaterally manipulated indicate 
there is a crossing over in the transmission from the VTA to areas more directly 
responsible for feeding. When one side of the VTA of rats was lesioned and the 
contralateral side stimulated, the increase in Fos expression was amplified compared to 
the increase seen in the unlesioned but unilaterally stimulated group 162. Similarly, a 
shortened latency to eat in the unlesioned, unilaterally stimulated group was amplified in 
the group with a contralateral VTA lesion. Unilaterally lesioned rats that received no 
VTA stimulation showed no changes in Fos or behavior. This indicated the lesions had 
suppressed the inhibition of afferent brain areas to the VTA 162. Further, unilateral block 
of excitatory input via N-methyl-D-aspartate (NMDA) receptors and current into the 
contralateral VTA led to a shortened feeding latency 254, suggesting at least the feeding 
effect is mediated by glutamate. 
 
 
Aims and Experiments 
 
 Since earlier studies and data collected in our lab show that PBN neurons project 
to the VTA 80,188, and lesioning the PBN attenuates taste-elicited release of DA in the 
NAc 216, we hypothesized this connection plays a crucial role in the control of feeding, 
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especially with regard to the processing of both appetitive and aversive stimuli, and the 
relationship of this processing to classical reward circuitry. We therefore utilized a 
number of neuroanatomical and behavioral techniques to probe taste and intake-related 
activity in the PBN, VTA, and the PBN-to-VTA circuit. The overarching goal was 
therefore to contribute to a comprehensive understanding of feeding neurobiology via 
improving the knowledge about these brainstem nuclei. The working model for the 
neurobiology of taste-mediated reward for this dissertation is illustrated in Figure 4-2. 
 
 
Analyze the PBN Response in Relation to Taste Valence and Characterize its 
Projection to the VTA 
 
 We used two experiments to look for differences in the expression of the IEG 
cFos in PBN neurons. In this and all other c-Fos experiments in this dissertation, c-Fos 
expression is measured with the use of a polyclonal antibody to the Fos protein; 
therefore, the term “c-Fos-like immunoreactivity” (FLI) is henceforth used. One 
experiment tested the hypothesis that FLI in the PBN is elevated specifically in response 
to taste stimuli by using the trpm5 -/- mutant, a mouse model based on the C57BL/6J 
(B6) phenotype but lacking the ability to taste sweet and bitter stimuli. We examined 
whether FLI within PBN subnuclei and at varied rostral-caudal levels differs among 
palatable and aversive stimuli. We expected trpm5 -/- mice to have lower FLI in the PBN 
than B6 after taste stimulation specifically in areas responsible for relaying taste 
information. 
 
 The second experiment retrogradely-labeled PBN neurons in B6 mice by their 
projection to either the VTA or gustatory thalamus (parvicellular region of the 
venteroposteromedial; VPMpc) and measured their corresponding FLI to palatable and 
aversive stimuli. Regional and functional comparisons of the PBN projections to either 
VTA or VPMpc were made to assess whether palatable or aversive taste stimuli 
preferentially elevated activity in one pathway or the other. Retrograde tracing was 
expected to reveal regional and functional differences in the PBN projections to either 
ventral (VTA) or thalamocortical pathways (reflecting reward and sensory processing, 
respectively). The intention was to further make functional differences apparent by 
combining tracing with sucrose- or QHCl -elicited FLI. 
 
 
Determine the Location and Morphology of VTA Neurons Responsive to Taste 
Stimuli with Varied Valence 
 
 Again, we conducted two experiments, except this time to examine the VTA. A 
continuation from the first PBN experiment, we observed taste-evoked FLI in the aVTA, 
pVTA, and tVTA. Trpm5 -/- mice were expected to have lower FLI in the VTA than B6 





Figure 4-2. Taste reward pathways. 
 
Taste information enters the central nervous system via cranial nerves VIIth, IXth, and 
Xth. After being relayed through the nucleus tractus solitarius (NTS), it travels to the 
parabrachial nucleus (PBN) in the pons. The PBN, along with two additional nuclei in the 
brainstem to which it projects, the ventral tegmental area (VTA) and substantia nigra 
(SN), integrate sensory information to generate affect. The PBN also projects to the CeA 
which projects back to the VTA and SN, two dopaminergic nuclei located in the 
midbrain. The midbrain DA projections to forebrain areas, including the ventral striatum 
(composed of the nucleus accumbens [NAc] shell and core), dorsal striatum, and 
prefrontal cortex (PFC), which begin motor circuits, complete this pathway.  
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 The most common neurotransmitters released by VTA neurons are DA and 
GABA 198; these neurons were identified by their fluorescently labeled synthetic 
enzymes, TH and GAD67, respectively. Taste stimuli were delivered as in previous 
experiments. FLI, TH, and GAD67 labeled neurons (and double-labeling) were counted 
in the VTA delineated by its regions and subnuclei. This was expected to elucidate any 
differential in VTA activity elicited by palatable or aversive taste stimuli. 
 
 
Modulate Feeding by Manipulating the VTA with DREADDs and Drugs 
 
 We targeted the VTA using two different methods to determine if feeding could 
be altered, presumably on the basis of effects on taste and/or reward circuitry. The first 
experiment aimed to measure the potential effects of activating the PBN-to-VTA circuit 
on taste-mediated feeding behavior. A two-part vector microinjection selected only the 
VTA-projecting PBN neurons for expression of excitatory DREADDs. Clozapine-N-
oxide (CNO) administration activated only the PBN-to-VTA circuit, allowing 
measurement of any feeding behavior it mediates. A behavioral task performed using a 
lickometer included measuring licks and trials initiated by mice after activation of the 
PBN-VTA circuit. Licked stimuli were varied on the basis of both taste valence and 
caloric content. Although activating this circuit was expected to affect feeding, the 
specific effects were challenging to predict due to uncertainty about whether PBN-VTA 
projections targeted only DA neurons or if VTA GABA neurons received input to the 
extent it would overwhelmingly oppose direct input to DA neurons. 
 
 Due to inconclusive preliminary results in the PBN-VTA experiment, we 
postponed it in lieu of one which targeted the VTA directly. We pharmacologically 
inhibited the VTA with a GABA agonist while using the same behavioral paradigm and 
stimuli variation described above. We expected to see an increase in consumption and to 
determine if the VTA was a necessary cause of any feeding effects.  
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CHAPTER 5.    GENERAL METHODOLOGY 
 
 
 The experiments of this dissertation continued work being done in the Boughter 
lab to elucidate the role of PBN connectivity in reward and feeding. Preliminary data 
from immunohistochemistry, tract tracing, genetic mouse mutants, and behavioral 
experiments indicated a functional connection for taste, reward, and feeding existed 
between the PBN and VTA. We continued the collection of this data in part by using the 
following general methods. Methodology specific to each experiment will be explained in 





 These studies used 104 male and female mice, including 74 B6, 18 trpm5 -/- 
knockout mice (KO), and 12 CB6-Tg(Gad1-EGFP)G42 mice (GAD67-GFP). The sample 
sizes chosen were the same or similar to those of relevant published reports, including 
from the Boughter lab 59,67,68,80,198,255-262. Additional mice were excluded for reasons noted 
in the following chapters. Mice were housed in the University of Tennessee Health 
Science Center (UTHSC) Lab Animal Care Unit with controlled humidity and 
temperature on a 12 h light/dark cycle (lights on at 0600 and off at 1800 h). Mice were 
fed a standard diet of dry pellet chow (22/5 rodent diet, Harlan Teklad, Madison, WI, 
USA). All studies were approved by the UTHSC Animal Care and Use Committee prior 
to experiments, and mice were handled in accordance with the National Institute of 




Intraoral Cannula Implant 
 
 Mice were anesthetized with an i.p. injection of 0.04 μL of ketamine/xylazine 
(approximately 100/10 mL/kg; Fort Dodge Animal Health, Fort Dodge, IA, USA and 
Lloyd Laboratories, Shenandoah, IA, USA). Additional injections of 0.01 or 0.02 μL of 
ketamine/xylazine were given until the mouse passed the toe pinch test (i.e., no flinching) 
and throughout the procedure as needed if the mouse appeared to be waking up (i.e., 
vocalizing, ambulating, whisking). To apply taste stimuli directly to the oral cavity (i.e., 
i.o.), a piece of polyethylene (PE 50; Intramedic, Sparks, MD, USA) tubing 
approximately 13 cm long was tunneled through the buccal mucosa along the lateral 
surface of the skull guided by a 25 g needle. The cannula exited through a ~ 0.5 cm hole 
made in the mouse’s scalp. Flaring one end of the cannula (to prevent its recession into 
the buccal mucosa), a screw in the skull (No.19010-10; Fine Scientific Tools, Foster City, 
CA, USA), and dental acrylic (Unifast Trad; GC Corporation, Tokyo, Japan) were used 
to fix the length (~ 2 cm) of the cannula between the oral cavity and top of the head. 
After the procedure, connecting the cannula to additional tubing, a syringe, and syringe 
pump (model 341A; Sage Instruments, Cambridge, MA, USA) allowed volume- and rate-
controlled injection of taste stimuli into the oral cavity. Cutting the cannula’s end at an 
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angle eased its entry into the larger connecting tube (PE 90; Intramedic, Sparks, MD, 
USA); the inner diameter of the connecting tube was ~ 0.1 mm smaller than the outer 
diameter of the cannula, sealing the connection. Occasionally, mice chewed the cannula, 
requiring additional shortening to prevent leakage. 
 
 
Adaptation and Tastant Stimulation 
 
 To habituate mice to extraneous stimuli before collecting FLI data, they were 
trained for 3 or 4 days by administering distilled water (DW) through the cannula at the 
same volume and rate to be used in testing. Training generally occurred in the same 
chamber and at the same time as that of testing (between 1000 and 1300 h). Mice were 
provided access to food and water ad libitum during training but were deprived 20 h prior 
to testing to promote sampling; this short deprivation period does not cause significant 
weight loss. On test day, taste stimuli were delivered i.o. for 15 min at a rate of 0.10 
mL/min (total volume = 1.5 mL). Taste stimuli were 3 mM QHCl and 0.5 and 1 M 
sucrose prepared fresh using reagent grade chemicals (Sigma-Aldrich, St. Louis, MO, 
USA) dissolved in DW; DW was used as a control stimulus (Table 5-1). A period of 2 h 
separated the beginning of stimulation from perfusion onset. Mice remained deprived 





 Mice were anesthetized with 0.4 mL of 25% urethane. Their thoracic cavities 
were opened to expose their hearts with a Chevron incision beginning directly below the 
xyphoid process moving laterally followed by two paramedian incisions anteriorly from 
the outer edges of the first cut. A needle was inserted into their left ventricles, and a slit 
was cut in their right atria for exsanguination. Mice were transcardially perfused with ~ 
25 mL of 0.1 M phosphate buffered saline (PBS), followed by ~ 50 mL of chilled (~ 4 
°C) 0.4% paraformaldehyde in 0.1 M phosphate buffer (PB; 0.4% PFA). Brains were 
carefully removed and placed in jars with 0.4% PFA for at least 24 h in 4 °C, followed by 
a 20/10% sucrose/glycerol solution in 0.1 M PB (cryoprotectant) for at least 24 h in 4 °C. 
Brains were frozen with dry ice and sliced into 40 μm thick coronal sections using a 
freezing microtome (860; American Optical Company, Buffalo, NY, USA). Brains were 
marked to identify left/right and ipsi/contra side. Sections were divided into two sets and 
kept in rostrocaudal order. One set of sections were Nissl-stained with cresyl violet (CV). 
When immunohistochemical (IHC) procedures were used, they preceded sections being 
mounted. Sections were mounted in rostrocaudal order by rolling them with a paint brush 
on to silane-coated slides (P4981-001; Thermo Scientific, Waltham, MA, USA). Slides 
were dried for at least 24 hours before CV staining or coverslipping. A mountant/xylazine 
(mountant was DPX for histology; Fluka, Milwaukee, WI, USA) mixture (1:1) was used 
to fix coverslips (except for CV, which used pure DPX). Coverslipped slides were dried 
at least 24 h prior to imaging.  
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Table 5-1. Stimuli used in anatomical, physiological, and behavioral studies. 
 
 Concentrations (M) 
Tastant Experiments 6.1, 6.2, 7.1, 7.2 Experiments 8.1, 8.2 
Sucrose 1, 0.5 0.3 
QHCl 0.003 0.0001 
Sucralose  0.003 
Water* N/A N/A 
 





 Except for the nickel-enhanced 3,3’-diaminobenzidine HCl (DAB) IHC procedure 
(Chapters 6 and 7), immunohistochemistry protocols followed the same 3 basic steps of 
binding the target molecule with primary antibodies, binding the primary antibodies with 
biotinylated secondary antibodies, and binding the secondary antibodies with 
fluorophore-conjugated streptavidin. However, binding with secondary antibodies and 
fluorophore-conjugated streptavidin steps were repeated twice to label two separate target 
molecules (except for mCherry, the antibody for which was already conjugated to 
fluorophore [Chapter 8]). Sections were washed with 0.02 M PBS beforehand, in 
between each step (except between blocking and antibody incubation), and after the last 
step. Blocking used 3% serum derived from the same animal in which secondary 





 Brightfield, fluorescent, and confocal microscopy were used to observe sections 
and collect images as data and for cell counting. Images were collected using: 1) a Leica 
(DMRXA2, Leica Microsystems, Bannockburn, IL, USA) episcopic-fluorescence 
microscope equipped with a digital camera (Hamamatsu ORCA-ER, Hamamatsu Corp., 
Shizuoka, Japan) and imaging software (SimplePCI, Hamamatsu Corp., Shizuoka, Japan) 
and, 2) a confocal microscope (Zeiss 710, Carl Zeiss, Thornwood, NY) and imaging 
software (ZEN, ZEISS, Thornwood, NY).  
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CHAPTER 6.    TASTE-EVOKED ACTIVITY IN PBN NEURONS INCLUDING 
PROJECTIONS TO EITHER THE VTA OR GUSTATORY THALAMUS 
 
 
 Physiological and neuroanatomical approaches have established that a substantial 
population of neurons are responsive to gustatory stimuli in the mouse PBN, and 
emerging evidence suggests a direct taste-reward pathway originates in this brainstem 
nucleus. However, much remains unknown about the selectivity and responsiveness of 
PBN cells that project directly to the VTA. Stimulus-evoked activity of neurons 
(including by taste stimuli) in the PBN has been frequently assayed using expression of c-
Fos (or FLI) 66,73,212,263. An advantage of this method, which involves 
immunohistochemical and microscopic analysis, is that it allows quantification of the 
entire population of reactive cells throughout a brain region. Previous studies in rats and 
mice show that taste stimuli of different taste qualities tend to evoke distinct patterns in 
the PBN. Additionally, some evidence indicates particular tastants preferentially 
stimulate certain classes of projection cells. Using a combination of retrograde tracing 
and taste-evoked FLI, Tokita et al. (2014) 59 showed that a sweet-tasting, caloric stimulus 
(sucrose) preferentially elevated activity in LH-projecting PBN neurons relative to other 
stimuli. Palmiter and colleagues (Carter et al., 2013 73) showed that QHCl selectively 
activates CGRP+, AMY-projection neurons in the el. 
 
 In most taste-IEG experiments, taste stimuli are presented in awake, freely 
moving animals through i.o. cannulas; this ensures equivalent stimulation among tastants, 
even to those that are hedonically negative such as QHCl. However, mice may still 
consume stimuli during this procedure. Although it is assumed that IEG expression based 
on i.o. stimulation is predominantly orosensory in nature (see Yamamoto et al., 1994 66), 
it is possible that some amount of it is also based on post-oral or visceral processing, 
especially for preferred stimuli. Therefore, in Experiment 6.1 we examined i.o. evoked 
FLI across the PBN to taste stimuli regarded as canonical examples of hedonically 
pleasurable (sucrose), displeasurable (QHCl), and neutral (water) in both B6 and “taste-
blind” KO mice. This approach should provide insight into the “type” of information 
potentially being relayed to upstream brain areas. 
 
 In Experiment 6.2 we used retrograde tracers injected into either the VTA or 
gustatory thalamus (VPMpc) in combination with i.o. evoked FLI to the same stimuli, to 
see if there is stimulus specificity in terms of activity of projection neurons. The VPMpc 
was chosen as a second projection target to provide a contrast to the VTA on several 
fronts. While we reasoned that a palatable stimulus would preferentially elicit activity in 
VTA-projection neurons due to our hypothesized role of this projection in taste-reward 
processing, we did not predict specificity in activity of thalamic projection neurons. As 
mentioned earlier, the VPMpc serves as the primary relay to GC, and this projection has 
been historically considered to play the primary role in conscious processing and 
discrimination of taste quality. Therefore, it seems reasonable to predict that stimuli of all 
qualities and valences should elicit activity in VPMpc-projecting cells. Another reason to 
compare the VTA projection with the VPMpc projection is to gain possible insight into 
PBN subnuclear function, i.e., Do specific PBN subnuclei project to either brain area? 
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and Do individual PBN neurons collateralize to both VTA and VPMpc, indicating input 
of “shared” information into either region? Previous retrograde tracing studies in the 
PBN in our lab show that the projection to thalamus is much stronger on the ipsilateral 
than contralateral side 69. An analogous study involving the VTA in mice has not been 
done, but anterograde tracing from the PBN interestingly indicates this projection is 








 36 male and female mice were used in this experiment, including 18 B6 inbred 
(10 males, 8 females) and 18 KOs (10 males, 8 females). Mice ranged from 62 – 175 
days old (mean = 96.6, median = 92) at the start of the experiment. Mice of both strains 
were grouped by i.o. stimulus, including those receiving water (n = 6/strain), 1 M sucrose 
(n = 6/strain), or 0.003 M QHCl (n = 6/strain) on the test day (Table 5-1). Concentrations 
were chosen on the basis of a previous study from this laboratory which used a similar 
paradigm 59. 
 
 The experiment tested the hypothesis that FLI in the PBN is elevated specifically 
in response to taste stimuli by using the trpm5 -/- mutant mouse model. Transient 
receptor potential cation channel subfamily M member 5 (TRPM5) KO lines have been 
generated independently by two separate labs. The KOs in our experiments came from 
Bob Margolskee’s line 245 as opposed to Charles Zuker’s 244. TRPM5 is a critical cation 
channel in the transduction of bitter and sweet tastants, and its absence was independently 
shown to cause a loss of signals in the chorda tympani and IXth 244,245. Therefore, 
differences in FLI expression between B6 and KO mice to bitter or sweet tastants can be 





 For the nickel-enhanced DAB (tablets, D5905-100TAB; Sigma-Aldrich) staining 
of c-Fos, sections were rinsed with 0.02 M PBS 3 times. They were then quenched with 
3% hydrogen peroxide (H2O2) for 30 min. After washing in 0.02 M PBS 3 times, sections 
were incubated overnight (~20 h) with a rabbit anti-c-Fos primary (sc-52, lot #F2510; 
Santa Cruz Biotechnology, CA, USA, diluted to 1:5000; sc-52, lot #F3016; Santa Cruz 
Biotechnology, diluted to 1:200; or, ABE457; Millipore, Burlington, MA, USA, diluted 
to 1:1000) in 0.8% triton-X 100 in 0.1 M PB (0.8% PBTx) with 5% normal horse serum 
(Jackson ImmunoResearch, West Grove, PA, USA) and 0.01% sodium azide. Following 
primary incubation, sections were washed 3 times and incubated for 1 h with donkey 
anti-rabbit IgG secondary (antibody 111-7103; Rockland, Limerick, PA, USA, diluted to 
1:50) in 0.8% PBTx. Sections were rinsed 3 times and incubated for 1 h in 0.2% 
peroxidase anti-peroxidase (PAP; Jackson ImmunoResearch, diluted to 1:500) in 0.8% 
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PBTx. DAB solution was made by dissolving DAB tablets in 0.05% nickel ammonium 
sulfate in 0.1 M PB (10 mL for each 10 mg tablet), filtering, and raising the pH dropwise 
with NaOH to 7.4. Sections were rinsed 3 times and reacted in DAB solution for 10 m. 
The reaction continued for another 10 m after H2O2 was added (14 μL to 5 mL DAB 





 FLI labeled neurons were plotted and quantified from high-resolution digital 
microscopic images (150 ppi) taken at 20x magnification using ImageJ (National 
Institutes of Health, USA) by an observer blind to strain and stimulus. FLI labeling was 
examined in six sections (every other section) along the rostral-caudal axis from a point 
about 100 μm rostral to the dorsal junction of the scp with the mesencephalic trigeminal 
tract to the initial appearance of the m, a range of approximately 450 μm that 
corresponded to about - 5.25 to - 5.7 mm from bregma. This span of 6 sections, spaced 
evenly over 440 μm, fits approximately within a length (480 μm) of the pons 
corresponding to images 106-110 of the coronal reference atlas at Allen Brain Atlas 
(which itself corresponds to - 5.26 to - 5.66 mm from bregma). For cell quantification, 
subnuclei were delineated according to our previous schema 50,59,69, which in turn was 
based on the histological delineation of subnuclei in mice by Hashimoto and colleagues 
(2009) 264.  Based on the aforementioned studies, we are confident this range captures the 
majority of taste activity in the mouse PBN, which tends to be found at more caudal 
levels. 
 
 The PBN was delineated on both sides of the brain within a section into dm, m, 
external medial (em), vl, cl, dl, and el. Moving from rostral to caudal through sections, 
the last section in which the scp intersected with the mesencephalic tract was identified as 
-5.5 mm post bregma. From this standardized section, the other 5 sections were 
designated starting at -5.26 and ending at -5.66 mm post bregma. Subnuclear delineation 
was consistent with our previous scheme, derived from cytoarchitectural boundaries 
evident in cresyl violet-stained sections (Figure 6-1), and based upon delineations 
amalgamated from several sources 50,69,264-266. Based on these studies, we are confident 
this range captures the majority of taste activity in the mouse PBN, which tends to be 
found at more caudal levels. FLI+ nuclei were only counted as valid if they were at least 
50% within the delineated area, and overlapping < 50% with another stained nucleus. 
75% of a dark nucleus could be seen and the structure was approximately at 50% 





 After decoding, cell counts were compiled and analyzed. Kolmogorov-Smirnov 
tests indicated most of the distributions within relevant groups were normal, and the 
decision to compare FLI between stimuli and strains using parametric ANOVAs (SPSS, 





Figure 6-1. Delineation of PBN at 5 rostral-caudal levels. 
 
Sections were Nissl-stained with cresyl violet to reveal cytoarchitecture. This span of 
sections is spaced out evenly over a 400 μm distance, starting at the most rostral section 
(A) approximately - 5.24 mm from bregma. Sections are ordered A-E, from most rostral 
to most caudal. PBN subnuclei are labeled as follows: dm, dorsal medial; m, medial; em, 
external medial; wa, waist area; vl, ventral lateral; cl, central lateral; dl, dorsal lateral; el, 
external lateral; il, internal lateral. All pictures at same magnification, scale bar in A = 
100 μm. vsc, ventral spinocerebellar tract; Me5, mesencephalic trigeminal nucleus; LC, 
locus coeruleus; BC, brachium conjunctivum; KF, Kölliker-Fuse nucleus.  
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Mauchly’s test of sphericity. The criterion for significant main effects and interactions 
was set a priori at α = 0.05. Where appropriate, post-hoc comparisons were made using 





 Stimuli (sucrose, QHCl, or water [control]) were delivered i.o. to B6 and KO 
mice. Examples of FLI in B6 and KO mice in response to i.o. stimuli are shown in 
Figure 6-2. Genetic testing confirmed KO mice lacked the trpm5 gene (Transnetyx, 
Cordova, TN, USA). In early observations of these sections, we noticed the PBNs of KO 
mice appeared to have less FLI than B6, which gave us cause to investigate more 
thoroughly using quantitative analyses. 
 
 We did not anticipate finding differences across left and right sides. To test this, 
data for subnuclei and AP sections were summed and an omnibus ANOVA (within-
subjects factor for side; between-subjects factors for stimulus and strain) was conducted. 
The data failed to pass Mauchly’s test for sphericity and the Greenhouse-Geisser 
corrected F-ratio was used for determination of side difference. No effect of side was 
found (F(1, 30) = 1.83, p = 0.187). Further, no interactions were found with stimulus (F(2, 30) 
= 0.66, p = 0.53) or strain (F(1, 30) = 0.08, p = 0.786). In between-subjects tests showed a 
significant effect of strain (F(1, 30) = 4.83, p = 0.036) but not stimulus (F(2, 30) = 1.78, p = 
0.185). 
 
 With effects of side ruled out, we averaged the FLI across left and right PBN. We 
then summed the FLI counts within subnuclei across AP level. Another ANOVA (within-
subjects factor for subnucleus; between-subjects factors for stimulus and strain) was 
conducted to test the hypotheses that differences would occur between stimulus and 
strain. Again, the data failed the sphericity test, so Greenhouse-Geisser corrected F-ratios 
were used. A significant main effect of subnucleus was found (F(6, 180) = 35.15, p < 
0.001), and an interaction was found for subnucleus X stimulus (F(12, 180) = 3.08, p = 
0.028) but not for subnucleus X strain (F(6, 180) = 2.25, p = 0.121). A between-subjects 
effect was found for strain (F(1, 30) = 4.83, p = 0.036) but not for stimulus (F(2, 30) = 1.78, p 
= 0.185). Therefore, it was strongly evident that FLI was different between strains 
(Figure 6-3) and the strain effect appeared to occur primarily due to differences in FLI to 
QHCl (Figure 6-3C). To test this, we ran ANOVAs on FLI separately for each stimulus 
(within-subjects factor for subnucleus). Although effects of subnucleus were present in 
all three tests (p < 0.001), only FLI to QHCl had significant main (F(1, 10) = 5.81, p = 
0.037) and interaction effects (F(6, 60) = 5.13, p < 0.001). A post hoc Bonferroni test 
revealed a significant difference in el (p < 0.05) but only trends in dm (p = 0.166), m (p = 
0.089) and cl (p = 0.11). 
 
 We also tested for differences of stimulus using ANOVAs separately for B6 and 
KO mice (within-subjects factor for subnucleus; Figure 6-4). Again, the effect of 
subnucleus was significant for both tests (p < 0.001), but neither group had a significant 





Figure 6-2. FLI in PBN measured with DAB immunohistochemistry in B6 and 
TRPM5 KO mice. 
 
A,B. Sucrose-elicited FLI. C,D. QHCl -elicited FLI. A, C. FLI in B6 mice. B, D. FLI in 
TRPM5 KO mice. scp, superior cerebellar peduncle. BC, brachium conjunctivum; dm, 
dorsal medial; em, external medial; m, medial; vl, ventral lateral; cl, central lateral; dl, 
dorsal lateral; el, external lateral; vsc, ventral spinocerebellar tract. All pictures at same 





Figure 6-3. FLI in mouse strains and to taste stimuli. 
 
A: Overall, FLI in B6 mice was significantly higher than in KO mice when counts in 
response to all taste stimuli are combined. This was expected for the mice stimulated with 
sucrose and QHCl given that KO mice are blind to sweet and bitter tastes. B-D: FLI 
expression in B6 and KO mice in each subnucleus, plotted for each intraoral stimulus. 
FLI expression between the two strains was similar across the PBN for sucrose (B) and 
water (D). However, B6 mice had significantly higher FLI expression as compared to KO 
mice in response to QHCl. dm, dorsal medial; m, medial; em, external medial; vl, ventral 
lateral; cl, central lateral; dl, dorsal lateral; el, external lateral; B6, C57BL/6J mice; KO, 





Figure 6-4. FLI in C57BL/6J (B6) and trpm5 -/- (KO) mice in PBN. 
 
Plots of FLI expression evoked by each stimulus across subnuclei for B6 mice (A) and 
KO mice (B). These are the same data as shown in Figure 6-3 B-D, but are re-arranged 
here for a better comparison of the responses to stimuli.  Letters denote statistically 
significant subgroups within particular subnuclei in post-hoc tests (p < 0.05).  
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However, we did find a significant interaction of subnucleus and stimulus in KO mice 
(F(12, 90) = 4.26, p < 0.001). Post hoc tests in B6 mice indicated FLI to QHCl in the el 
(mean = 144.6) was significantly higher than to water (mean = 59.6, p < 0.05; Figure 
6-4A). In KO mice, FLI to sucrose in cl (mean = 67.8) was significantly higher than to 
water (mean = 23.1, p < 0.05; Figure 6-4B) and FLI to sucrose (mean = 114.2) in the el 









 14 male and female B6 mice were used in this experiment, ranging from 69 – 126 
days in age at the start of the experiment. Mice were grouped by i.o. stimulus, including 
those receiving water (n = 4), 0.5 M sucrose (n = 6) or 0.003 M QHCl (n = 4) on the test 
day (Table 5-1). Concentrations were chosen on the basis of a previous study from this 





 Mice were anesthetized and scalped as described in Chapter 3 for i.o. cannula 
implantation. Mice were mounted in a stereotaxic frame (Stoelting, Wood Dale, IL, 
USA), and the skull was leveled between bregma and lambda by adjusting the bite bar. 
On the right side, 1% cholera toxin subunit B (CTb; List Biological Laboratories, 
Campbell, CA, USA) and 5% Fluoro-Gold (FG; Fluorochrome, LLC, Denver, CO, USA) 
was microinjected into VPMpc (AP: -1.95, mediolateral [ML]: 0.4, dorsoventral [DV]: 
4.3 mm relative to bregma) and VTA (AP: -3.1, ML +0.6, DV 4.7), respectively. Tracers 
were injected by either iontophoresis (2 mA, 5 s on/off for 15 min) with a precision 
constant current source (CAT. NO. 51595; Stoelting, Wood Dale, IL, USA) or pressure 
with a picospritzer (52-302-900; General Valve Corporation, Fairfield, NJ, USA). Glass 
micropipettes (30 – 35 μm tip diameter for iontophoresis; 50 – 60 μm for pressure) were 
positioned with a micromanipulator (SM-191; Narishige, Tokyo, Japan) and left 
unaltered for 10 min prior and after injections. I.o. cannulas were implanted on the 
ipsilateral side of the tracer microinjections. Animals were allowed to recover for 1 week 
following surgery, during which time i.o. cannulas were periodically flushed with water. 
Following this period, they were trained for 3 consecutive sessions with water 
administration through the cannula, then tested on the 4th day with solutions as described 





 We stained the sections as in Chapter 3. Prior to the primary incubation, we used 
3% normal donkey serum for blocking (Jackson ImmunoResearch). Then, we incubated 
sections in goat anti-CTb (List Biological, diluted to 1:5000) and rabbit anti-c-Fos (sc-52, 
lot #F2510; Santa Cruz Biotechnology, diluted to 1:5000; sc-52, lot #F3016; Santa Cruz 
Biotechnology, diluted to 1:500; or, ABE457, Millipore, diluted to 1:2000). Next, we 
used biotinylated donkey anti-goat IgG for secondary (Jackson ImmunoResearch, diluted 
to 1:1000) and the fluorescent cyanine dye, Cy3-conjugated streptavidin for a fluorophore 
(Jackson ImmunoResearch, diluted to 1:1000). In the last steps, biotinylated goat anti-
rabbit for secondary (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), 
and streptavidin–Cy2 (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) or 
streptavidin–Alexa Fluor 568 (Molecular Probes/Invitrogen, San Diego, CA, USA) 
diluted to a concentration of 1:1000. Several sections were placed in the same solution 




Quantification and Analysis 
 
 Cell plots and counts were made from high-resolution digital images (150 ppi) 
taken at 20x magnification of 3-color fluorescent labeling, using ImageJ by an observer 
blind to stimulus group. The range of sections and subnuclear delineation was similar to 
Experiment 6.1. PBN labeling of tracers and FLI was examined in 5 sequential sections 
(every other section) along the rostral-caudal axis. This span of sections, spaced evenly 
over 360 μm, fits approximately within a length (400 μm) of the pons corresponding to 
images 106-110 of the coronal reference atlas at Allen Brain Atlas. The PBN was 
delineated on both sides of the brain within a section into dm, m, em, vl, cl, dl, and el, 
and here the “waist” region (i.e., within the brachium wa) and internal lateral (il) were 
added. 
 
 Each type of label (FG, CTb, and FLI) was initially counted from a single channel 
color image. Only complete cellular (FG, CTb) or nuclear (FLI) profiles were counted. 
Moreover, intensity of the profile had to exceed the average background intensity, which 
was determined for each image from a 150 X 150 pixel ROI placed over a non-PBN 
region of the brainstem within that image. Double-labeled (DL) and triple-labeled cells 
were then counted using merged images. Data was assessed for normality, which it 
passed. To assess whether appetitive or aversive taste stimuli preferentially elevated 
activity in subnuclei or pathways, we analyzed data collected by projection, FLI 
positivity, and double labeling. ANOVAs were used to test for differences, followed by 








 Tracer injection sites in both the VTA and VPMpc were reconstructed for all mice 
and are shown in Figure 6-5. An example of fluorescent labeling, taken at 10X 
magnification to show the entire PBN, is shown in Figure 6-6. In this example, taken 
from the caudal PBN (similar to Figure 6-1D), FG expression is stronger on the 
contralateral side; cells labeled with this tracer tend to be located dorsally within the 
nucleus. CTb expression, on the other hand, was greater on the ipsilateral side, with the 
strongest expression medially and in the wa. FLI expression (evoked by i.o. sucrose in 
this mouse) is roughly similar within the PBN on both sides, and is also found expressed 
medial to the PBN itself, in the mesencephalic trigeminal nucleus (Me5) and locus 
coeruleus (LC). More detailed examples of tracer and i.o.-evoked FLI labeling, and DL 
cells, are shown in Figure 6-7. 
 
 Initially, we examined overall counts of labeled cells for each tracer, and for FLI, 
in each stimulus group and on both sides of the brain. Based on previous tracing studies, 
we expected that the 2 retrograde tracers (injected into mice several weeks before i.o. 
stimulation) would differ in expression on either side of the brain, and across PBN 
subnuclei, but would not differ according to stimulus group. This hypothesis was tested 
with a 3-way ANOVA for each tracer (within-group factors for side and subnucleus, and 
a between-group factor for stimulus). For FG expression, there were significant effects of 
side (F(1, 11) = 23.15, p = 0.001) and subnucleus (F(8,88) = 49.73, p < 0.001), but not 
stimulus. Only the side X subnucleus interaction was significant (F(8, 88) = 11.72, p < 
0.001). Total FG expression (collapsed across group and subnucleus) was lower on the 
ipsilateral (mean total cells/animal = 284.86) side as compared to the contralateral (mean 
cells/animal = 421.64) side. In general, FG expression was highest in the dm, m, vl and cl 
subnuclei relative to other subnuclei. Comparing individual subnuclei across side (i.e., 
collapsed across group) showed significant increases of labeled cells in the dm, m, and vl 
subnuclei on the contralateral side. 
 
 For CTb, the 3-way ANOVA similarly yielded significant effects of side (F(1, 11) = 
73.24, p < 0.001) and subnucleus (F(8, 88) = 66.90, p < 0.001), as well as a significant side 
X subnucleus interaction (F(8, 88) = 54.29, p < 0.001). However, stimulus did not 
significantly impact counts. Unlike FG, CTb was expressed in overall greater numbers on 
the ipsilateral side (mean counts = 578.36 vs. 202.21 for ipsilateral and contralateral 
sides, respectively). CTb also varied from FG in its subnuclear expression, notably in its 
robust expression in the el, reflecting a difference in topography of neurons projecting to 
these distinct brain regions. When the sides were statistically compared (collapsed across 
group), larger numbers of labeled cells were found ipsilateral in the m, wa, and el 
subnuclei. The fact that only a handful of cells were found to collateralize to both VTA 






Figure 6-5. VTA and VPMpc injection sites. 
 
A. Representative fluorescent image of FG injection site in the VTA. B. Plots of injection 
site and size in the VTA for each animal according to stimulus group. C. Representative 
fluorescent image of CTb injection site in the VPMpc. D. Plots of injection site and size 
in the VPMpc for each animal according to stimulus group. Colors identify single 
animals within each group, consistent for injections at both brain sites. Scale bars = 1 
mm. SNC, substantia nigra pars compacta; SNR, substantia nigra, pars reticulata; IP, 
interpeduncular area; ml, medial lemniscus; cp, cerebral peduncle; RN, red nucleus; fr, 
fasciculus retroflexus; PF, parafascicular thalamic nucleus; VPM, venteroposteromedial 







Figure 6-6. Labeling in the caudal PBN. 
 
Low-power (10X) fluorescent images taken from both sides of a single brain section; the 
mouse received sucrose stimulation. Retrograde FG labeling (blue) from the VTA was 
stronger on the contralateral side, whereas retrograde CTb labeling (green) was stronger 
on the ipsilateral side. Expression of sucrose-evoked FLI (red) was similar on both sides. 





Figure 6-7. Examples of FG, CTb, and FLI labeling in the PBN. 
 
Images shown merged, as well as individual channels for each fluorophore (FG, blue in 
the merged image, is shown more clearly in greyscale). The stimulus for each set of 
images (from separate mice) was sucrose. A. Several cells doubled-labeled for CTb and 
FLI (yellow arrowheads) are found in the ipsilateral, caudal PBN in the medial (m) 
subnucleus. B. Cells double-labeled for FG and FLI (pink arrowheads) in the central 
lateral (cl) subnucleus on the contralateral side in a more rostral level of the PBN. All 
images same magnification, scale bar = 100 μm.  
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FLI and Double-labeled Cells 
 
 Because FLI did not significantly differ on either side of the brain, counts were 
averaged across sides and analyzed according to i.o. stimulus (Figure 6-8; 2-way 
ANOVA, subnucleus X stimulus). There was a significant effect of both subnucleus (F(8, 
88) = 23.83, p < 0.001) and stimulus (F(2, 11) = 13.82, p = 0.001), as well as a significant 
interaction (F(16, 88) = 6.34, p < 0.001). Post-hoc multiple comparison tests (p < 0.05) 
between stimuli at each subnucleus indicated significant differences in 5/9 comparisons. 
Each stimulus resulted in different counts in the dm, where QHCl evoked the most FLI, 
and water the least. Sucrose and QHCl both evoked more FLI than water in the m and el, 
but did not differ from each other. Sucrose stimulation resulted in more FLI than either 
QHCl or water in the dl, and sucrose, but not QHCl, evoked more FLI in the cl. 
 
 Cells DL for both tracers, or one tracer and FLI, were generally found in low 
amounts (< 7% for all types) relative to overall counts of each marker type (only a couple 
of cells were triple-labeled across all mice and are not dealt with any further). DL cells 
were therefore examined as total counts across all subnuclei. The number of cells 
doubled-labeled for either FG + FLI, or CTb + FLI, likely depends on the total numbers 
of cells expressing each individual marker. When expressed as a percentage of tracer-
marked cells, there was a significant effect of stimulus group (F(2, 22) = 7.88; p = 0.003), 
but not side, on the percentage of cells doubled-labeled for FG and FLI, with higher 
numbers of these in sucrose-stimulated mice on the ipsilateral side relative to water, but 
not QHCl. There were significant effects of both stimulus (F(2,22) = 9.79; p < 0.001) and 
side (F(1, 22) = 5.97; p = 0.023) on the percentage of cells doubled-labeled for CTb and 
FLI. Significantly more DL cells were found in the sucrose and QHCl groups relative to 
water on the ipsilateral side. However, when expressed as a percentage of total FLI 
expression in each mouse, no significant differences among stimulation groups occurred 
for either FG + FLI or CTb + FLI cells. Collectively, this evidence suggests that the 
double-label measure (i.e., co-expression of FLI and tracers) is most likely proportional 
to the amount of FLI evoked by the i.o. stimulus. Although these i.o. stimuli consistently 
evoked activity in a small proportion of tracer-labeled cells, the hypothesis that stimuli of 
different qualities differentially elevate activity in neurons projecting to either VTA or 





 In Experiment 6.1, B6 mice had higher levels of expression of FLI than TRPM5 
KO mice in the PBN following i.o. administration of taste stimuli. On the surface, this 
result was expected based on behavioral and electrophysiological studies with these KO 
mice that show an attenuation, or even total lack of, oral sensitivity to sweet and bitter 
tastants 244,245. However, a careful examination of FLI expression in each strain across 
subnuclei suggested that this effect depended on which stimulus was used. In particular, 
the strain difference appeared to largely rely on the effects of increased FLI to QHCl in 
B6 mice. Intriguingly, sucrose-evoked FLI was basically similar between strains. It is 





Figure 6-8. Quantification of FG, CTb, and FLI labeling in the PBN by 
subnucleus. 
 
A. Mean number of VTA-projecting (FG+) neurons, combined across stimulus groups, 
varied according to both subnuclear location and side of the brain. B. Mean number of 
VPMpc-projecting (CTb+) neurons, combined across stimulus groups, also varied 
according to subnucleus and side. C. Mean FLI expression by intraoral stimulus group, 
plotted for each subnucleus–here data from both sides of the brain are averaged for each 
animal.  Asterisks in A, B show significant ipsilateral-contralateral differences in 
particular subnuclei (p < 0.05). Letters/horizontal bars denote statistically different 
groups (p < 0.05) in C.  
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TRPM5-independent pathway. The effects of TRPM5 are thought to be specific to sweet 
receptor (T1R) and bitter receptor (T2R) expressing taste cells. In the transduction of 
these classes of stimuli, TRPM5 plays a vital role in taste cells as a calcium-gated cation 
channel; when this channel opens in response to elevated intracellular calcium it produces 
a depolarizing generator potential 2. However, recent studies uncovered a host of non-
T1R mechanisms expressed in taste cells that may play a role in sweet transduction, 
including sugar transporters, metabolic sensor channels, and brush-border enzymes 267,268. 
Though, an important caveat to this possibility is that although alternative pathways for 
sweet transduction exist, mice without TRPM5 show severely diminished behavioral 
sensitivity to sucrose 245,246, yet in our study sucrose was equally potent as an activator of 
FLI in KO mice as it was in B6 mice (Figure 6-3B). 
 
 A more likely explanation is that the robust FLI in response to sucrose in both 
strains stems from viscerosensory effects. Even a diminished preference to the sucrose in 
the KO mice might lead to them consuming the solution during i.o. stimulation in a 
manner similar to the B6 mice. Further, the mild restriction both strains underwent before 
testing might also explain consumption of a stimulus by KO mice. B6 mice likely 
consumed more sucrose and less QHCl because of perceived palatability, and KO mice 
likely consumed all three stimuli at the same rate that B6 consumed water. Importantly, 
PBN effects may not strongly depend on volume consumed. Therefore, the elevated FLI 
could represent some aspect of consummatory behavior, such as gastric load, nutrient 
signaling in the small intestine, or feedback from other brain areas concerned with the 
onset of satiety. Indeed, the most robust response to sucrose occurred in the lateral PBN, 
in the cl or el, areas known to have a definite visceral-related function. Interestingly, 
QHCl evoked a much stronger response in B6 mice than in KO mice in some of these 
same lateral subnuclei. In previous experiments we have conducted in B6 mice using i.o. 
stimulation with QHCl (Boughter, unpublished), it is clear that the mice do not consume 
much of this stimulus; instead they display an obvious aversive reaction, even letting 
much of the solution drain from their mouths as they shake their heads. Therefore, 
elevated FLI in the B6 mouse (and the lack of it in the KO) in response to QHCl surely 
represents a taste- or at least orosensory-mediated effect. This in turn suggests that these 
lateral PBN subnuclei, especially cl and el, contain both taste- and viscerally-related 
neurons. This idea has much support in the literature 73. In fact, in rats, it has been noted 
that aversive stimuli such as QHCl or hydrochloric acid produce FLI in an “inner” 
division of the el, whereas visceral stimulation occurs in primarily an “outer” layer of this 
same subnucleus 66,269. In the much smaller el subnucleus in mice, any cytoarchitectural 
or functional division remains uncertain; in the present study, it is not clear that sucrose 
and QHCl FLI are topographically distinct. Future studies examining the independence of 
these modalities in the PBN could use next generation techniques such as TRAP to 
visualize activity to multiple stimuli, or to specifically interrogate the function of 
responsive neurons (e.g. McCullough et al., 2016 270). 
 
 The results of Experiment 6.1 impact the interpretation of the results of 
Experiment 6.2, in that stimulus-evoked FLI of projection neurons can be categorized by 
either their taste or visceral responsiveness. In this experiment, we found that sucrose and 
QHCl were roughly equivalent in terms of their FLI in either VTA or VPMpc-projecting 
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neurons. This equivalence extended to water, when the total amount of FLI expression 
was considered. The projection to VTA was stronger on the contralateral side, and almost 
completely independent of the projection to VPMpc (few cells DL for these tracers). This 
contrasts with prior findings that single PBN neurons often collateralized to two forebrain 
regions, i.e. VPMpc and AMY, or VPMpc and LH 69. It is also interesting that VTA-
projecting neurons were only rarely found in the el subnucleus, an area (as discussed 
above) with robust bitter taste and visceral responses. Of course, physiology studies find 
bitter-responsive neurons in other subnuclei as well 49, and tracing studies indicated a mix 
of taste (rNST) and visceral (cNST) to most parts of PBN 76. Therefore, activation of 
VTA projection neurons by sucrose or QHCl in other PBN regions may still be visceral 
or orosensory in nature, respectively. 
 
 We did notice a difference between stimulus-evoked FLI in the two experiments, 
with a significant effect of stimulus present in Experiment 6.2 but not in 6.1. The main 
driver in this difference was a greater level of water-evoked FLI in Experiment 6.1. It is 
possible that the different immunohistochemical techniques used for FLI in both 
experiments contributed to this difference, with a greater level of sensitivity perhaps 
found with the DAB staining technique as opposed to immunofluorescence.  
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CHAPTER 7.    LOCATION AND MORPHOLOGY OF VTA NEURONS 
RESPONSIVE TO TASTE STIMULI WITH VARIED VALENCE 
 
 
 NAc DA release and VTA activity in response to palatable taste stimuli has been 
well-established. It was previously found that the VTA increased FLI in response to 
palatable meals 212. First, we wanted to replicate this result and see if it was primarily a 
taste-evoked response or dependent on post-ingestional feedback. To achieve this end, we 
used TRPM5 KO mice as was mentioned in Chapter 6. Given that these mice were shown 
to be taste-blind to sweet and bitter stimuli 244,245, they allowed us to separate out 
responses to post-ingestional input. A second experiment set out to determine if activity 
in known VTA cell types produced a differential pattern based on taste valence. 
 
 We wanted to see if bitter and aversive QHCl would elicit FLI in the VTA as 
might be inferred from studies that showed the VTA to be responsive to aversive 
footshock 80 and the NAc to release DA to various aversive stimuli 127. Although the 
VTA responds to both palatable and aversive tastes, its DA neurons generally increase 
their phasic responses to palatable stimuli and decrease to aversive, although a small 
percentage are actually excited by aversive air puffs 92,151. Further investigation may help 
to explain some of the more nuanced responsiveness of the VTA. Both of the 
experiments in this chapter tested for responses to bitter QHCl and compared them to 
those to sweet sucrose. 
 
 The VTA may differentiate palatable and aversive tastes using separate 
anatomical pathways and with distinct activity within specific cell types or projections. 
Several subnuclei have long been defined within the VTA based on clustering patterns of 
TH+ cells 156 and projection 94. Although the VTA is known for being primarily DAergic, 
a relatively high population of GABA cells was also previously found 201. Some GABA 
cells in the VTA project to the same forebrain areas as the DAergic 198, and VTA DA and 
GABA neurons have been classified into various types based on responses to conditioned 
and reward stimuli 92. It would be interesting to know how activity in each of these cell 
populations in the VTA compares based on stimulation with pleasurable and 
displeasurable stimuli. 
 
 Additionally, we included the RRF and RMTg in our measurements of the 
midbrain anatomy. The RRF is a separate but related nucleus to the VTA; it has been 
anatomically well-studied but remains functionally nebulous 271,272. Waraczynski and 
Perkins (2000) 272 showed that inactivating it causes a loss in the reinforcing effect of 
electrically stimulating the medial forebrain bundle. Thus, the RRF was included in this 
study to determine if it contributed to taste reward. One longstanding controversy 
regarding the VTA GABA cells and subnuclei concerns whether the RMTg should be 
considered a VTA subnucleus. While we did not set out to resolve the issue, we did use 
our possession of transgenic mice with green fluorescent protein (GFP) hemizygously 
expressed on their gad1 promoters (GAD67-GFP mice) to attempt to observe this lesser 
understood subnucleus. Previous studies located the subnucleus in the posterior end of 
the VTA, sometimes referring to it as the “tail of the VTA” 166,194,197. We used these 
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studies along with our other delineation methods to attempt to quantify GAD67 neurons 
in the RMTg as well as the rest of the VTA. 
 
 To evaluate VTA activity with respect to particular regional and cell type 
populations, we conducted two experiments in which labeled neurons responsive to taste 
stimuli were quantified. Experiment 7.1 was a continuation of Experiment 6.1, but 
instead taste-evoked FLI was examined in the VTA. A second experiment used 
fluorescent labeling and confocal microscopy to observe FLI in DA or GABA cells in the 
VTA’s subnuclei and the RRF. The overall goal was to discover patterns in VTA activity 





 The same 36 B6 and KO mice used to collect DAB-stained FLI data from the 
PBN in Experiment 6.1 were also used for the VTA. Likewise, the same nickel-enhanced 
DAB immunohistochemistry was used to measure FLI in the VTA (Figure 7-1). 
 
 As an anatomical reference to align the section’s AP level, moving from rostral to 
caudal sections, the first section in which the medial lemniscus (ml) touched the cerebral 
peduncle (cp) was identified as -3.64 mm (post) bregma. FLI was measured separately in 
3 sections used in previous experiments to approximate the aVTA (-3.08), pVTA (-3.52), 
and tVTA (-3.88) 67,160-164,166,167,262. Except that counts were being done in the VTA, the 
same quantitative conditions for validity of FLI-positivity were applied as those done in 
Experiment 6.1 for the PBN. FLI labeled neurons were plotted and quantified from high-
resolution digital microscopic images (150 ppi) taken at 20x magnification using ImageJ 
(National Institutes of Health, USA) by an observer blind to condition. 
 
 After counting, conditions were revealed so the data could be categorized by 
strain and stimulus. Kolmogorov-Smirnov tests indicated most of the distributions were 
normal, and FLI was compared using parametric ANOVAs (SPSS). Greenhouse-Geisser 
corrected F ratios were used where Mauchly’s test indicated the sphericity assumption 
was not met. Significance level was α = 0.05 for main effects and interactions, and post 





 Fos was stained in the VTA with DAB to measure FLI in B6 and KO mice after 
i.o. stimulation with palatable sucrose, aversive QHCl, and neutral water. In initial 
observations of these sections (Figure 7-1), those of B6 appeared to have higher FLI than 
sections taken from KO mice. Thus, we tested this quantitatively. 
 
 We had no reason to expect left-to-right side differences, so we summed FLI in 
the AP sections and conducted an omnibus ANOVA (within-subjects factor for side; 





Figure 7-1. FLI in VTA measured with DAB immunohistochemistry in B6 and 
TRPM5 KO mice. 
 
A, B. Sucrose elicited FLI. C, D. QHCl-elicited FLI. A, C. FLI in B6 mice. B, D. FLI in 
TRPM5 KO mice. IF, interfascicular nucleus; IPN, interpeduncular nucleus; ML, medial 
lemniscus; PBP, pigmented parabrachial nucleus; PN, paranigral nucleus; RLi, raphe 
linear nucleus. Scale bar = 100 μm.  
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for sphericity and the Greenhouse-Geisser corrected F-ratio was used for determination 
of side difference. No effect of side was found (F(1, 30) = 0.88, p = 0.357). Further, no 
interactions were found of side with stimulus (F(2, 30) = 0.21, p = 0.81) or strain (F(1, 30) = 
0.13, p = 0.725). Between-subjects tests were not significant for strain (F(1, 30) = 1.27, p = 
0.268) or stimulus (F(2, 30) = 0.95, p = 0.399). 
 
 With effects of side ruled out, we averaged the FLI across left and right VTA. 
Since prior studies suggested differences in AP levels of VTA 164, our follow-up ANOVA 
expanded this as a within-subjects factor (and kept between-subjects factors for stimulus 
and strain). We expected to find a significant strain difference reflecting our visual 
observation of FLI (Figure 7-1); stimulus group differences were also expected, 
especially for sucrose, which is palatable (and rewarding), compared to neutral water. AP 
level data passed Mauchly’s test of sphericity. The effect of AP level was significant (F(2, 
60) = 8.62, p = 0.001); however, no effects of strain (F(1, 30) = 1.27, p = 0.268) or stimulus 
(F(2, 30) = 0.95, p = 0.399) were found. Neither were interactions for AP level with strain 
(F(2, 60) = 0.07, p = 0.937) or stimulus (F(4, 60) = 0.81, p = 0.526). A post hoc Bonferroni 
test indicated FLI was lower in sections collected at - 3.52 mm post bregma (mean = 15.5 
± 2.9) as compared to the other two AP levels (mean difference to - 3.08 = -19.7, - 3.88 = 
-15.8, p < 0.05). This prompted us to keep the data for FLI across side averaged but 
analyze data in each section level for stimulus and strain differences with two-way 
ANOVAs. Again, no main or interaction effects for strain or stimulus were found (Table 
7-1). Mean number of FLI neurons for each stimulus/strain group were individually 
calculated and displayed with Figure 7-2. 
 
 To determine which groups were responsible for the lower FLI at - 3.52 mm post 
bregma, one-way ANOVAs (AP level) were used to test each stimulus/strain group 
individually. Results of these analyses are shown in Table 7-2, including whether 
Mauchly’s test of sphericity passed indicating whether a corrected F-ratio was used to 
determine significance. Although most of the p values from these tests were near the a 









 CB6-Tg(Gad1-EGFP)G42 transgenic mice bred with GFP expressed 
hemizygously on the gad1 promoter (GAD67-GFP mice) allowed the identification of 
GABAergic neurons 198,273,274. 12 GAD67-GFP mice were used for the GAD67 
experiment (ages on stimulation d: 68 – 89 d, mean = 77 ± 3 d, 6 male, 6 female). Sample 
sizes of groups were similar to those published in other studies 198.  
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Table 7-1. Results of ANOVAs at VTA AP levels. 
 
 Strain  Stimulus  Strain X Stimulus 
Level  F* p-Value  F* p-Value  F* p-Value 
-3.08  0.36 0.552  0.29 0.753  0.60 0.553 
-3.52  3.24 0.082  1.40 0.263  0.04 0.965 
-3.88  1.02 0.322  1.60 0.218  0.48 0.622 
 







Figure 7-2. FLI in B6 and KO mice to taste stimuli. 
 
Mice were i.o. infused with sucrose, QHCl, and water. Data from sections were averaged 
across left and right; then, these section values were summed to produce a total number 
of FLI neurons in the VTA for each case. Cases in each strain/stimulus group were 
averaged to provide its mean number of FLI neurons. Apparent trending differences 
between FLI in B6 and KO mice were not statistically different.  
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Table 7-2. Results of ANOVAs testing AP level for each strain/stimulus group. 
 
Test Mauchly's Fa,b p-Value G-Gc Significantd 
Sucrose B6 0.023 2.31 0.185 Yes No 
Sucrose KO 0.511 2.28 0.152 No No 
QHCl B6 0.943 1.30 0.315 No No 
QHCl KO 0.911 3.32 0.078 No No 
H2O B6 0.015 3.81 0.104 Yes No 
H2O KO 0.618 2.38 0.143 No No 
 
a. Greenhouse-Geisser corrected F-ratio was used if Mauchly’s test of sphericity was not 
passed. 
b. df were 1, 5 
c. Decision if Greenhouse-Geisser indicated to use corrected F-ratio. 





 To stain TH and FLI, we stained the sections as in Chapter 5. Prior to the primary 
and secondary incubation steps, we used 3% normal donkey serum for blocking (Jackson 
ImmunoResearch Laboratories). We incubated sections in mouse anti-TH (22941, 
ImmunoStar, Hudson, WI, USA, diluted to 1:5000) and rabbit anti-c-Fos (sc-52, lot 
#F2510 Santa Cruz Biotechnology, diluted to 1:5000; sc-52, lot #F3016 Santa Cruz 
Biotechnology, diluted to 1:500; or, ABE457, Millipore, diluted to 1:2000). Next, we 
used biotinylated donkey anti-rabbit IgG for secondary (Jackson ImmunoResearch, 
diluted to 1:1000) and DyLight 649-conjugated streptavidin for a fluorophore (SA-5649, 
Vector Laboratories, Burlingham, CA, USA, diluted to 1:1000). In the last steps, 
biotinylated donkey anti-mouse for secondary (Jackson ImmunoResearch, diluted to 





 As an anatomical reference to align the section’s AP level, moving from rostral to 
caudal sections, the first section in which the ml touched the cp was identified as -3.64 
mm (post) bregma. VTA subnuclei and the RRF (abbreviated as “subnuclei” from this 
point forward) were delineated using the Paxinos and Watson atlas, except for a few 
sections indicated by previous studies to contain VTA more anteriorly (see Lammel et al., 
2008 94). Detailed diagrams of the subnuclei delineated can be seen in Figure 7-3. TH-, 
GAD67-, and FLI-labeled neurons were plotted and quantified using ZEN software 
(black, black lite, and blue lite editions; Carl Zeiss, Thornwood, NY, USA). 14 
representative sections, primarily at beginning and end points of subnuclei, were selected 
rostrocaudally mm relative to bregma: -2.73, -2.97, -3.05, -3.29, -3.37, -3.45, -3.53, -3.69, 
-3.77, -3.85, -4.01, -4.25, -4.33. Beginning and end points of subnuclei were as follows: 
PBP, -2.73 to -3.93; RLi, -3.05 to -3.93; IF, -3.05 to -3.8; PN, -3.37 to -3.77; RMTg, -
3.53 to -4.41; RRF, -3.77 to -4.25; and, CLi, -4.01 to -4.41. 
 
 Obvious landmarks were used to delineate subnuclei, including the 
interpeduncular fossa that appears medially (~-3.05) and dorsal to the mammillary 
nucleus (MM), the detachment of the MM (~-3.13), and expansion of the rostral 
subnucleus of the interpeduncular nucleus (IPN; beginning ~-3.21). In the most anterior 
sections, the medial and lateral pigmented parabrachial subnuclei (mPBP and lPBP, 
respectively) were approximated in the atlas’ unlabeled triangle within the LH, zona 
incerta (ZI), or posterior hypothalamus (PH). This area overlaps where Paxinos and 
Watson label the VTA’s location in more posterior figures (Note: sagittal sections of 
Paxinos and Watson, Allen Brain Atlas, and Lammel et al. indicate the VTA extends 
more anterior than what is labeled in coronal sections of Paxinos and Watson; Lammel et 
al. indicates mPBP begins at this most anterior, but Allen Brain Atlas only appears to 
label lateral). The midline was approximated down the middle of the section using medial 
structures. The cp, SN, and ml were used to approximate the most lateral boundary. In 
more anterior sections a line was drawn ventrally from the ml to separate lPBP from the 





Figure 7-3. Semi-consecutive representative sections containing VTA subnuclei. 
 
Sections were Nissl-stained with cresyl violet to reveal cytoarchitecture. Values in 
bottom right denote mm post bregma. Left boundary of images is midline. VTA 
subnuclei: PBP, pigmented parabrachial; RLi, rostral linear nucleus of the raphe; IF, 
interfascicular; PN, paranigral; RMTg, rostromedial tegmental; RRF, retrorubral field; 
CLi, caudal linear nucleus of the raphe. All pictures at same magnification, scale bar in N 
= 25 μm. cp, cerebral peduncle; IPN, interpeduncular nucleus; ml, medial lemniscus; 
MM, mammillary nucleus; RN, red nucleus; SN, substantia nigra.  
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A line drawn from the ml or tracing the TH+ cells medially approximated the dorsal 
boundary. In anterior sections, a line drawn dorsal to the MM or the IPN or outlining the 
TH+ cells from the lateral boundary approximated the ventral boundary. In posterior 
sections, the PBP ended and the RRF and CLi were approximated by outlining clusters of 
TH+ cells corresponding to locations labeled in the Paxinos and Watson atlas. The PBP 
was split into medial and lateral areas by a line drawn from the center of the MM or IPN 
and dividing the scp/red nucleus (RN) in half. The ventral disappearance of the ventral 
tegmental decussation was estimated as the ventral limit of the RLi and dorsal limit of the 
IF. The dorsal boundary of the IF and ventral boundary of the ml was used to estimate the 
PN in more anterior sections. Moving posteriorly, at the section when the distance 
between the ml and cp became shorter than the thickness of the IF, the thickness of the 
PN was estimated to be equal to that of the IF. The remaining boundaries of subnuclei, 
except the RMTg, were approximated according to Paxinos and Watson and/or where 
noticeable TH+ cells clustered. The RMTg was approximated by drawing a circle around 
the cluster of GAD67+ cells which first appear in the lPBP and, continuing posteriorly, 
appear to migrate medially. This GAD67+ cluster overlapped other subnuclei (e.g., PBP 
and RLi); thus, some overlap of cell counts occurred for this subnucleus only. However, 
RMTg data was analyzed separately from that of the remaining VTA and RRF. 
 
 When left and right side anatomy was noticeably asymmetrical, the difference in 
the AP level was estimated by multiplying the number of sections between each side’s -
3.64 section by 80 μm. If the difference in AP level was < ~ 160 μm, medial and lateral 
subnuclei were matched as though no difference existed; if the difference was ≥ ~ 160 
μm, medial and lateral subnuclei were treated as though they were 80 μm apart (i.e., 
staggered medial and lateral subnuclei counts by 1 section). 
 
 
Quantification and Analysis 
 
 Z-stack images were collected with confocal microscopy (equipment details in 
Chapter 5) through the sections with the aim of using the best image in the stack (i.e., one 
in which the entire VTA had cells visible) for counting. This resulted in roughly 2 to 6 
images per stack through 10 to 15 μm for each dry section. Images were collected at 20x 
magnification, and the optical section thickness ranged from about 1 to 3 μm. 
Cells/nuclei were counted in ZEN by visualizing the images in double or single channels. 
DL cells/nuclei were marked first followed by single-labeled. Total counts were 
calculated by adding DL cells/nuclei to the single-labeled counts within the same 
categories. A cell/nucleus was only counted as valid if it was > 50% within the delineated 
area and not overlapping with another cell/nucleus counted in the same category (i.e., 
FLI, TH, or GAD67). A cell/nucleus was only counted as TH+ (cyan), GAD67+ 
(magenta), or FLI+ (yellow) if > 75% of the structure was in the plane visualized and 
approximately ≥ 50% brightness/density relative to other visible structures of that same 
classification (judged by observer). Cells were only counted as TH+, if a bright cell body 
was visibly enclosing a dark nucleus. To be counted as double or triple-labeled, criteria 
for 2 or 3 of the above labeling requirements had to be met for the same cell/nucleus, and 
where it would be expected, a change in color visualized had to occur (e.g., GAD67 and 
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FLI overlap in the nucleus and blend colors). Quantification only included the right side, 
i.e., ipsilateral to the cannula. Bar graphs were made to compare DA and GABA cell 
counts/ratios between nuclei by AP level (see Figures S3C and S4E in Lammel et al., 
2008 94). To assess whether appetitive or aversive taste stimuli preferentially elicited 
activity in subnuclei or cell types, we analyzed data collected by projection, FLI 
positivity, and double labeling. ANOVAs were used to test for differences, followed by 





 Figure 7-4 depicts example micrographs of TH, GAD67, and FLI labeling found 
throughout the subnuclei. FLI double-labeling (with TH or GAD67) was also found, but 
double-labeling of TH and GAD67 was not. Both TH+ and GAD67+ cells varied 
significantly in shape and size and typically had processes visibly extending from their 
somas. FLI+ nuclei were typically circular or ovoid in shape. DL TH+ and FLI+ cells met 
both sets of criteria above as well as a FLI+ nucleus approximating the shape of the dark 
area within the TH+ cell body. DL GAD67+ and FLI+ cells met both of their criteria 
above; the overlap of the FLI+ nucleus and GAD67+ cell produced an off-white merged 
color. A priori criteria for DL TH+ and GAD67+ as well as triple-labeled cells were 
defined; however, neither was found in sections. 
 
 
TH and GAD67 Cells 
 
 DA and GABA neurons were identified by fluorescently labeling TH and 
GAD67, respectively. We expected to find similar distributions of TH+ cells in specific 
subnuclei as were previously found 94,156 as well as a distinct cluster of GAD67+ cells 
posteriorly in the RMTg 166,197. The mean number of TH+ cells found was 743, and for 
GAD67+, 198. Although we expected cell-type labeling to differ by subnuclei, we did not 
expect a difference for stimulus group. We tested this for both cell types with ANOVAs 
(within-subjects for subnuclei, between-subjects for stimulus). As expected, TH differed 
for subnucleus (F(6, 54) = 112.17, p < 0.001), but not stimulus (F(2, 9) = 0.17, p = 0.851); 
GAD67 also differed for subnucleus (F(6, 54) = 66.12, p < 0.001), but not stimulus (F(2, 9) = 
1.02, p = 0.4). Since the VTA varies substantially along its AP axis, a similar pair of 
analyses was conducted for AP level by reorganizing the data and repeating the tests. 
Again, we expected difference in subdivision (i.e., AP level), but not stimulus group. In 
this case, TH differed for AP level (F(13, 117) = 33.75, p < 0.001), but not stimulus (F(2, 9) = 
0.17, p = 0.851); likewise, GAD67 differed for AP level (F(13, 117) = 17.85, p < 0.001), but 
not stimulus (F(2, 9) = 0.2, p = 0.821). TH+ and GAD67+ cells were distributed throughout 
the VTA within its subnuclei and at varying AP levels as shown in Figures 7-5 and 7-6. 
Most of the TH+ cells were located within the lPBP (Figure 7-5A). The second-highest 
counts of TH+ cells were in the RLi and RRF, followed by the PN, IF, mPBP, RMTg, 
and CLi (Figure 7-5B). Most of the GAD67+ cells were found in the RMTg, followed by 
the lPBP and RRF (Figure 7-5C). Next to these, some GAD67+ cells were found in the 





Figure 7-4. Examples of taste-elicited c-Fos in TH and GAD67 VTA neurons. 
 
A-C. Sucrose elicited c-Fos. D-F. QHCl-elicited c-Fos. A, C, & D. Lateral pigmented 
parabrachial subnucleus. B & E. Border of pigmented parabrachial and paranigral 
subnucleus. F. Rostral linear nucleus of raphe. Cells with FLI are indicated with red 





Figure 7-5. TH+ and GAD67+ cells in VTA subnuclei. 
 
Depending on the subnucleus, different numbers of TH+ and GAD67+ cells were found, 
in part due to the differences in subnuclei volume and cell density. A. TH in the VTA: 
lPBP had an overwhelmingly large proportion of TH. To give a better perspective of TH 
in VTA, a second graph was made excluding lPBP, B. B. In order of means from highest 
to lowest, TH neurons were found in the RLi, RRF, PN, IF, mPBP, RMTg, and CLi. C. 
GAD67 in the VTA: lPBP, RMTg, and RRF had far more GAD67+ neurons in the VTA. 
Again, a second graph was made to allow perspective for the GAD67 in the remaining 
subnuclei, D. D. mPBP and RLi had fairly high GAD67, while the IF, PN, and CLi were 





Figure 7-6. TH+ and GAD67+ cells in the VTA organized by AP level (mm 
relative to bregma). 
 
A. TH+ cells increase moving posteriorly until ~-3.29 where they plateau until they 
decrease again beginning at ~-3.85. B. GAD67+ cells form to peaks, the first of which 
begins its increase after -2.97 and drops back by -3.29, only to increase again starting at -
3.45 and decrease again at -3.85. Lines between A and B indicate the subnuclei present at 
each anterior-posterior level.  
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and -3.85 mm post bregma (Figure 7-6A). GAD67+ cells formed two peaks at -3.05 and 
-3.77 mm post bregma (Figure 7-6B). 
 
 The RMTg was recognizable as a roughly ovoid cluster of GAD67+ cells with 
boundaries that overlapped with several of the other subnuclei (e.g., RRF, lPBP, CLi). 
Also noteworthy was this subnucleus’ movement from a more lateral position to more 
medial moving posteriorly. ANOVAs to test for differences between stimulus groups 
revealed none occurred for TH (F(2, 9) = 0.43, p = 0.611) nor GAD67 (F(2, 9) = 0.07, p = 
0.935). A peak in TH+ cells was seen at -3.77 mm post bregma (Figure 7-7A), and 
GAD67+ cells were fairly stable from -3.53 to -4.01 mm post bregma but dropping off 
more posteriorly (Figure 7-7B). 
 
 
FLI and Double-labeling 
 
 FLI was measured in the subnuclei and cell types (DA, GABA) after stimulating 
them with sucrose, QHCl, and water (control). Differentials in FLI were expected (either 
by subdivision [i.e., subnuclei, AP level], by cell type, or some combination of these) on 
the basis of taste stimulus group. FLI measurements alone in the subnuclei and at several 
AP levels did not pass normality tests. Hence, “FLI ratios” were calculated (FLI of 
subdivision / total FLI in VTA) and analyzed. The majority of the FLI ratios were 
distributed normally around means and passed normality tests; thus, parametric statistical 
tests were used on the calculated FLI ratios. Two-way repeated measures ANOVAs were 
used to test for differences in subnucleus and AP level as within-subjects variables and 
for stimulus group as a between-subjects factor. Differences in subdivision were 
expected, but these would more likely be due to differences in volumes and raw counts of 
cells than to actual differences in responsiveness to stimuli across subnuclei; we also 
hypothesized a differential in responses to taste stimuli may occur in subdivisions, which 
would be indicated by significant taste stimulus or stimulus X subdivision effects. 
Subnucleus was a significant main effect (F(6, 54) = 50.5, p < 0.001), but no difference was 
found for stimulus group (F(2, 9) = 2.92, p = 0.105). Further, no difference was found for 
the subnuclei X stimulus interaction effect (F(12, 54) = 1.47, p = 0.165; Figure 7-8). No 
difference was found for the stimulus group with the data organized by AP level either 
(F(2, 9) = 0.05, p = 0.953). However, FLI in AP levels was different (F(13, 117) = 25.7, p < 
0.001), and the AP level X stimulus group interaction was significant (F(26, 117) = 1.95, p = 
0.009; Figure 7-9). Follow-up Bonferroni tests revealed the section difference to be due 
to FLI ratios at -3.85 and -3.93 post bregma, which were higher (p < 0.05) to QHCl (-
3.85 mean = 0.131; -3.93 mean = 0.153) than to sucrose (-3.85 mean = 0.061; -3.93 mean 
= 0.073) and water (-3.85 mean = 0.087; -3.93 mean = 0.066). Data in sections at -3.85 
and -3.93 were extracted for further tests to check for differences to taste stimuli in their 
subnuclei, but no differences were found.  
 
 FLI occurred in both TH and GAD67 cells, but no cases of TH + GAD67 or 
triple-labeling were found. Labeling of FLI, TH, and GAD67 likely influence the counts 
of TH + FLI and GAD67 + FLI DL cells; thus, this data was analyzed both for 





Figure 7-7. TH+ and GAD67+ neurons in the RMTg subnucleus of the VTA. 
 
A. TH+ cells form a peak beginning their increase at -3.69 to decrease at -3.85. B. 






Figure 7-8. FLI ratios in VTA subnuclei to taste stimuli. 
 
FLI ratio varied significantly across subnuclei (p < 0.001) likely reflecting changes in 
subnucleus volume and cell density. However, no differences were found between taste 





Figure 7-9. FLI ratios to taste stimuli in the VTA by anterior-posterior level. 
 
Variation in FLI ratio across AP level was significant, but this was probably due to the 
area and cell density at each level. Taste stimulus was not a significant factor; however, 
the AP level X stimulus group interaction was significant (p = 0.009). Further, FLI ratio 
to QHCl was found to be significantly higher than water or sucrose in the sections at -
3.85 and -3.93. Asterisks denote significance level: * p < 0.05, ** p < 0.005.  
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constituents (e.g., TH + FLI counts in each subdivision [i.e., subnucleus, AP level] were 
divided by that subdivision’s TH and analyzed, then by that subdivision’s FLI and 
analyzed separately). Differences in subdivisions were expected as well as the possibility 
that some differential may occur in cell types to taste stimuli. Tests for sphericity failed, 
and Greenhouse-Geisser corrected F-ratios were used for determining significance. 
Results from the analyses of the TH + FLI double-label counts are presented in Figure 
7-10. The effect of subnucleus was significant (F(6, 54) = 3.95, p = 0.02), but stimulus 
group (F(2, 9) = 0.59, p = 0.576) and the subnucleus X group interaction (F(12, 54) = 0.76, p 
= 0.606) were not (Figure 7-10A). When the data was reorganized into AP level (Figure 
7-10B), similar results were found with a significant effect of level (F(13, 117) = 3.95, p = 
0.011) and acceptance of null hypotheses for stimulus (F(2, 9) = 0.59, p = 0.576) and the 
interaction (F(26, 117) = 1.38, p = 0.243). The effects of subdivisions in these cases can be 
explained by differences in the number of neurons as the volume or cell density of a 
subdivision changes. Analyzing ratios of double-label counts with respect to their 
constituents allows a test which compensates for this; thus, their significant subdivision 
effects are more meaningful. When TH + FLI counts were divided by FLI, subnucleus 
remained significant (F(6, 54) = 4.39, p = 0.022) and an effect of stimulus group was found 
(F(2, 9) = 4.51, p = 0.044). However, no interaction of subnucleus X group was found (F(12, 
54) = 1.61, p = 0.206). When TH + FLI counts were divided by TH, subnucleus was again 
found to be significant (F(6, 54) = 6.74, p = 0.002). Although the stimulus group for this 
adjustment was not significant (F(2, 9) = 1.21, p = 0.343), the subnucleus X group 
interaction was (F(12, 54) = 3.61, p = 0.01). These results suggest responses to taste stimuli 
vary in subnuclei but do so in a way relative to their overall FLI and TH expression. 
While adjusting for FLI revealed a difference in VTA TH + FLI expression to taste 
stimuli, adjusting for TH suggested the differences were within individual subnuclei. 
Bonferroni post hoc analyses were conducted for both of the adjusted DL counts to 
determine which subnuclei and taste stimuli were responsible for the effects. The analysis 
of TH + FLI relative to FLI data indicated a higher mean ratio to QHCl in the RLi and 
CLi (mean ratios = 0.4, 0.33, respectively) compared to water (mean ratio = 0.1, 0, 
respectively; p < 0.05). Mean ratios of taste stimuli in the rest of the subnuclei were not 
found to be significantly different. The analysis of TH + FLI with respect to TH data 
indicated mean ratios in CLi for water (mean ratio = 0), sucrose (mean ratio = 0.09), and 
QHCl (mean ratio = 0.17) were all significantly different (p < 0.05); again, the other 
subnuclei showed no differences. Together, these results strongly suggest a differential 
response to taste stimuli in the VTA TH neurons, especially in those of the CLi 
subnucleus (Figure 7-11). Like the double- label counts, the data for both ratios were 
reorganized into AP level. When TH + FLI was adjusted by the FLI count, AP level was 
not significant (F(13, 117) = 2.38, p = 0.101; Figure 7-12). Interestingly, an effect of 
stimulus group occurred (F(2, 9) = 5.61, p = 0.026), confirming the overall result for VTA 
found when analyzing the subnuclei data. The interaction of AP level X stimulus group 
was not significant (F(26, 117) = 0.97, p = 0.46). When TH + FLI was divided by TH, AP 
level was significant (F(13, 117) = 5.26, p = 0.021); however, the lack of significance in the 
counts with respect to FLI suggests this effect is partially stochastic and merely differed 
as the result of overall FLI differences. Stimulus group (F(2, 9) = 1.27, p = 0.327) and the 
interaction of group and level (F(26, 117) = 0.71, p = 0.57) were also not significant. A 





Figure 7-10. TH + FLI counts to taste stimuli in the VTA. 
 
Subdivision was a significant factor when analyzing double-labeled TH + FLI cells in the 
VTA’s subnuclei (A) and at its AP levels (B); however, this was possible to the extent 
that subdivision volume and cell density varied. No differences were found in this raw 





Figure 7-11. TH + FLI ratios to taste stimuli relative to constituents in VTA 
subnuclei. 
 
When double-labeled TH + FLI counts were analyzed as ratios of their constituents, 
differences remained significant within subnuclei and stimulus group became a 
significant factor. A. Relative to TH counts, TH + FLI cells were different for the 3 
stimuli in CLi (p < 0.05). B. Relative to FLI, the RLi and CLi contained significant 





Figure 7-12. TH + FLI ratios to taste stimuli relative to constituents along AP axis 
of the VTA. 
 
When TH + FLI was adjusted by the FLI count, AP level was not significant. An effect of 
stimulus group occurred, confirming the overall result for VTA found when analyzing the 
subnuclei data. The interaction of AP level X stimulus group was not significant. When 
the double-labeled counts were divided by TH (data not shown), no effects were found, 
suggesting the stimulus group effect occurred as a result elevated TH counts.  
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Table 7-3. Significant effects were only found for subnucleus DL counts and GAD67 + 
FLI with respect to FLI. The former are expected to be due to variation in subnuclei 
volume and cell density, and the latter likely occurs from variation in GAD67+ neuronal 
count since the effect was not found when the data was adjusted for GAD67 cells. 
 
 The RMTg was segregated in the analyses because its area overlapped with other 
subnuclei. We conducted separate but similar analyses on FLI, double-labeling, and ratio 
data from the RMTg. The main difference in these was the only subdivision analyzed was 
AP level (it is only one subnucleus and it was not compared with statistical tests to the 
others). FLI ratios were calculated for the RMTg and tested for AP level and stimulus 
group effects with a two-way repeated measures ANOVA. AP level was significant (F(7, 
49) = 2.52, p = 0.027). Stimulus group (F(2, 7) = 4.55, p = 0.054) and interaction effects 
(F(14, 49) = 1.59, p = 0.116) were not. DL data for the RMTg was analyzed in a similar 
manner as the other subnuclei. In TH + FLI counts, neither AP level (F(7, 49) = 1.33, p = 
0.257) nor stimulus group (F(2, 7) = 1.64, p = 0.261) were significant. A significant AP X 
stimulus interaction effect was found (F(14, 49) = 1.95, p = 0.044), but this may reflect 
changes in the constituents instead. No other significant effects were found when the TH 
+ FLI data were analyzed with respect to their constituents, nor were any found for 





 Results gained from measuring i.o.-evoked FLI in the VTA using DAB histology 
were inconsistent with the PBN study (Experiment 6.1) both in terms of stimulus effects 
and mouse strain (B6 vs. KO). Previously, microdialysis and electrophysiological studies 
showed that oral sucrose stimulation is followed by DA being released from neurons 
within the midbrain DAergic complex. With the VTA being one step away from the 
periphery compared to the PBN and receiving PBN input, we expected the VTA’s i.o.-
evoked activity to reflect the PBN’s. Deletion of the TRPM5 channel gene results in a 
loss of transduction in bitter and sweet TRCs. However, no FLI differences occurred in 
the VTAs between B6 and KO mice, suggesting the VTA may lack responsiveness to the 
taste aspects of these stimuli. Although we found FLI in the VTA to both sucrose and 
QHCl, it was not greater than that resulting from water stimulation. We were also unable 
to show a differential in FLI to sucrose versus QHCl–tastes with opposite hedonic 
impacts. Several explanations for this lack of consistency between areas are possible: 
greater neuronal representation of visceral or TRPM5-independent gustatory inputs 
(discussed in Chapter 6) in the VTA; or conversely, PBN input conveying specificity 
about tastants vs. water may represent only a small part of the VTA activity following the 
type of behavior we measured here. It is also possible that FLI is not an optimal 
technique for estimating neuronal activation in this area relative to the PBN (see 
discussion of limitations in Chapter 9). The one effect found was lower FLI in the section 
at - 3.52 mm post bregma, but this was found in all 3 groups and could be due to 
differences in cell counts. An additional cross-cutting analysis of data from Experiments 
6.1 and 7.1 was conducted to help explain the unexpected discord between the PBN and 
VTA FLI. Those results are discussed in Chapter 9.  
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Table 7-3. Effects in VTA GAD67 + FLI double-labeled neurons. 
 
Subdivision* DL/Denominator Factor df F p-Value 
subN DL subN 6, 54 5.33 0.015 
stimulus 2, 9 0.99 0.410 
subN X stimulus 12, 54 1.89 0.156 
subN FLI subN 6, 54 5.32 0.011 
stimulus 2, 9 0.91 0.438 
subN X stimulus 12, 54 0.96 0.462 
subN GAD67 subN 6, 54 0.50 0.570 
stimulus 2, 9 1.13 0.372 
subN X stimulus 12, 54 0.40 0.685 
AP DL AP 13, 117 2.14 0.134 
stimulus 2, 9 0.99 0.410 
AP X stimulus 26, 117 1.13 0.374 
AP FLI AP 13, 117 1.55 0.220 
stimulus 2, 9 1.26 0.329 
AP X stimulus 26, 117 0.93 0.492 
AP GAD67 AP 13, 117 1.65 0.177 
stimulus 2, 9 0.83 0.466 
AP X stimulus 26, 117 0.72 0.682 
 
* subN, subnucleus; AP, anteroposterior level  
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Table 7-4. Effects in RMTg double-labeled neurons. 
 
Cell Type DL/Denominator Factor df F p-Value 
TH DL subN 7, 49 1.33 0.257 
stimulus 2, 7 1.64 0.261 
subN X stimulus 14, 49 1.95 0.044 
TH FLI subN 7, 49 0.42 0.622 
stimulus 2, 7 0.81 0.482 
subN X stimulus 14, 49 0.66 0.600 
TH TH subN 7, 49 0.77 0.449 
stimulus 2, 7 0.24 0.793 
subN X stimulus 14, 49 0.55 0.651 
GAD67 DL AP 7, 49 3.07 0.058 
stimulus 2, 7 0.39 0.692 
AP X stimulus 14, 49 1.21 0.343 
GAD67 FLI AP 7, 49 0.52 0.672 
stimulus 2, 7 0.13 0.885 
AP X stimulus 14, 49 0.48 0.815 
GAD67 GAD67 AP 7, 49 0.59 0.552 
stimulus 2, 7 1.27 0.340 




 The contradictory results between Park and Carr (1998) 212, Kest et al. (2012) 161, 
and Mungarndee et al. (2008) 275 further suggests a need for nuance when discussing the 
communication of taste-to-reward nuclei, i.e., distinctions between oral and visceral 
origins must be considered. FLI elicited in the VTA of rats in the Park and Carr study 212 
was to meals of chow, sucrose, and vegetable shortening, a substance the rats found 
palatable and were allowed to fully ingest. Similarly, Kest et al. (2012) 161 found elevated 
FLI in VTA TH neurons after rats consumed food pellets. In these two studies, one 
cannot determine whether FLI in the VTA was due to oral, visceral, or a combination of 
their input. However, rats in Mungarndee et al. (2008) 275 had surgically-fistulated 
stomachs which emptied into troughs at the bottom of their cages, i.e., no 
viscerosensation occurred. With this manipulation, differences in FLI between water and 
taste stimuli could easily be assumed to be specific to taste, but none occurred in the 
VTA to 0.6 M sucrose solution. These findings further support the idea that 
viscerosensation produces a strong, and perhaps the only, effect in the VTA to appetitive 
stimuli. Two final notes can be made that these studies used rats while ours involved 
mice; we used a PAP immunohistochemical protocol while the others used ABC 
methods. Neither of these methodological differences provides parsimonious 
explanations for the conflicting results; however, they may be all that is available to help 
explain why we found no difference in FLI in the VTA in our sucrose-stimulated mice, 
which should at the least have been elevated by the intact viscerosensation. 
 
 The TH+ and GAD67+ cells were seen distributed throughout the VTA and RRF 
as expected, including with significant counts of TH+ neurons in the PBP and PN 
subnuclei as were found in previous studies 94,156. A cluster of GAD67+ cells, identified 
as the RMTg, were found posteriorly which started laterally and moved medially in more 
posterior sections, overlapping with other subnuclei. The identification of these midbrain 
areas allowed the investigation into their potential differential activity to taste stimuli. 
 
 FLI ratio in the AP data was significant in posterior sections, and TH + FLI data 
with respect to constituents showed significant activity in CLi. These findings suggest a 
differential effect is occurring in these posterior TH+ cells to taste stimuli. More so, this 
effect appears to be due to responses to QHCl, which somewhat conflicts with the 
narrative that palatable stimuli should be more effective. Instead, these data show the 
VTA response to an aversive stimulus, however, one with a likely potent salience (e.g., if 
bitter was equated with poison). The effect of TH + FLI with respect to FLI to taste 
stimuli remained a trend when DL counts were adjusted by TH, suggesting the 
differential was only marginally reduced by accounting for the number of TH cells which 
could have potentially shown activity. Although few studies have attempted to narrow in 
on the differential of reward responses of individual VTA subnuclei (especially the RLi 
and CLi), the RLi was previously found to have a role in reinforcing the behaviors 
involved in heroin use 276. This is interesting in light of our finding that RLi TH + FLI 
was elevated in response to QHCl when data was adjusted by FLI. An AP X stimulus 
interaction effect in the RMTg TH + FLI data was found. However, this subnucleus is 
defined by its GAD67+ cell population; effects in GAD67 + FLI data would have been 
more impressive but were not found. Further, the lack of effect in the TH + FLI data with 




 The difference in findings between the DAB and double-labeling data may be due 
to a couple of additional factors accounted for in the double-labeling data. For one, cell 
labeling, i.e., TH positivity, allowed a reference for neuronal count in the VTA. Second, 
measures and comparisons of individual subnuclei were made in Experiment 7.2. Also, 
the a, p, and t distinction (essentially, an AP level factor) may not be as functionally 
important (at least not for taste stimuli) as subnuclei distinctions. Activity in GABA 
neurons appeared unimportant since few of these were FLI+. Anatomical studies of the 
VTA and forebrain, including tracing investigations using advanced methods, will help to 
identify VTA function in motivated behaviors like feeding. For example Beier et al. 
(2015) 202 found an anterior cortex to VTA-DA to lateral NAc circuit to be reinforcing. 
De Luca (2014) 239 was also able to show that DA release in forebrain areas that receive 
medial input (i.e., NAcc and mPFC) does not habituate. Thus, our finding that the DL TH 
+ FLI occurred in two of the VTA medial subnuclei may be supported by this evidence of 
ML differential. While the lateral circuitry may be more important for the development of 
preference, the medial projections may inform the system about aversive stimuli. 
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CHAPTER 8.    MODULATION OF FEEDING BY MANIPULATING THE VTA 
 
 
 Our neuroanatomical approaches strongly suggested that taste stimuli varying in 
their hedonic valence, and in post-ingestive potency, elevated activity in neurons in the 
PBN and VTA, including PBN neurons that project to the VTA. A reasonable topic for 
subsequent inquiry was to investigate What effect might this circuit have on feeding? 
Hajnal and Norgren (2005) 216 showed that oral application of sucrose results in DA 
release in the NAc, and lesioning the PBN diminished this release, indirectly implicating 
the PBN-VTA circuit as one which may mediate the affect associated with 
consummatory and appetitive  feeding behaviors. Considered with other observations that 
the PBN projected to the VTA 80, including our own (Chapter 6), it seemed plausible that 
destruction of the PBN could have caused the decreased DA release in the NAc through 
direct disruption of this pathway. Other studies have shown DA release in the NAc to 
palatable stimuli 127,239 suggesting the system for incentive salience is being activated 10. 
Therefore, manipulating this pathway to increase or decrease that DA function should 
also affect feeding. 
 
 Activating the VTA-to-NAc neurons with DREADDs increased active lever 
pressing for sucrose pellets 277, confirming this circuit’s sufficiency in increasing urge for 
obtaining palatable food. A separate study showed activating the VTA DA neurons 
decreased average meal size and total food intake; however, feeding frequency increased 
241. Specifically activating the VTA-to-NAc was enough to reproduce the meal size and 
feeding frequency effects, but did not lower total food intake. Bilateral electrolytic 
lesions of the VTA decreased sucrose consumption, and lesioning the VTA with 6-
OHDA blocked the appetitive effects of i.p. midazolam (positive allostatic modulator of 
GABAR) or subcutaneous morphine (opioid agonist) 211. Therefore, the VTA mediates 
feeding behavior, and to a certain extent the mechanism works via GABA and opioid 
systems. In fact, modulation of GABA receptors with intra-VTA muscimol or baclofen 
increased feeding (food pellets, Purina rat chow) 251,252, effects which can be blocked by 
GABAB or opioid antagonism. 
 
 While some investigations showed systemic administrations of opioid and GABA 
modulators generally increased feeding and positive facial reactions 278,279, others have 
attempted to use pharmacological manipulation to investigate the contribution of specific 
brain areas to taste-related feeding behaviors. For example, injecting the mu-opioid 
agonist DAMGO into the lateral PBN increases food intake 280. Manipulations of the 
PBN via GABA mechanisms also modulates feeding 237, and intra-PBN midazolam 
increased hedonic impact and increased feeding of a palatable stimulus 238. However, 
results were not always consistent, as when sweeteners, such as saccharin, became 
aversive and total intake decreased when morphine was injected into the PBN 234. Other 
manipulations of the PBN also have inhibitory effects on feeding such as activating a 





 Past studies have shown evidence that visceral and taste circuits each provide 
paths for different information to systems that modulate feeding, suggesting that factors 
regarding both palatability and caloric-content of stimuli need to be considered. 
Responsiveness in the PBN to i.g. stimulation differs from i.o. 67. Additional work has 
shown that viscerosensation and the transmission of caloric signals may be effective at 
driving consumption even if the ability to sense a palatable taste is disrupted. Sweet-blind 
trpm5 -/- mice gradually develop a preference to the caloric sweetener, sucrose, but not to 
the non-caloric sucralose 246. The authors suggest these effects are due to post-ingestive 
feedback, which remain intact despite the disruption to the taste pathways. Moreover, 
separate circuits in brain areas other than the PBN and VTA were implicated in the 
communication of hedonic and nutritional information about sugar 240. 
 
 To fortify the argument that the PBN’s projection to the VTA serves to modulate 
feeding, we designed an experiment to isolate this circuit and measure the effects on 
feeding of activating it with DREADDs. This experiment proved methodologically 
challenging and yielded an inconclusive null result. Simplifying the question and 
methodology, we instead focused on what effect inhibiting the VTA with the GABAA 
agonist, muscimol, had on palatability and appetite. Behavior was assessed using the MS-
160 lickometer. The advantage of measuring licking behavior is that both orosensory and 
post-ingestive factors of ingestion can be measured and analyzed (as opposed to long-
term intake tests). The lick count (or rate) in response to stimuli delivered in this 
apparatus in brief trials (≤ 10 s) by mice is considered a taste-salient behavior; on the 
other hand, the number of trials initiated in a session, as well as the cumulative intake 








 16 B6 mice were used for this experiment (ages on surgery d: 59 – 90 d, mean = 
75 ± 3 d; 8 male, 8 female). Mice were randomly assigned to 1 of 3 groups: experimental, 
saline controls, and CNO controls. The conditions for the experimental group are 
explained in the upcoming sections. The saline control group received virus 
microinjections like the experimental, but i.p. saline replaced the CNO injections. The 





 Mice were anesthetized with ketamine/xylazine (100/10 mg/kg), and placed in a 
stereotaxic device. A midline incision was made to expose the skull. Burr holes with ~1 – 
2 mm diameters were drilled over the injection site. Glass pipettes with inner diameters 
of 50 – 60 μm were used with a picospritzer (52-302-900, General Valve Corporation, 
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Fairfield, NJ, USA) for pressure injections. After the surgery, the incision was superglued 
or sutured closed, and mice were given antibiotic and buprenorphine. 
 
 To measure the potential effects of activating the PBN-to-VTA circuit on feeding 
behaviors (Figure 8-1), we used combined microinjections of a CRE-dependent 
DREADD and CRE-expressing vectors that targeted this pathway 277,282. Other studies 
used similar methodology to target projections for DREADD activation 277,283. Despite 
typically migrating anterogradely, adeno-associated viruses (AAV) have produced 
retrograde transfections when used in methods like the one proposed here 284. Stock titers 
were diluted to 1 part stock in 4 parts deionized water. The diluted virus was successfully 
injected up to 1 week post-thaw. The stock titer of the rAAV was 5 X 1012. A 0.1 μL 
bolus containing a vector for designer receptor exclusively activated by designer drug 
(DREADD; rAAV8-hSyn-DIO-hM3D(Gq)-mCherry) was pressure injected into the PBN 
bilaterally (AP: -5.4, DV 3.75, R&L: +/- 1.2; +1 mm DV adjustment for brain 
depression). A 0.1 μL bolus of CRE-recombinase expressing virus (AAV8-hSyn-
mCherry-CRE) was pressure injected into the midline VTA (AP: -3.64, DV: 3.88, ML: 0; 
+1 mm DV adjustment for brain depression), and its diffusion was expected to extend to 
bilateral limits without crossing into the SN. A fast rate of infusion (and thus, a 
temporally shorter, but increased pressure) was intended to overcome any inhibition by 






 A Davis MS-160 contact lickometer was used here and in the following 
experiment (8.2) for habituation, training, and testing procedures. The apparatus 
consisted of a plastic test chamber (30 X 14.5 X 16 cm) with a stainless steel front wall 
and mesh floor (DiLog Instruments; Tallahassee, FL, USA). For details of basic use in 
our lab, see Boughter et al. (2002) 285, St. John and Boughter (2009) 286, and Saites et al. 
(2015) 259; for the full scope of use in the field, the reader may reference other studies 
240,255,256,287. Where specified below, access to one or more bottles containing aqueous 
stimuli was provided through a small aperture in the front wall of the chamber, closeable 
via a shutter. Trials began and ended with the opening and closing of the shutter, 
respectively. Licks were detected and counted via a computer when a (undetectable) low 






 All tastants were prepared fresh daily using reagent grade chemicals (Sigma-
Aldrich) dissolved in distilled water. Calorie-free taste stimuli were initially selected to 
prevent metabolic effects from interfering with outcome measures: 0.1 mM QHCl and 3 





Figure 8-1. Targeted activation of the PBN-to-VTA circuit may affect feeding. 
 
A. Schematic of the experimental design. Viral vectors were microinjected into the PBN 
and VTA, causing DREADD expression only in this circuit. Subsequent i.p. injection of 
CNO ostensibly activated this circuit which was expected to affect feeding. B & C. 
Example microinjections of the mCherry-expressing AAVs into the PBN and VTA. IPN, 





 The entire training and testing schedule is summarized in Table 8-1. Viral 
microinjections were done in the first week of the experiment, and mice were allowed to 
recover at least 3 days before training began. The training started with a 5 min 
“habituation” session in the chamber without stimuli. Sipper tube training sessions 
consisted of a single, 20 min access trial to water. Trial training sessions included 27 – 5 
s trials separated by 7.5 s inter-trial intervals. After the shutter opened, a given trial could 
be initiated by a lick. If the mouse did not lick within 2 min of the shutter opening, the 
shutter closed and reopened after the inter-trial interval. These events were noted as 
skipped or missed trials. Finally, a single session ended after 30 min regardless of 
whether the mouse had completed all 27 trials. The training week (Week 2) included, 
consecutively: 1 d habituation, 1 d 20 min water, and 3 d trial training. Subsequent weeks 
(Weeks 3 and 4) started with 2 d trial training followed by pre-testing and testing. To 
habituate the mice to the stress of i.p. injections, saline was given before each training 
session starting the first day of trial training. 
 
 The viral incubation period overlapped with training but ended before testing 
began. Mice were placed on water restriction the first week: they only received 2 mL of 
water after the session, and only if they initiated at least 3 trials and licked at least 10 
times during the session (no lick count per trial requirements were made; no water was 
provided, if mice did not meet the requirements). Mice were then placed on food 
restriction (no food) in Weeks 3 and 4 (except in rest periods beginning Fridays after 






 A volume of 2.5 μL sterile DMSO was used to dissolve 0.5 mg CNO. Aliquots of 
CNO in DMSO were stored at -10 ºC and prepared freshly before use. On test days, 5 mL 
sterile saline was added, and the solution was filtered with a 0.2 μm sterile syringe filter. 
The final concentrations of DMSO and CNO were 0.5% and 0.1 mg/mL, respectively. 
CNO was administered i.p. 15 min prior to testing. From the body weight (BW) 
measured, the volume calculated was based on 1 mg/kg dose. Following the 19 day 
incubation period, i.p. injection of CNO ostensibly, selectively activated the PBN-to-
VTA circuit via DREADD-modulation, allowing measurement of any changes in 
palatability or appetite it mediates. The effects of CNO in DREADD-expressing mice 
could last up to 9 hours; however, appropriate viral titers and CNO dose supposedly 





 Effectiveness of DREADD-activation and cannula placements were checked via a 
posteriori analyses. After DREADD testing was complete, mice were given an i.p. 
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Table 8-1. PBN-to-VTA activation behavioral paradigm schedule. 
 
Week Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
1  Microinject Microinject Microinject Microinject Microinject rest 
        
2 rest habituate & 
water restrict 
20 min H2O 
train 
5 s trials H2O 
train 
5 s trials H2O train 5 s trials H2O train & 
water replete 
rest 
        
3 rest 5 s trials H2O 
train & food 
restrict 
5 s trials 
H2O train 
5 s trials 
sucralose, QHCl 
& H2O pre-test 
5 s trials sucralose, 
QHCl & H2O pre-
test 
5 s trials sucralose, 
QHCl & H2O pre-test 
& food replete 
rest 
        
4 rest 5 s trials H2O 
train & food 
restrict 
5 s trials 
H2O train 
5 s trials 
sucralose, QHCl 
& H2O test 
5 s trials sucralose, 
QHCl & H2O test 
5 s trials sucralose, 




a. Week 1: Virus microinjections were done. 
b. Mice were restricted in water and food consumption beginning in Week 2 on Mondays 
and ending on Fridays. 
c. Habituate: Training started with a 5 min session in the chamber without stimuli to 
allow mice to acclimate. 
d. 20 min H2O train: The second training session was 20 min with only a water bottle. 
e. 5 s trials: Trial training, pre-test, and test sessions included 27 – 5 s trials separated by 
7.5 s inter-trial intervals. After the shutter opened, a given trial could be initiated by a 
lick. If the mouse did not lick within 2 min of the shutter opening, the shutter closed 
and reopened after the inter-trial interval. These events were noted as skipped or 
missed trials. Finally, a single session ended after 30 min regardless of whether the 
mouse had completed all 27 trials.  
f. More details may be found in the methods section.  
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injection of CNO (saline controls received saline) and perfused 2 h later. Brains were 
collected and 4/16 (4/6 of experimental group) were sectioned as described previously. 
Sections in and around the AP level of the VTA and PBN were collected for the 
immunohistochemistry preparation. To label mCherry and c-Fos, we treated the sections 
as in General Methods, except the primary was already conjugated with Alexa Fluor 594 
(no additional steps required) and blocking included 6% bovine serum albumin (9048-46-
8, Sigma-Aldrich) in addition to 3% normal donkey serum (Jackson ImmunoResearch 
Laboratories). An overnight incubation in a rabbit anti-c-fos (sc-52, lot #F2510 Santa 
Cruz Biotechnology, CA, USA, diluted to 1:5000; sc-52, lot #F3016 Santa Cruz 
Biotechnology, CA, USA, diluted to 1:500; or, ABE457, Millipore, Burlington, MA, 
USA, diluted to 1:2000) and rat anti-mCherry (M11240, Molecular Probes, Eugene, OR, 
USA, diluted to 1:100) primaries was followed by a biotinylated donkey anti-rabbit IgG 
secondary (1:1000, Jackson ImmunoResearch Laboratories) and Cy2-conjugated 
streptavidin (1:1000, Jackson ImmunoResearch Laboratories). Sections were observed 






 Pre-test and test data collection included the same trial specifications as trial 
training but used 3 bottles in a randomized, block design: 9 blocks in which each stimulus 
is randomly presented once. Collection of pre-test data excluded CNO administration. 
BW, licks to water/stimuli, lick latencies, and trial initiations were measured and plotted 
for graphical analysis. No further analysis of DREADDs data was conducted due to the 





 Although activating this circuit was expected to affect feeding, specific effects 
were challenging to predict due to a paucity of congruent data available and lack of 
consensus in current publications. Although PBN projections to VTA are glutamatergic, 
we were uncertain to what extent this signaling influences DA versus GABA neurons in 
the VTA 177,198. In fact, activating this circuit could have caused water, or even QHCl, to 
be consumed at levels similar to sucrose if it mimicked neuronal responses typically used 
to encode that a stimulus was palatable or caloric. Our model somewhat arbitrarily 
predicted consummatory and appetitive behavior to increase (based on the work of de 
Araujo and colleagues 240,246). 
 
 Some cases were excluded due to one or more of the viral transfections being off 
target; however by and large the more pressing concern became the inability to validate 
activation of the circuit. The design included 3 microinjections total (both sides of the 
PBN and the midline VTA), which elevated the risk of exclusion (compared to fewer 
injections) for off-target injections. While the 4 cases observed had acceptable PBN 
injections, 2/4 were excluded due to off-target VTA injections. Moreover, a major 
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setback occurred when PBN sections were observed and no FLI could be found in cells 
identified as having been isolated by the two viral transfections. Although the activation 
of PBN-to-VTA neurons could not be verified with immunohistochemistry, data from the 
experiment was graphed and observed (not shown). No obvious effects in licks or trial 
initiations to water, sucralose, or QHCl between groups were apparent, and data were not 
analyzed for statistical inferences. Instead, we opted to first measure the feeding effects 








 23 mice were used for this VTA manipulation experiment (ages on surgery d: 45 
– 82 d, mean = 63 ± 3; 14 male, 10 female). 9 additional mice were excluded from the 
VTA manipulation experiment: 5 did not learn during training, 1 died after the taste 
stimulation data was collected, 1 showed no activity during testing, and 2 had misplaced 
cannula. Mice were assigned either to the drug group or the vehicle (control) group. Mice 
were tested in 3 iterations with varying number of mice per iteration. The test procedure 
was the same for all 3 iterations, except the first iteration received a higher QHCl 
concentration during the caloric test. The behavioral apparatus used was the same as that 
described in Experiment 8.1. 
 
 
Intra-VTA Guide Cannula Implantation 
 
 Guide cannula were implanted in a separate cohort of mice to target the VTA for 
inhibition before measuring feeding. Mice were anesthetized with ketamine/xylazine and 
mounted on a stereotaxic frame. A small burr hole was drilled in the mouse’s skull over 
the VTA (AP: -3.5, DV: 4.0, ML: 0.0), and a guide cannula (custom 4 mm C315G-SPC, 
PlasticsOne, Roanoke, VA, USA) was inserted. The guide cannula ended 2 mm dorsal to 
the intended target allowing this length to remain unaffected except by the injection 
cannula (custom C315I-SPC, PlasticsOne) which extended the remaining length when 
fully inserted. A screw (00-96 X 1/16, Invivo1, PlasticsOne) was placed near the cannula, 
and dental acrylic (resin liquid and powder, Lang Dental Manufacturing, Wheeling, IL, 





 Mice were allowed to recover for at least two days after surgery before food and 
water restriction began for training (Table 8-2). High restriction of mice was based on 
BW: 0.5 – 2.5 mL of water was provided after a session (Table 8-3) only if the mouse 
licked at least 10 times and initiated at least 3 trials during the session (no lick count per 
trial requirements were made; no water was provided, if mice did not meet the 
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Table 8-2. VTA inhibition train and test schedule. 
 
Phasea Procedureb Restrictionc Post-surgery Dayd Contingency to Next Phase 
0 surgery/recovery none 0 Survival of successful surgery 
     
1 10 s S train high At least 2 At least 2 sessions in which at least 3 trials are initiated 
and at least 2 trials include 20 or more licks (individual) 
     
2 “replete” & 10 s S train none  Body weight ratio average above 1.01 and at least 2 days 
(all) 
     
3 10 s WQS train low  1 day 
     
4 10 s WQS pre-test low  1 day 
     
5 taste test low At least 8 1 day 
     
6 10 s WQcSc train low  1 day 
     
7 10 s WQcSc pre-test low  1 day 
     
8 calorie test low  1 day 
 
a. Mice remain at a behavioral phase until its contingency is passed. Phase 1 is passed 
individually; phase 2 requires all mice pass before phase 3 begins. 
b. All behavioral procedures (i.e., procedure “10 s S train” and on) include 27 – 10 s 
trials with 120 s waits for first licks and 7.5 s IPIs. Procedure “10 s S train” uses 1 tube 
with sucralose. All procedures after use 3 tubes (water [W], bitter [Q], and sweet [S]). 
The session time minimum is ~ 8 m and the maximum is ~ 62 m, which is within the 
period of drug effects. Beginning when all mice have entered phase 2, mice are held in 
the hand for 2 min prior to the session to habituate the mice to stay calm for the intra-
VTA injection and the stress before “hard data” collection. The airflow to prevent 
olfactory cues is also initiated when all mice have entered phase 2 to habituate them to 
the sound and feeling of the air. In “taste test” and “calorie test”, muscimol is infused 
into the VTA. Calories are added by exchanging sucralose for sucrose and adding 
sucrose to a higher concentration of QHCl. 
c. Partial water and food high restriction: 0.5 – 2.5 mL of water is given only if the 
mouse licks at least 10 times and initiates at least 3 trials; 0.5 – 2.5 g of food is given 
based on BW (chart below); if BW drops below 75% without passing to next phase, 
the mouse is excluded and “repleted”. Partial water&food low restriction: 1 – 3 mL of 
water is given daily after session based on BW (chart below); 1 – 3 g of food is given 
based on BW (chart below); if BW drops below 85%, the water and food given are 
doubled. 
d. All surgeries are completed the first day of the experiment. All mice are given at least 
2 days to recover from the surgery before training begins. All mice are allowed at least 
8 days before testing begins.  
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Table 8-3. VTA inhibition water and food partial restriction schedules. 
 
  Water or Food (mL or g) 
Training Day 1 BW (g)  High Low 
10 - 14.9  0.5 1.0 
15 - 19.9  1.0 1.5 
20 - 24.9  1.5 2.0 
25 - 29.9  2.0 2.5 




requirements); 0.5 – 2.5 g of chow was given daily regardless of session behavior (Table 
8-3); if BW dropped below 75% without the mouse passing to the next phase, it was 
excluded and “repleted”. A lower restriction, also based on BW, was used while test data 
was collected: 1 – 3 mL of water and 1 – 3 g of chow was given daily after the session 
regardless of session behavior (Table 8-3); if BW dropped below 85%, the water and 
food given were doubled. This type of combined restriction (i.e., high and low) is 
common in taste experiments; animals are motivated by appetite to sample palatable 
stimuli in a concentration-dependent manner, while they are not as strongly fluid 
restricted. A high level of fluid-only restriction (i.e. little or no daily supplemental water) 
tends to result in mice licking any neutral-to-palatable fluid at a maximal rate, causing a 
loss of sensitivity in palatability and appetite measurements. Thus, higher restriction 
works well to accelerate training, but lick data collection may benefit from lower 
restriction. While using this procedure, percentage of initial BW, which may be used as a 
rough estimate of appetite, indicated these intentions were achieved (Figure 8-2). BW% 
dropped sharply during training, and after a shallower drop, it remained relatively stable 
during testing. 
 
 Table 8-2 provides a detailed explanation of the training and testing schedule 
used for this experiment, including each phase’s procedures, (water/food) restrictions, 
start relative to post-surgical day, and contingencies placed on mouse behavior for 
passing to the next phase. The first two phases varied in the number of days depending on 
how quickly mice learned to lick 3 mM sucralose from the sipper tube in the rig. To pass 
the first phase, mice had to accumulate at least 2 sessions (1 session per day) in which 
they initiated at least 3 trials and in at least 2 of those an accumulation of at least 20 licks. 
Mice passed phase 1 individually. The second phase allowed mice to become replete after 
the previous phase’s high restriction and before the low restriction of the subsequent 
phases. This second phase lasted at least 2 days after the last mouse completed phase 1 
and required the cohort to maintain a BW ratio average of at least 1.01. The mice passed 
phase 2 as a cohort. The additional phases were 1 day each, of which 3 were training. 
Phase 3 initiated the low restriction. Neophobia can occur in mice wherein novel taste 
stimuli, regardless of palatability, are consumed less avidly to prevent accidental 
poisoning (see Learning in Feeding and Synaptic Adaptation section in Chapter 9 for 
more on neophobia). Prior exposure before testing allows mice to habituate and prevents 
collection of aberrant test data. Phases 3 and 6 gave mice prior exposure to taste stimuli 





 Muscimol was prepared from a stock solution kept at 10 g/L (M1523-5MG, 
Sigma-Aldrich) by mixing 20 μL of stock into 480 μL of 0.9% sterile saline for a final 
concentration of 0.4 g/L. Both the stock and test concentrations were kept at 4 ºC until 
testing. Mice in the drug group were microinjected into the VTA with 0.3 μL of 
muscimol solution at a constant rate over 2 min, and the injection cannula was left in 
place for an additional 2 min before placing the mouse in the rig for testing. The vehicle 





Figure 8-2. Body weight (BW) fluctuation throughout experiment. 
 
BW remained relatively stable throughout the experiment as compared to the Day 1 
measurement taken (dotted horizontal line). BW dropped sharply upon initiation of the 
high restriction schedule and gradually increased as mice passed training and became 
replete. The drop in BW was shallower going into testing (solid vertical line) and 





 All tastants were prepared fresh daily using reagent grade chemicals (Sigma-
Aldrich) dissolved in distilled water. Calorie-free taste stimuli were tested first to prevent 
metabolic effects from interfering with outcome measures: 0.1 mM QHCl and 3 mM 
sucralose. Caloric stimuli were tested second; to test for palatability and aversiveness 
effects while keeping in calories constant sucrose concentration was used for both 
palatable and aversive stimuli but it was adulterated with QHCl to make it aversive: 0.3 





 Mice were anesthetized prior to intra-VTA microinjection of Chicago sky blue 
(Sigma-Aldrich) and perfusion. Brains were collected and sectioned for histological 






Non-caloric Taste Test 
 
 All mice (groups combined) reliably licked the three stimuli (3 mM sucralose, 0.1 
mM QHCl, and water) throughout the 27 trials (9 trials/stimulus) in the pretest session. 
Total consumption during this session was 408.5 licks (range = 149 – 833), although 
mice consumed the sucralose much more avidly (mean licks = 341.4; 82% of the total) 
than either QHCl (mean licks = 38.64; 11% of the total) or water (mean licks = 28.5; 7% 
of the total). These percentages did not differ between groups, although lick totals did. 
Total consumption per session (sum of licks to all stimuli combined) was examined 
between groups during both the pretest and (drug) test session using a 2-way ANOVA 
(between-subjects factor for group X within-subjects factor for session). There was a 
significant effect of group (F(1, 20) = 20.85; p < 0.001) but not session; however, there was 
a significant group X session interaction (F(1, 20) = 12.47; p = 0.002). This interaction 
effect seemed to indicate a drug-dependent effect on total consumption, with a decrease 
only evident in the mice receiving muscimol. However, post-hoc comparisons showed 
significant group differences (p < 0.05) in licking during both pre-test and test session, 
although the mean group difference was much larger on the test day (421.5 licks) than on 
the pretest day (239.0 licks). 
 
 Further analysis showed total licks were highly correlated between both days in 
the 11 mice receiving vehicle (r = 0.86, p < 0.001), but not in the drug group. In other 
words, although consumption in the vehicle group increased slightly from pretest to test 
session, individuals behaved consistently regardless of whether they had relatively low or 
high lick counts (e.g., range for this group was 149 – 833 licks in the pretest session). On 





Figure 8-3. Exemplar of VTA cannula placement indicated by injections. 
 
After testing, Chicago Sky blue was injected via guide cannula to check for correct 
placement. Most cannula were within the acceptable anterior-posterior limits of the VTA, 
and therefore, muscimol was considered to have targeted the desired location. Only 2 out 
of 25 cannula missed the VTA. Note that the smaller volume of dye (0.1 μL) used was 
not expected to fully recapitulate the diffusion of muscimol, but only to provide an 
estimation of the point from which the drug was infused; the full 0.3 μL infusion of 
muscimol likely diffused throughout the entire VTA. PBP, pigmented parabrachial; RLi, 
rostral linear nucleus of the raphe; IF, interfascicular; PN, paranigral; cp, cerebral 
peduncle; IPN, interpeduncular nucleus; ml, medial lemniscus; RN, red nucleus; SN, 
substantia nigra. Scale bar = 500 μm.  
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consumption on the test day, presumably due to an inhibitory effect of the muscimol. The 
cause of individual and group differences among B6 mice in our experiment during the 
pretest (where we did not expect to see group differences, as no drug was administered) 
was not immediately clear, and may have been coincidental. Total licks were not 
explained by variation in age, BW, or sex (correlation analyses; ns). Of course, 
phenotypic variation among even highly isogenic individuals (i.e., within inbred strains) 
has been found in just about every type of behavior, including consumption (e.g. 
Wahlsten et al. 2003 289; Loos et al. 2015 290). 
 
 To account for individual baseline differences in licking (and thereby correct for 
group differences), potential drug effects on the individual taste stimuli were examined 
by computing a pre-test/test ratio (mean of total licks on test day / mean of total licks on 
pretest day) for each mouse. This data is shown in Figure 8-4. Ratio data were log-
transformed to correct for non-normality and analyzed with a 2-way ANOVA (group X 
stimulus). Only the interaction between these variables was found to be significant (F(2, 59) 
= 3.59; p = 0.038). Post-hoc tests (Bonferroni) showed that the groups significantly 
differed (p < 0.05) in pre-test/test ratio for sucralose, but not QHCl or water, with drug 
mice showing reduced licking (mean ratio = 0.73) relative to vehicle mice (mean ratio = 
1.30; Figure 8-4A). In general, this reduced licking was spread out evenly across the test 
session—i.e., mid-session onset of satiety did not appear to play a role in attenuation of 
licking. One way to quantify this is by comparing the number of trials initiated to each 
stimulus. Vehicle mice essentially licked sucralose in all possible trials (of which there 
are 9) during both pretest (mean = 8.82 trials) and test (mean = 8.91) sessions, whereas 
drug-treated mice showed, on average, a slight decrease in trials initiated on the test day 
(8.73 to 7). However, these differences were not quite significant for sucralose, or for the 
other stimuli, as assessed via non-parametric tests. A second way to assess whether 
decreases in licking are spread evenly across the test session is to visualize cumulative 
lick functions for each group on each day (Figure 8-5). For mice receiving vehicle, 
functions are linear for sucralose in both sessions, indicating consistent sampling 
behavior across the 9 trials. The drug group also has a linear function on the pre-test day, 
but deviates somewhat from this on the test day, reflecting the tendency of some of the 
mice in this group to terminate licking behavior to sucralose earlier in the session. 
Notably, however, the functions for both groups for QHCl on both days are similar, again 
underlining the specificity of the drug effect on sucralose. Water licking was not 
examined in this fashion due to it being the least avidly consumed of the three stimuli. 
 
 
Caloric Taste Test 
 
 We next examined total consumption in the sessions with caloric stimuli (0.3 M 
sucrose, 0.3 M sucrose + 0.3 mM QHCl [S + Q], water). Among all mice, total 
consumption in the pre-test averaged 640.9 licks; 61% of these were to sucrose, 37% to 
the sucrose adulterated with QHCl, and just 2% to water. As before, these percentages 
did not vary among group, but total licks did. There was both a significant effect of group 
(F(1, 14) = 8.82; p = 0.01), as well as a group X session interaction (F(1, 14) = 6.75; p = 0.02) 





Figure 8-4. Test-pretest ratios to non-caloric and caloric taste stimuli. 
 
Mice that received intra-VTA muscimol injections consumed less palatable and caloric 
and caloric stimuli relative to controls which received saline. No effect was seen to 
aversive, non-caloric QHCl or neutral, non-caloric water. Data shown was log-





Figure 8-5. Cumulative licking in sessions to non-caloric taste stimuli. 
 
Cumulative licking was used as one method to assess effects on appetite. Consumption of 
stimuli during the non-caloric trials was relatively linear and unaffected from pre-test to 
test conditions or by intra-VTA muscimol injections, indicating no effects on appetite. 
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stimuli, vehicle mice licked more than drug mice in both sessions, with this group 
difference being greater on the test day (mean difference = 660.6 licks) than on the 
pretest day (mean difference = 329.4 licks). Again, within the vehicle group, both “high” 
and “low” consumers were relatively consistent with their behavior from one session to 
the next (r = 0.87; p = 0.005), whereas 7/8 mice in the drug group decreased consumption 
on the test day (r = 0.29; ns). 
 
 When pretest/test ratios (log transformed) for each stimulus were compared 
(Figure 8-4B), a significant effect was found for group (F(2, 40) = 13.92; p < 0.001) but 
not stimulus. Post-hoc tests confirmed that the ratios were reduced for both sucrose and 
S+Q (p < 0.05), but not water, indicating a decrease in licking of these stimuli relative to 
baseline resulting from muscimol infusion. In addition, drug-treated mice initiated 
significantly fewer trials than vehicle mice to both sucrose (mean # trials = 6 vs. 9; p = 
0.002) and S+Q (6 vs. 9; p = 0.01). When cumulative licking of either stimulus was 
visualized (Figure 8-6), the drug group showed a marked deviation from linearity on the 
test day; these functions show that these mice generally ceased licking behavior to both 
stimuli earlier in the session than they did in the pre-test. Vehicle mice possessed linear 
functions for both sessions, maintaining their consumption of these stimuli at a near 
constant rate. Unlike the data collected with non-caloric stimuli, these data suggest that 
muscimol not only affected avidity for caloric stimuli within trials, but that it also 





 Although our methods were unable to isolate the PBN-to-VTA circuit, we did 
show that both taste and caloric information must be processed in the VTA. Boekhoudt et 
al. 2017 241 found, somewhat unexpectedly, that activating the VTA-to-NAc circuit 
decreased food intake. One might have hypothesized that NAc DA levels would have 
increased from activating this circuit, leading to increased consumption of food. 
However, the food may be neutral or only slightly palatable unlike a sucrose pellet or 
solution. Increased consumption with VTA-to-NAc activation may require the meal be 
palatable. Further, their manipulation did increase feeding frequency, suggesting the urge 
to consume had been increased. Hence, if our method worked, we might infer from their 
results that the PBN innervates cells in the VTA other than the DAergic projections to the 
NAc. Otherwise decreased consumption of water and increased trial initiations might 
have occurred. In contrast, no effects were found when we tried to specifically activate 
the PBN-to-VTA circuit using virally-delivered CRE-dependent DREADDs. However, it 
remains possible our methods did not successfully activate this circuit. Therefore, it is 
possible that our data show that this circuit has no appreciable effect on feeding, but 
further investigation is certainly needed to confirm this. Our experiment was discontinued 
because FLI was not found in cells which appeared to be positive for DREADDs. Thus, 
we were unable to validate PBN-to-VTA activation was occurring. Although other means 
were possible to verify circuit activation (e.g., electrophysiology), this was not an option 





Figure 8-6. Cumulative licking in sessions to caloric taste stimuli. 
 
Consumption of caloric stimuli during the caloric trials was relatively linear and 
unaffected from pre-test to test conditions in control mice. Mice that received intra-VTA 
muscimol injections showed a marked deviation in their consumption of caloric stimuli 
during testing (from both controls and their pre-test behavior), indicating the onset of 
satiety had occurred sooner as a result of the GABA agonist.  
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a different and more direct experimental option—i.e., inhibiting the VTA with 
intracranial muscimol and gauging the effects on taste and consummatory behavior. 
 
 The group of mice with muscimol-inhibited VTAs decreased consumption 
compared to their own pre-test measurements and to a control group of mice that received 
saline on test day. The control group’s behavior remained consistent from pre-test and 
test day, supporting our inference that the VTA manipulation decreased consumption. 
Muscimol-inhibited-VTA mice decreased consumption of sucralose, but not QHCl or 
water, suggesting this effect is taste-specific (in this case, for a palatable stimulus as 
opposed to aversive or neutral). However, consumption of both a palatable and aversive 
tasting stimulus decreased when it also contained calories. It is also likely the mixture of 
sucrose and QHCl, while not as appetitive as sucrose, was also not as repulsive as an 
imaginary “caloric version of QHCl” could have been. Although test-pre-test ratio 
decreases to caloric stimuli were like those to non-caloric sucralose, an apparent calorie-
induced satiety effect was caused by inhibiting the VTA. Consumption of both sucrose 
and S+Q decreased more rapidly (i.e., less consumption in later trials) in mice that 
received muscimol on test day, presumably an effect of hastening satiety onset. Intra-
VTA muscimol also notably affected locomotion which became erratic or slowed; 
however, the lack of a difference in water consumption in the drug group means the 
locomotor effects were not a factor influencing our interpretation of altered response to 
taste and caloric stimuli. 
 
  Our results contrast with other studies in which intra-VTA muscimol caused 
increased feeding 251,252. One possible reason our results might differ could be a 
differential effect in the VTA based on the location of injections (see Beier et al., 2015 202 
for VTA to different outputs). Echo et al. (2002) 251 and Khaimova et al. (2004) 252 did 
intra-VTA injections bilaterally which may have inhibited more lateral aspects of the 
VTA than our midline injection. Shimura et al. (2002) 211, who also found increased 
feeding after injecting the benzodiazepine agonist, midazolam, did so systemically with 
i.p. administration. Thus, our results here may confirm that manipulating VTA neurons in 
different subnuclei has different effects on behavior. Additional experiments could test 
this by using small volumes of drug and injecting into slightly different VTA locations 
while measuring consumption behaviors. A second difference between the Echo et al. and 
Khaimova et al. studies and ours is the palatability/appetitiveness of the stimulus. The 
cited studies used rat chow to measure feeding which might at best be considered slightly 
palatable. Further, no alternatives were offered to the rats meaning the effects on stimuli 
with varying palatability were not measured. Our method allowed us to simultaneously 
assess the effects of inhibiting the VTA on consumption of aversive, appetitive, and 
neutral stimuli. 
 
 The lowered consumption of caloric stimuli on test day could raise a question 
about the interpretation of responses to calories themselves. How can we have a caloric 
effect if the mice are not ingesting caloric stimuli? Possible explanations include 1) 
caloric content can be sensed in the oral cavity and does not actually require ingestion, 
and 2) mice responded to stimuli in accordance to the memory of “caloric” taste. 
Although artificial sweeteners and caloric sugars both taste sweet, it is possible that some 
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means of differentiating noncaloric from caloric stimuli exist at the level of the oral 
cavity. This may occur via the “taste” transduction mechanisms themselves (followed by 
differential caloric sensation but similar taste sensation) or this could occur through a 
completely separate transduction mechanism. Further investigation is necessary to 
determine the process mediating this effect. It is also possible the mice formed a memory 
after the sucrose-calories pairing experienced in the first two sessions. The decreased 
consumption would have been due to a response to the taste cue signaling a caloric 
stimulus. In this case, the behavioral response is still in part due to the caloric content of 
the stimulus but less directly. Finally, it should be reiterated that the responses were 
shown to be due to the stimuli themselves because the response to water was unaffected. 
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CHAPTER 9.    DISCUSSION 
 
 
 The experiments conducted for this dissertation collectively present further 
investigation into the connectivity between the PBN and VTA and the possible role of 
this taste/reward interface in feeding. Although a selective manipulation of the PBN-to-
VTA circuit could not be satisfactorily achieved, both the projection’s existence and the 
ability of the VTA to alter feeding were supported. This investigation elucidates one 
example of a direct connection between canonical taste and reward nuclei. Together with 
other taste/reward interfaces, these connections likely help produce the complex and 
highly-regulated feeding behaviors that both prevent us from accidental poisonings and 
urge us to consume to remain nutritionally replete. 
 
 We quantified the amount of neuronal activity (FLI+ cells) in the PBN in 
response to taste stimuli with varying palatability similar to previous studies 59,66,67. These 
studies showed subnuclei specific effects to taste stimuli. For example, Yamamoto et al. 
(1994) 66 used similar DAB staining in rats for FLI and found caudal el and em activity to 
aversive bitter stimuli and dl and cl activity to palatable. Tokita and Boughter (2016) 45 
recently characterized the PBN with electrophysiology, finding roughly topographic and 
somatotopic patterns in taste-responsiveness, some of which were specific to subnuclei. 
Sucrose-best neurons were found in higher numbers in BC and QHCl-best in lateral 
subnuclei. Our results agree to an extent with these previous studies and also suggest the 
dependence of FLI on taste transduction via the TRPM5 channel. We found an elevation 
in FLI to QHCl in the el, an aversive bitter stimulus, in agreement with the Yamamoto et 
al. finding. This was corroborated when we compared the FLI response to QHCl with the 
response to water; further, we showed KO mice had a diminished FLI response to QHCl 
in the el. These results also agreed with the general finding that QHCl-best neurons were 
typically found laterally 45. It was interesting that sucrose also elicited a significant FLI 
response in the el of KO mice compared with responses to water or QHCl. However, the 
response was comparable to the elevation seen in B6 mice. Together, these results 
confirm the finding from Palmiter and colleagues (Carter et al., 2013 73). The FLI in the 
el was also higher in more visceral, rostral sections of the PBN (data not shown). 
Regardless, this effect to sucrose was more likely post-ingestive as this subnucleus has 
been implicated for in other studies 73. Indeed, Palmiter and colleagues have repeatedly 
found a subset of CGRP+ neurons which project to the CeAlc from the PBN and both 
inhibit feeding (induce satiety) and are capable of recapitulating a CTA like that caused 
by pairing i.p. LiCl with a taste stimulus 72. PBN neurons in the el may respond primarily 
to aversive and repulsive stimuli, and by relaying information about such perceptions to 
the CeAlc, participate in a role to decrease consumption of possibly toxic substances. 
With evidence that the CeA also projects to the VTA, it is possible this el-CeAlc circuit 
further influences the VTA and DA release as well. This would likely impact the 
incentive salience of associated stimuli possibly via a learning mechanism (see below). 
 
 The sparse overlap between FG and CTb labeling in the PBN suggested these 
pathways are mostly discrete. Unlike the findings for the previously recognized thalamic 
and ventral pathways, in which more overlap was found 59,69, the projections to the VTA 
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and VPMpc barely collateralize at all. In fact, the two projections mostly originated from 
opposite sides of the brain with VTA projecting from the dm, m, and vl, while the 
VPMpc from the m, wa, and el. If the PBN is indeed sending taste quality or hedonic 
information to the VTA, future studies will need to account for this in their design to 
effectively test the hypothesis. These findings also contrast with some previously found 
when retrograde tracing identified mostly ipsilateral PBN projections to the VTA 80. This 
previous study also found labeling in all PBN subnuclei; however, VTA projection cells 
tended to be more laterally located than in our study. This discrepancy may indicate an 
anatomical difference between mice and rats or some variation specific to the B6 strain. 
These mostly separate pathways to the VTA and VPMpc also suggest that any taste or 
visceral information being relayed could be target-specific. For example, the VPMpc may 
play a major role in taste quality recognition and discrimination, whereas the pathway to 
the VTA may function more for taste and visceral reward. Placed in the context of other 
models of reward circuits, the PBN-to-VTA communication may provide influence in 
assessments of stimulus salience and promote urges to continue or discontinue 
consumption of sapid stimuli. 
 
 FLI in the retrograde tracer study in response to sucrose and QHCl was elevated 
as compared to water. Further, some differential activity in individual subnuclei was 
found including in the dm, m, el, cl, and dl. As in Yamamoto et al. (1994) 66, we found 
the cl and dl to be responsive to palatable stimuli. Unfortunately, less could be concluded 
from the results of quantifying double labeled cells. Although the pathways to the VTA 
and VPMpc were discrete, the FLI in projection cells may be stochastic with respect to 
stimulus, i.e., the amount of double-labeling merely correlated with overall FLI. 
Nonetheless, it is worth simultaneously examining the results of tracing and FLI to see 
what the data suggest about how the PBN subnuclei inform downstream targets about 
taste stimuli. In this case, the various differences in how the PBN projects to VTA and 
VPMpc and in how activity is elicited to stimuli of varying palatability might suggest the 
contralateral m PBN is most capable of communicating the salience of sucrose to the 
VTA while contralateral dm may transmit information about aversive QHCl. Meanwhile, 
the VPMpc appears to receive input from ipsilateral m and el to communicate about 
palatable sucrose or aversive QHCl. 
 
 TH+ and GAD67+ cells were identified throughout the VTA, including in 
specific subnuclei. Unsurprisingly, the TH labeling was useful in identifying this nucleus 
and its subnuclei. Our delineations easily followed from other publications identifying the 
localization of these subnuclei (e.g., Oades and Halliday, 1987 156; Lammel et al., 2008 
94), including the RMTg 198,201. Others have observed the VTA might co-express DA and 
GABA (e.g., Gonzalez-Hernandez et al., 2001 291; Olson and Nestler, 2007 183; Nair-
Roberts et al., 2008 201), but our study suggests that the small percentage of cells found in 
these studies may in fact be due to the inadequate methods they used. Nair-Roberts et al. 
critiqued of their study, “the cell labeling methods [we] used...are not suitable for an 
accurate quantitative analysis of DL neurons as both the in situ and immunohistochemical 
reactions produced opaque precipitates that interfered with the detection of the other. An 
accurate analysis of the possible colocalization of TH [and] GAD...will require the use of 
different cell labeling methods that utilize different markers e.g. fluorescence...labeling” 
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(Nair-Roberts et al., 2008 201). Indeed, our study took advantage of two methods which 
fluorescently labeled VTA neurons, and in conjunction with high-resolution confocal 
microscopy, provided detailed data about the 3-dimensional presence of TH- and 
GAD67-expressing cells, of which none were DL. This finding supports the conclusion 
that DA and GABA neurons compose entirely separate cell populations in the VTA. The 
RMTg was identified with GAD67+ cells and seen to cross from a relatively lateral 
position to medial as it was traced posteriorly. Like the subnuclei identified with TH, the 
localization of the RMTg was in agreement with other publications 198. 
 
 Surprisingly, no significant differences of FLI to tastants were found when we 
stained the VTA with DAB, even in comparisons of B6 and KO mice. This contrasts with 
studies in which DAB was used to identify increases in response to food in rats 212. This 
might reflect a low sample size (n = 6), however it was similar to that of other studies 
which specifically found elevated FLI expression in response to palatable meals in rats 
212. Thus, our results seem to suggest it may in fact be the case that the VTAs of mice are 
not so sensitive to effects of tastes with varying palatability. In contrast, when measuring 
FLI with fluorescent IHC, FLI in a posterior region of the VTA was significantly higher 
to QHCl than water or sucrose. With respect to FLI, the RLi and CLi had significant 
responses to QHCl compared to water; with respect to TH, CLi had significant 
differences in water, sucrose, and QHCl. The RLi is present at the AP level at which the 
heightened response to QHCl was found. The CLi is present more posteriorly, but the 
CLi data agree when adjusted by both TH and FLI. The short span in the AP dimension 
of VTA in which this effect was found may explain why it was apparently missed when 
DAB IHC was used. That is, the one section sampled (tVTA, -3.88 mm post bregma) that 
overlapped in these two experiments happened to not contain a significantly higher level 
of FLI, but this may be less conclusive if this study missed the relatively few sections in 
which QHCl did elicit more FLI. Another possible explanation is that one or more outlier 
measurements occurred in which the sections were shifted posteriorly as compared to 
those measured for FLI to sucrose and water. This seems unlikely for two reasons: 1) the 
effect was found in two consecutive sections, meaning the shift had to be greater than 160 
μm, and 2) the delineations used throughout the VTA sections were standardized and 
consistently applied, meaning the shift would have caused highly noticeable alterations in 
the anatomy present. In fact, one case, in which the anatomy was noticeably different, 
actually seemed to shorten rather than extend this region. Although this case was forced 
into the standardized delineations mentioned, examination of the data indicates its 
unusual anatomy had little effect when it was averaged across cases. We conclude a 
posterior portion of the VTA, likely in the area of the RLi/CLi is responsive to taste 
stimuli, especially when they are aversive. 
 
 Some interesting considerations present when we compare the findings from the 
experiments described in Chapters 6 and 7. In the DAB and fluorescent cases in these 
studies, both the PBN and the VTA had higher FLI measured using DAB as compared to 
the fluorescent IHC methods. This may reflect a methodological limitation of DAB 
immunohistochemistry, if only the highest intensity of FLI was seen when visualized 
with fluorescence. This finding suggests an important consideration to make when 
comparing the significant results to taste stimuli in the PBN and VTA. For example, one 
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disparity occurs in the effects seen in the cl of the PBN, in which sucrose caused a higher 
FLI response than water. It is interesting that no el PBN projection occurs to the VTA, 
yet the VTA seems most responsive to the QHCl taste stimulus. Perhaps the 
QHCl/aversive taste information is reaching the VTA through other pathways, but it is 
also possible the PBN is using the projection from the dm to send this information. As 
mentioned, an additional cross-cutting analysis of data from Experiments 6.1 and 7.1 was 
conducted to help explain the discord between the PBN and VTA FLI results when using 
DAB. To examine this, we calculated the correlations of the FLI data between the PBN 
and VTA. The sucrose and QHCl were correlated, but water was not (r = 0.7, 0.81, and 
0.32, respectively). This suggested the VTA responded to stimuli other than taste or had a 
“noisier” baseline. Although our methods aimed to control for such a possibility (e.g., 
comparing tastes to water, comparing wild-type to putatively taste-blind mice), methods 
which better compensate for the noise might produce different results. 
 
 Inhibiting the VTA with muscimol decreased the consumption of palatable, 
appetitive, and caloric stimuli. Further, it may have shortened the onset of satiety of 
caloric stimuli. Although little effect was found in the VTA to essentially the same 
stimuli (actually of higher concentrations) in FLI experiments, these behavioral results 
suggest the VTA is necessary for increasing the consumption of foods when they are 
palatable and/or nutritious (i.e., high in calories). The shortened onset of satiety to caloric 
stimuli may reflect a default behavior which occurs when the VTA does not send signals 
that the stimulus is caloric. Interestingly, a study in which the VTA was injected with 
muscimol or the GABAB agonist, baclofen, rats increased their consumption of food 251. 
A few methodological differences that may explain the difference between this and our 
study are the use of rats instead of mice, the provision of essentially palatably-neutral rat 
chow versus more palatable taste solutions in our study, and a shorter access period to the 
stimulus being used for the consumption measurement (4 h vs ~ 30 min, respectively). 
Our methods of injecting the VTA also differed, a factor which likely makes a difference 
in behavioral outcome as was shown in Beier et al. (2015) 202. As opposed to our midline 
injections, Echo et al. (2002) 251 and Khaimova et al. (2004) 252 did intra-VTA injections 
bilaterally which likely inhibited lateral aspects more effectively. Indeed, our TH + FLI 
results support this in that midline nuclei, the CLi and RLi, were the two with significant 
differences. Shimura et al. (2002) 211, who also found increased feeding after injecting the 
benzodiazepine agonist, midazolam, did so systemically with i.p. administration. These 
findings strongly suggest VTA subnuclei differ in responsiveness to taste and caloric 
stimuli and can cause different behaviors based on which are excited/inhibited (i.e., 
medial vs lateral). 
 
 Our findings in context with the ongoing research in the field help fill in the gap 
in understanding the network mediating feeding that exists between the peripheral inputs 
and forebrain. The release of DA in the ventral striatum to sucrose in trpm5 -/- mice was 
shown to be due to caloric post-ingestive feedback (sucralose was used as a control) 246. 
Later, neurons in the insular cortex (IC) was suggested to code post-ingestive information 
about sucrose 292, since IC-lesioned trpm5 -/- mice do not develop preferences for 
sucrose. “Dorsal IC is not necessary for the detection of the postingestive value of 
sucrose” (Oliveira-Maia et al., 2012 292). The differences were explained in their 
 
101 
consumption measurements based on when the measurement was made: pre-
conditioning, conditioning, or post-conditioning. Lesioned mice, like sham mice, drank 
more sucrose than water in the conditioning sessions indicating they were detecting the 
post-ingestive value of sucrose. Since lesioned mice did not make the association of 
sipper tube position with post-ingestive effects of sucrose, dorsal IC must be necessary 
for this function. Moreover, separate circuits at levels higher than the PBN and VTA 
were implicated in the communication of hedonic and nutritional information about sugar 
240. Stimulating D1R expressing ventral striatum (VS) neurons increased sucralose intake 
but not when it is adulterated with bitter denatonium. Stimulating D1R expressing dorsal 
striatum (DS) neurons increased sucralose intake, even when it is adulterated. Stimulating 
D2R expressing neurons had little effect. Activating the VS projection to the VP 
increased sweetener intake, and activating the VP blocked this effect, confirming the VS-
VP projection is GABAergic. Activating the DS projection to the substantia nigra pars 
reticulata (SNpr) also increases sweetener intake, which is not blocked by VP activation, 
but is by SNpr activation. The principle investigator of these studies, Ivan de Araujo, 
makes the argument that reward of foods is not from taste, but from post-ingestive 
effects. He concludes that sweetness is neither necessary nor sufficient for formation of 
memories of energy sources 293. However, the DA system and its mesoaccumbens and 
nigrostriatal pathways have been shown to be connected to centers for both taste and 
feeding; modulation of DA release likely drives urges to consume palatable food and to 
approach its associated cues. Further, while visceral/caloric input may explain long term 
feeding behavior, it cannot explain the short term indulgence in palatable foods to which 
subjects are naïve. Our findings provide evidence of a parallel and proximal pathway 
which may contribute to these short term increases in consumption when novel, palatable 





 The inherent limitation to the use of the expression of the IEG cFos as an 
indicator of neuronal activity is well known 294. FLI can be found in neurons that are not 
found to be activated using electrophysiological measurements. Conversely, it has also 
been shown that c-Fos expression underestimates the actual number of neurons activated 
294,295. Given these limitations, one may wonder why bother to use such a method. In 
response, we argue that, like other activity proxies (e.g., calcium imaging, oxygen in 
fMRI), FLI correlates to neuronal activation more often than not. We accept this 
limitation and agree our measurements are approximations of activation. In fact, i.o. 
stimulation with citrate elicits Fos expression in the same forebrain areas that PET 
identified as active 296. More importantly, the expression of c-Fos itself indicates a 
biological event has occurred within the cell regardless of whether it fired an action 
potential. Therefore, investigating the neurobiological correlates of this cellular event 
may prove to be useful in and of itself. Finally, FLI measurement has the advantage over 
electrophysiology of providing accurate localization of the activity, meaning the two 




 Another limitation specific to this investigation, as opposed to the field at large, 
was the inability to validate the activation of PBN neurons transfected with DREADDs. 
Unfortunately, this failure may reflect our reliance on elevated FLI as the measure chosen 
for validation. This is, however, considered an acceptable means of validation. It is 
possible that electrophysiological recordings in the PBN may have revealed activation of 
neurons after CNO administration. Most regrettably, the negative results found when 
ostensibly activating the PBN-to-VTA circuit remain inconclusive as a direct 






A Feeding CPG 
 
 Additional work will be necessary to help explain how the PBN and VTA fit into 
the larger network of nuclei which control feeding. One nucleus long known to be 
strongly implicated in the control of feeding is the LH. Takashi Yamamoto and Tsuyoshi 
Shimura (2008) 57 indicate the LH as the endpoint for converging circuits modulating 
feeding 297. Anand and Brobeck (1951) 298 found that bilateral destruction of the LH in 
rats caused complete cessation of feeding. Later, Delgado and Anand (1953) 299 
stimulated the LH in cats and saw a 1000% increase in food intake. Taken together, these 
results suggest the LH is both necessary and sufficient in causing feeding. Importantly, 
the LH and other areas also interact with the areas for affect to influence feeding. For 
example, OX and MCH neurons project to NAc, VTA, LC, hippocampus, thalamus, 
AMY, cortex, and various nuclei of the hypothalamus 222-224. Activating LH neurons with 
OX increased reinstatement of reward seeking. Similar results were found when it was 
injected directly into the VTA 300. LH-projecting PBN neurons show increased activity to 
i.o. gustatory stimuli 59. The lateral habenula has inhibitory control over the mesolimbic 
DA system and forms reciprocal connections with the LH and VTA 212,301-303. Thus, 
taking the LH as a “center” for feeding, one could work backward to construct a network 
for feeding that includes taste and reward nuclei such as the PBN and VTA. 
 
 Ultimately, the neurobiology of feeding must prime or cause the motor behavior 
that produces these processes through central pattern generators (see Selverston, 2010 for 
a review of CPGs 304), but many investigators point out multiple neural origins motivate 
behavior, including some with higher cognitive functions. Some feeding behaviors with 
evidence for CPGs include licking, masticating, and swallowing. Basal ganglia and 
substantia nigra pars compacta (SNpc) are involved with serial grooming behavior and 
may also be related to facial expressions used to measure hedonic impact in taste 
reactivity experiments. These findings fit in with a general theory that striatal neurons are 
part of a system mediating the “syntax of sequential motor behavior (action syntax)” 305. 
GC neural states and their transitions were identified (with Hidden Markov Modeling 
[see Miller and Katz, 2010 306]), which predict expel/swallow decisions from 
electromyocardiograms by < 500 ms 307. This state follows an identification state in the 
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ensemble. Future studies could work to discover the roles the PBN and VTA play in these 
overall network behaviors which affect feeding. 
 
 Results of experiments in which the VTA is unilaterally manipulated may indicate 
there is a crossing over in the transmission from the VTA to areas more directly 
responsible for feeding, but our finding that the PBN projections to the VTA are 
contralateral could also feasibly influence this. When one side of the VTA of rats was 
lesioned and the contralateral side stimulated, the increase in Fos expression was 
amplified compared to the increase seen in the unlesioned but unilaterally stimulated 
group 162. Similarly, a shortened latency to eat in the unlesioned, unilaterally stimulated 
group was amplified in the group with a contralateral VTA lesion. Unilaterally lesioned 
rats that received no VTA stimulation showed no changes in Fos or behavior. This 
indicated the lesions had suppressed the inhibition of afferent brain areas to the VTA 162. 
Further, unilateral block of excitatory input via NMDA receptors and current into the 
contralateral VTA led to a shortened feeding latency 254, suggesting at least the feeding 
effect is mediated by glutamate. Taken with our finding that the PBN-to-VTA circuit 
connects contralaterally, the effects of unilateral manipulations could work in part due to 
descending feedback that then crosses over from the pons to the midbrain. 
 
 Two distinct anatomical DA subpopulations in the VTA, especially between 
medial and lateral, may reflect differential functions for various behaviors, including 
feeding. Caudal and rostral lVTA neurons project to the lateral NAcs 83. Dorsolateral 
VTA neurons project to lateral NAcs or dorsal striatum 96. Caudal mVTA neurons project 
to the BLA, as well as the medial NAcs, NAcc, and PFC 83,96. Further, a major distinction 
of inputs to the VTA can be made in terms of where the receiving VTA neuron projects. 
For example, VTA neurons receiving excitatory glutamatergic and cholinergic input from 
LDTg inputs project to the NAcs 143,177, whereas VTA neurons receiving inhibitory 
GABAergic input from the RMTg project to the NAcc and PFC 143,177,308. Additional 
work is needed to determine what, if any, differential these projection patterns contribute 
to feeding behaviors. 
 
 
Learning in Feeding and Synaptic Adaptation 
 
 Three types of taste learning are attenuation of neophobia, CTA, and conditioned 
taste preference 57,309. Animals are initially conservative about how much of a novel 
tasting stimulus they will consume, hence the term “neophobia.” It is thought this 
behavior reduces any deleterious effects of a possibly toxic, unknown substance. After 
exposure to the substance and pending agreeable post-ingestive effects, the animal will 
consume the substance more readily. This is known as attenuation of neophobia. CTA, 
originally discovered by John Garcia (1955) 310, occurs when a novel substance is 
consumed that evokes gastrointestinal malaise 43,311,312 After which, the animal avoids the 
consumption of that substance and others that taste similar. Conditioned taste preference 
may occur if an animal associates positive experiences after ingesting something with an 




 Activation of the el-CeAlc projection also induces CTA 72. Evidence from CTA 
studies suggest the displeasure of taste may be mediated via the CeA and PBN. Despite 
the work by Richard Palmiter and colleagues, Yamamoto and Shimura suggest the BLA 
may be more important than the CeA in acquisition and retention of CTA 57,66,297,317. 
However, lesioning the BLA may cause a loss of neophobia rather than loss of CTA 43. 
Lesioning the CeA, but not the BLA prevents CTA development 318. Still, it is known that 
the PBN projects to the BLA, possibly giving this nucleus an indirect role in CTA. 
Lesions of the PBN prevents the acquisition of CTA, predicted to be due to a reduced or 
abolished perception of illness US 43,319-322. Lesioning of the m is assumed to prevent 
integration of the neural representations of the US and CS because none of the other four 
stages of CTA development are disrupted 43,321,323. Since neurotoxic DA lesions leave 
evidence that mechanisms for CTA development remain intact 17,144, phasic DA 
responses may not be necessary for displeasure to taste to occur. Instead, recent work 
suggests displeasure of taste may be mediated via GABA. Systemic baclofen, a GABAB 
agonist, had no effect on the expression of conditioned flavor preference, but reduced its 
acquisition 324. It also enhanced the acquisition of conditioned flavor aversion. 
 
 Synaptic adaptations in VTA neurons accompany functional and behavioral 
changes seen with regards to DA release and reward-seeking and could play an important 
role in learning about taste and food stimuli and their cues. Depending on whether the 
stimulus is stress, drugs, or some other motivational stimulus, DA release is evoked in 
anatomically and functionally different DA cell subpopulations. Such variation in 
synaptic adaptations are suggested by differences Maria De Luca and colleagues have 
found in forebrain DA release to food versus drugs 239. Habituation of DA release to food 
rewards occurs in the NAcs, but not in mPFC and NAcc. Chronic, but not acute 
morphine, can sensitize the NAcs so that habituation of DA release to food reward no 
longer occurs. This may mean that although food itself cannot cause “food addiction” via 
sensitizing the DA system, the prior use of some addictive substances can. Synaptic 
adaptations are largely known to be mediated via glutamatergic input. Activating post-
synaptic NMDA receptors leads to bursts of action potentials in VTA DA neurons 83,325. 
Synaptic adaptations in the VTA are well-known to be affected by various addictive 
drugs 326. Among the most important neural circuit modifications that contribute to 
development of addiction are changes in the properties of excitatory synapses on 
midbrain VTA DA neurons 83,326. For example, drugs of abuse induce potentiation of α-
amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor-mediated 
synaptic transmission in VTA DA neurons 83. Various LTDs and LTPs are produced in 
VTA. Since the PBN projection to the VTA is glutamatergic, it contributes an excitatory 
potential and could have strong learning effects up to those resembling addiction to food 
taste. At the least, it seems likely that synaptic adaptations in the VTA affect the changes 
in DA release De Luca found and could in turn mediate learning long-term, taste-feeding 
contingencies. 
 
 Additional functional anatomical investigation has begun to tease apart the 
interaction of the DA system with the two hedonic dimensions of affect (i.e., pleasure and 
displeasure) 177. The circuits from the laterodorsal tegmentum to DAergic VTA to NAcs 
are for reward (e.g., activation mediated conditioned place preference [CPP]). The 
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circuits from the lateral habenula to DAergic VTA to mPFC are for aversion (e.g., 
activation mediated conditioned place aversion [CPA]). Therefore, it seems plausible 
these two sets of circuits could play similar roles in the development of conditioned 
preferences and aversions of tastes, respectively. The lateral habenula also forms 
GABAergic projections to the RMTg. D1 antagonists to the mPFC prevented CPA 
development. D1 and D2 antagonists to the lateral NAcs prevented CPP development. 
This suggests a plausible neurobiological substrate for how the mesocorticolimbic DA 
system could produce urge generally, leaving the determination of behavioral 
directionality to the involvement of polarized systems. Another mechanism at work for 
the interaction between displeasure and urge may be GABA agonists or glutamate 
antagonists in the caudal NAcs leading to inhibition of GABAergic medium spiny 
neurons which disinhibit neurons in LH, VP, or VTA 210,327-333. Future work should 
attempt to determine what roles these circuits for affect play in development of taste 





 Overall, this project has confirmed that both the PBN and VTA function to 
communicate taste and reward information. Although its function remained elusive, the 
evidence of the direct path from the PBN to the VTA was fortified. Further, to our 
knowledge, this was the first time evidence has been found of its existence as a mostly 
separate pathway from the thalamic pathway. Combined with the knowledge of this 
circuit, the activity in these nuclei and the ability to affect consumption by inhibiting the 
VTA suggest the PBN and VTA work together to influence feeding by detecting and 
integrating information about palatability and calories. Future work will be able to 
identify the precise functions of this circuit as well as those of the more indirect 
connections of the PBN to the VTA. 
 
 We have made strides since Pavlov and Thorndike began explaining conditioning, 
processes that include some we use to learn to consume savory and satiating foods. After 
Olds and Milner came Schultz, then Berridge, further enlightening us to the basic neural 
mechanisms underlying our tendency to reward ourselves. We can now thank Lammel, 
De Luca, de Araujo, Palmiter, and others for continuing to elucidate the network 
underlying taste-mediated feeding, including how it responds to stimuli from either end 
of the valence spectrum. Finally, the evidence discovered from experiments described in 
this dissertation added a few more dots which may be connected to the theoretical whole 
that explains how an electrically-connected, cellular network generates the complex 
output of self-nourishment.  
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